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1. Introduction 
1.1 Development of the murine nervous system 
Early during the embryonic life of the mouse, the neural plate starts to form at 
about 7.25 to 8 days post conception (dpc) from the embryonic ectoderm layer. 
Within a few days, the neural plate starts to fold and the neural groove deepens as 
seen in figure 1A. The two neural folds become elevated until gradually meeting 
each other at the middle point of the embryo back (figure 1B & C). By the time, it 
continues to close in both directions, cranially and caudally, to form the neural tube 
(figure 1D & E).  
.  
Figure 1: Formation of the neural tube. A-D neural tube in cross view. Early in the 
development, the notochord (A) induces the ectoderm cells to become the primitive 
nervous system (i.e., neuroepithelium). The neuroepithelium wrinkles and folds over (B).                                                                 
The tips of the folds fuse together and a hollow tube (the neural tube) forms (C). The 
ectoderm and endoderm continue to curve around and fuse to create the body cavity 
transforming the embryo from a flattened disk to a three-dimensional body. Cells 
originating from the fused tips of the neuroectoderm (neural crest cells) migrate to various 
locations throughout the embryo to initiate the diverse body structures (D, Goodlett and 
Horn, 2001). (E) Chick embryo of thirty-three hours incubation, viewed from the dorsal 
aspect (Grey’s anatomy).  
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The formed neural tube is the embryo’s precursor of the central nervous system 
(CNS) which consists of the brain and the spinal cord. CNS can be divided into 
four subdivisions; prosencephalon (fore-brain precursor), mesencephalon 
(midbrain precursor), rhombencephalon (hindbrain precursor) and the spinal cord. 
As soon as the cranial part of the neural tube folds to form the brain, neurogenesis 
begins in the different parts with slight differences in the onset, peak and end. 
Neurogenesis is a process that includes cell division, migration and differentiation. 
These three steps are critical and universal steps in the formation of the complex 
structure of the nervous system.  
Neurogenesis in the neocortex commences when some progenitor cells divide 
asymmetrically generating postmitotic neurons that migrate away from the 
ventricular zone (VZ) towards the outer edge of the cortical wall along the basal 
fiber of the radial glial cells (Rakic, 1978; Goffinet, 1984). Neocortical development 
begins with the appearance of the preplate (PP) above the ventricular zone 
(Figure 2). The preplate is the earliest cortical layer generated by postmitotic cells 
migrating from the VZ (Luskin and Shatz, 1985; Marin-Padilla, 1998; Rickmann, et 
al., 1977; Uylings, et al., 1990; Bayer and Altman, 1991) and is composed of 
subcortical afferents and two populations of postmitotic neurons, the Cajal-Retzius 
(CR) cells and the subplate (SP) neurons (Marin-Padilla 1998; Super, et al., 1998). 
The PP becomes soon divided into the superficial, cell-sparse, marginal zone (MZ) 
and the deeper SP by the invasion of successive waves of neurons produced from 
the VZ (Marin-Padilla, 1971, Luskin and shatz, 1985, Caviness, 1982; Caviness, et 
al., 1995; Sheppard and Pearlman, 1997). CR cells are among the earliest 
neurons to be generated in the mammalian neocortex, where they occupy 
positions near the pial surface on the superficial aspect of the brain (Meyer & 
Goffinet 1998, König, et al 1977). The next phase of development occurs when the 
cortical plate (CP) neurons exit the cell cycle near the ventricular surface and 
invade the PP. Migrating neurons move past the SP, displacing this layer away 
from the CR cells, which remain adjacent to the pial surface in the MZ. As new 
cortical plate neurons arrive travelling along the radial glia, they migrate past the 
older SP and cortical plate neurons before inserting directly beneath CR cells. The 
systematic migration of younger neurons past their predecessors results in the 
“inside-out” pattern of development, in which the cortical plate (future Layers II-VI) 
develops between the MZ (future Layer I) and the SP.
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Figure 2: A simplified view of corticogenesis of the developing cerebral wall in 
mammals. (A) Corticogenesis in mammals begins with the appearance of the preplate 
(pp), which is located directly above the proliferating cells in the ventricular zone (vz) and 
contains Cajal-Retzius neurons (CR) and subplate (SP) neurons, among others. Cells 
destined for the cortical plate are generated near the ventricular zone and the first wave of 
cortical plate (CP) cells (gray) migrates past the subplate and stops beneath the Cajal-
Retzius cells in the marginal zone (mz). Successively generated waves (gray to white) of 
cells migrate past their predecessors and stop beneath the Cajal-Retzius cells. (B) By E16.5 
in the mouse, young cortical plate neurons are positioned above the older neurons except 
Cajal-Retzius cells. 
Migrating neurons are arranged in six distinct layers as they migrate towards the 
pial surface and occupy their final positions. These young migrating neurons are 
guided through the SP mainly by a glycoprotein named reelin which is produced 
by CR cells in the MZ. Reelin is also responsible for the formation of the 
characteristic “inside first, outside last” cortical laminar structure of layers II-VI 
(D'Arcangelo, et al., 1995; Rice and Curran, 2001). These layers were identified in 
the developed cortex by Karbinian Brodmann and they can be described as 
follows: 
1. The molecular layer (I), the outermost layer which contains few neurons and 
consists mainly of extensions of apical dendrites and horizontally-oriented 
axons. 
2. The external granular layer (II), which contains small pyramidal neurons and 
numerous stellate neurons 
3. The external pyramidal layer (III), which contains predominantly small and 
medium-size pyramidal neurons as well as non-pyramidal neurons with 
vertically-oriented intracortical axons. 
A B 
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4. The internal granular layer (IV), which contains different types of pyramidal 
and stellate neurons. 
5. The internal pyramidal layer (V), which contains large pyramidal neurons. 
6. The multiform layer (VI), which contains few large pyramidal neurons and 
many small spindle-like pyramidal and multiform neurons (Brodmann, 1909).  
The different cortical layers start neurogensis at consequent -mostly overlapping- 
days starting from the older deeper layer (layer VI) reaching the more superficial, 
younger layers (layer II/III) as shown in the table below. 
Table 1: Timing of neurogenesis stages of the different cortical layers. A timetable that 
shows the approximate embryonic days on which neurogenesis starts, peaks and ends in 
the different cortical layers of mouse embryo (Ashwell, et al., 1996; Dunlop, et al., 1997; 
Finlay and Darlington, 1995; Robinson and Dreher, 1990).  
Neurogenesis 
stage 
Cortical layer VI Cortical layer V Cortical layer IV Cortical layer II/III 
Start (in dpc) 11.4 12.8 14.4 15.2 
Peak (in dpc) 13 14.2 15.5 16.9 
End (in dpc) 14.3 15.3 17.1 18.3 
Shortly after neurogenesis reaches its end, differentiation starts to take first place 
in the deeper layers (about 18.5 to 19 dpc in layer V, Finlay and Darlington, 1995) 
and continues for some time after birth. It was believed earlier that neurogenesis 
and differentiation of neurons totally ceases in adulthood and no more mitotic or 
differentiating cells could be found in mature nervous system. Interestingly, recent 
researches have shown that this hypothesis does not apply for all brain structures. 
It could be observed that some brain structures continue to undergo neurogenesis 
in the adult mammalian brain. This phenomenon known as adult neurogenesis has 
been shown to take place in many mammalian species like rat, rabbit, cow and 
mouse (Wyss and Sripanidkulchai, 1985;  Gueneau, et al., 1982; Kempermann, et 
al., 1997). Examples for brain structures showing adult neurogenesis and/or 
differentiation are the lateral subventricular and subgranular zones of the dentate 
gyrus which produce stem cells that migrate and differentiate in the olfactory bulb 
(Cameron and McKay, 2001). In addition, multipotent stem cells capable of adult 
neurogenesis were detected in the cereberal cortex, optic nerve, spinal cord, and 
many brain stem and forebrain structures (Van Praag, et al., 2002). These neural 
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stem cells derived from adult brains can be propagated in vitro using a variety of 
cytokines, neurotrophins, and conditioned media to give rise to neurons or glia 
(Gensburger, et al., 1987; Arsenijvic and Weiss, 1998; Ahmed, et al., 1995; 
Richards, et al., 1992; Reynolds and Weiss, 1992; Lois and Alvarez Buylla, 1993; 
Johansson, et al., 1999;  Doetsch, et al., 1999; Vescovi, et al., 1993; Kilpatrick and 
Bartlett, 1995; Gage, et al., 1995; Palmer, et al., 1997). However reported to exist 
since over three decades, the functional roles of the new cells produced by adult 
neurogenesis process are still largely under investigation. Knowing that 
hippocampus is important for some forms of learning and memory and related 
mechanisms of neural plasticity had directed the research to focus on finding a 
relationship between adult neurogenesis and memory function.  
1.2 Extracellular matrix 
Differentiation and morphogenesis of neural tissue involve a diversity of potentially 
important interactions between neural cells and their environment known as the 
extracellular matrix (ECM). ECM can be defined as a complex association of 
different macromolecules whose structure and function are critical for maintaining 
normal tissue architecture. It can be divided into interstitial matrix which exists in 
the intercellular spaces (among the cells) and basement membranes which are 
sheet-like depositions of ECM on which various epithelial cells rest (Kumar, et al., 
2004). Molecular components of ECM are classified into proteoglycans like 
heparan-, chondroitin- and keratan sulafate and non-proteoglycans like hyaluronic 
acid, elastin, collagen, fibronectin, laminin, tenascins and thrombospondin 
molecules. Proteoglycan molecules together with hyaluronic acid  in ECM form a 
highly hydrated, gel-like “ground substance” that resists compressive forces on the 
matrix while permitting the rapid diffusion of nutrients, metabolites, hormones and 
growth factors between the blood and the tissue cells. 
Many of these components were originally discovered in non neuronal tissues but 
were later discovered in developing neural tissues (e.g. fibronectin, laminin, 
vitronectin, collagens, and thrombospondin) (Reichardt and Tomaselli, 1991). 
Some others like S-laminin and agrin were originally discovered in the neural 
tissues which exist in the basement membrane of neuromuscular junctions (Reist, 
et al., 1987; Hunter, et al., 1989a & b) and F-spondin which is expressed in the 
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spinal cord floor plate (Klar, et al., 1992). Early during develpoment when neural 
progenitors differentiate and migrate and neuronal axons elonagte, abundant ECM 
is present in the CNS. But by the end of development, the expression of ECM 
elements is substantially reduced. ECM in the developing neural tissues functions 
not only as a scaffold for cellular support but also as an immediate 
microenvironment. The interaction of cells with this microenvironment can trigger 
regulatory signals that influence cell proliferation, migration, and fate decision. 
These signals can directly regulate cells locomotory activity like polymerization of 
cytoskeletal components that promote extension and adhesion of lamellipodia and 
filopodia. In addition, these signals may also act directly on cell nuclei to alter gene 
expression of proteins involved in neuronal migration and morphogenesis 
(Letourneau, et al., 1994; Lathia, et al., 2007). Laminins generally function as 
potent stimulators of cell growth, migration, axon- and neurite outgrowth and 
myelination in addition to important roles in axonal sorting of peripheral nerves 
(Yu, et al., 2009; Yu, et al., 2005; Yang, et al., 2005; Cohen, et al., 1986). Laminin-
1 as a member of the laminin family is a fibrous glycoprotein member of laminin 
family proteins and is found in the basement membranes of the nervous tissue 
(Timpl and Brown, 1996; Yurchenco, 1994; Yurchenco and O’Rear, 1994). It is 
expressed very early during embryogenesis and becomes largely absent in adult 
tissues and was shown to promote cell survival, increase proliferation and 
maintain differentiation state (Dziadek and Timpl, 1985; Shim et al., 1996; Smyth 
et al., 1999; Thorsteinsdottir, 1992; Wu, et al., 1983). Another molecule is 
tenascin, which is implicated in neural crest and cerebellar granule cell migration 
and in promoting neuroblastoma cell migration (Tan, et al., 1987; Bronner-Fraser, 
1988; Mackie, et al., 1988; Stern, et al., 1989; Halfter, et al., 1989; Husmann, et 
al., 1992). This glycoprotein is also reported to exert a neurite guidance and 
outgrowth promoting effect when used as a homogenous substrate for culturing 
neurons in vitro (Joester and Faissner, 2001; Gotz, et al., 1996; Lochter, et al., 
1991; Wehrle and Chiquet, 1990; Husmann, et al., 1992).  
A further example is a basement membrane-associated protein detected first in 
non neuronal tissues and is known as heparin-binding growth-associated molecule
(HB-GAM, Mitsiadis, et al., 1995). In addition to its known neuronal survival and 
angiogenic effects (Hida, et al., 2003; Laaroubi, et al., 1994), HB-GAM in its 
substrate bound form shows a neurite outgrowth promoting effect on rat cerebral 
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neurons and is involved in neuronal maintainance and differentiation (Raulo, et al., 
1992; Kuo, et al., 1990; Li, et al., 1990; Rauvala, 1989; Bradshaw, et al., 1993). In 
1996, Kinnunen and coworkers were able to link this neurite outgrowth promoting 
effect of substrate bound HB-GAM to a specific interaction between the matrix 
bound protein and heparin like, highly sulfated regions of heparan sulphate chains 
at the cell surface (Kinnunen, et al., 1996). It was shown earlier that these cell 
surface proteoglycans including heparin/heparan-, chondroitin- and keratan 
sulafate act as cell-surface receptors or co-receptors for growth factors and 
molecules that mediate cell-to-ECM and cell-to-cell interactions (Rouslahti and 
Yamaguchi, 1991; Bernfield, et al., 1992; Lander, 1993;  Lindahl, et al., 1994; 
Letourneau, et al., 1994; Jalkanen, et al., 1993; Yanagishita and Hascall, 1992).  
There are also some of the ECM components that can exist as cell surface 
components where they bind the cell surface with a membrane anchor and are 
released or secreted into the ECM e.g. the neural cell adhesion molecule (N-CAM) 
(Sonderregger and Rathjen, 1992; Letourneau, et al., 1994). This protein exists as 
a cell surface adhesion component and is associated with ECM components. In 
addition, it also exists extracellularly in the cerebrospinal fluid. Concerning its 
functions, N-CAM was shown to exert a neurite outgrowth promoting effect on 
different kinds of neurons in vitro (He, et al., 1987; Doherty and Walsh, 1991).  
All these examples reflect the importance of ECM bound components during the 
different developmental stages of the nervous system. Collectively, many ECM 
adhesion proteins in addition to some neurotrophic factors like nerve growth factor 
(NGF) and FGF-1 & -2 are characterized by playing a central role in neural 
development and by promoting neurite outgrowth. In the same time these 
molecules are identified to exert a multitude of influences on cell activities 
including adherence, spreading, migration, proliferation and differentiation (Ross, 
et al., 1991; Gospodarowics, et al., 1987; Attiah, et al., 2003). 
1.3 Growth factors, cytokines and neurotrophic factors 
1.3.1 Nomenclature  
Growth factors and cytokines are proteins that control cell growth and proliferation 
by binding specific membrane receptors. This ligand-receptor interaction triggers a 
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cascade of intracellular biochemical signals resulting in the activation of 
transcription factors and hence the activation or repression of various subsets of 
genes (Aaronson, et al., 1990). Many growth factors stimulate cell proliferation in 
different kinds of cells but some others are specific for a particular cell-type. 
According to their structure and mode of action, growth factors can be divided into 
different super families as shown in the table below.  
Table 2: Examples of the super families of growth factors (McKay and Leigh, 1993). 
                 Super families                           Examples 
1-Large peptide factors Transforming growth factor (TGF-β) 
Platelet-derived growth factor (PDGF)  
Epidermal growth factor (EGF) 
Fibroblast growth factor (FGF) 
Insulin-like growth factor (IGF) 
Tumor necrosis factor (TNF) 
Interleukin 6 (IL-6) 
Nerve growth factor (NGF) 
2-Individual large peptide factors  Glial growth factor (GGF) 
Hepatocyte growth factor (HGF) 
Interferon alpha (IFN-α) 
Macrophage colony stimulating factor (M-CSF) 
Interleukin 2 (IL-2) 
3-Small peptide factors  Bombesin 
Ranatensin 
Neuromedin B (NMB) 
Gastrin related peptide (GRP) 
Adrenocorticotrophic hormone (ACTH) 
Alpha-melanocyte stimulating hormone (α-MSH) 
4-Individual small peptide factors  Angiotensin II 
Bradykinin 
Vasopressin 
Oxytocin 
Thrombin 
Gastrin 
5-Commonly used non-peptide    
growth factors  
Androgens 
Growth factors were shown to exert their action through different modes including 
an autocrine and a paracrine mode of action. In the former mode the growth factor 
stimulates the cell that releases it and in the latter it stimulates an adjacent or a 
nearby cell as identified by Sporn and Todaro (Sporn and Todaro, 1980). Also an  
earlier known mode of action was the endocrine mode by which hormones are 
acting. In addition to these modes there is a condition in which some growth 
factors can be produced inside the cell and exert observable effects but are not 
secreted outside, what is known by the intracrine mode of action (Logan, 1990).  
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1.3.2 Roles of growth factors 
1.3.2.1 General roles 
Roles of growth factors are not restricted to growth and tissue formation or cell 
proliferation. During development, they provide important extracellular signals to 
regulate proliferation and determine the fate of stem and progenitor cells in CNS 
(Calof, 1995). For example, glial growth factor -2 (GGF-2; Marchionni, et al., 1993) 
can act on early neural crest cells to direct their commitment to a glial rather than a 
neuronal pathway of differentiation (Shah, et al., 1994). In contrast, other factors 
like fibroblast growth factors do not determine the cell fate of early neural 
progenitors during vertebrate neurogenesis, but rather they regulate the number of 
cell divisions a precursor cell undergoes. In olfactory epithelium cultures, many 
FGFs (FGF-1, -2, -4 and -7) were shown to prolong neurogenesis of immediate 
neuronal precursors shortly mentioned as INPs (DeHamer, et al., 1994). This 
effect is mostly achieved by repressing the terminal differentiation of the cells in 
G1 stage and permitting an extended proliferation of INPs progenitors (Clegg, et 
al., 1987; DeHamer, et al., 1994). This proliferation stimulating effect of FGFs was 
reported to be widespread in the brain. It was detected in a number of regions 
including E10 telencephlon (Murphy, et al., 1990; Kilpatrick and Bartlett, 1995), 
cerebral cortex (Gensburger, et al., 1987), corpus striatum (Cattaneo and McKay, 
1990; Vescovi, et al., 1993), hippocampus (Ray, et al., 1993) and retina (Lillien 
and Cepko, 1992).  
1.3.2.2 Neuron-related roles 
In addition to the previously reported roles, growth factors can apparently regulate 
the survival of neuronal precursor cells at particular stages of differentiation. A 
popular example for growth factors exerting such an effect is the nerve growth 
factor (NGF). NGF has been long known as a survival factor for post mitotic 
sympathetic neurons (Korsching, 1993) that acts by signalling through tyrosine 
kinase A (trkA) receptors (Birren, et al., 1993, DiCicco-Bloom, et al., 1993). Roles 
include stimulation of proliferation and promotion of neuronal cells survival which 
are now reported for many other factors that are collectively termed neurotrophic 
factors.  
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Neurotrophic factors are defined as polypeptides that support growth, 
differentiation and survival of neurons in the developing nervous system and 
maintain neurons in the mature nervous system (Longo, et al., 1993, Bothwell, 
1995). Recent data support the view that some neurotrophic factors may also be 
involved in the modification of neuronal connections in the developing brain 
(Thoenen, 1995). These molecules exert their effects by binding to and activating 
specific cell surface receptors. Activated receptors initiate a cascade of 
intracellular events, which ultimately induce gene expression and modify neuronal 
morphology and function. The following table gives a summary of some 
neurotrophic factors’ families and their signalling receptors (Yuen, et al., 1996). 
Table 3: Some neurotrophic factors families and representative examples of each family 
(Yuen, et al., 1996).  
Family member receptor 
Neurotrophins Nerve growth factor (NGF)  
Brain-derived neurotrophic factor 
(BDNF)  
Neurotrophin-3 (NT-3)  
Neurotrophin-4/5 (NT-4/5)  
TrkA 
TrkB 
TrkC, less to TrkA and TrkB 
TrkB 
Neuropoietins Ciliary neurotrophic factor (CNTF)  
Leukemia inhibitory factor (LIF or 
CDF/LIF) 
CNTF receptor complex 
(CNTFRα, gp130,LIFRβ
subunits) 
LIF receptor complex (gp130, 
LIFRβ subunits) 
Insulin-like 
growth factors 
Insulin-like growth factor-I (IGF-I)  
Insulin-like growth factor-II (IGF-II) 
IGF Type I receptor (IGF1R), 
less to insulin receptor (IR) 
IGF1R, less to IR 
Transforming 
growth  
factor beta 
Transforming growth factor b (TGFb1, 
TGFb2, TGFb3) 
Glial cell line-derived neurotrophic factor 
(GDNF) 
TGFb type I, II and III 
receptors 
Unknown 
Fibroblast 
growth factors 
Acidic fibroblast growth factor (aFGF or 
FGF-1)  
Basic fibroblast growth factor (bFGF or 
FGF-2)  
Fibroblast growth factor-5 (FGF-5) 
FGF receptors 1–4 (FGFR-1–
4) 
FGFR-1–3 
FGFR-1, FGFR-2 
Other growth 
factors 
Transforming growth factor alpha (TGF-
a)  
Platelet-derived growth factor 
(PDGF: AA, AB and BB isoforms)  
Stem cell factor (mast cell growth factor)
EGFR 
PDGFα- and β-receptors 
c-kit 
Neurotrophins, a four-member family of neurotrophic factors, have been shown to 
protect against neuronal dysfunction and death in animal models of injury and 
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neurological disease (Yuen and Mobley, 1995). This role raised the exciting 
possibility that neurotrophins may act to protect neurons in diseased as well as 
normal neurons. It was an important step in neurosciences to realize that 
neurotrophic factors play important roles in the adult nervous system as well as 
during development (Barde, 1990; Lu and Figurov, 1997; Chao, 2000). The 
expression of these factors is usually very high during early development which is 
a time of substantial growth, differentiation, and modelling of the nervous system. 
In later stages, the levels of neurotrophic factors generally drop but they do not 
subside completely. In fact, in most cases in which it has been explored, the 
continued presence of these factors is substantial and is critical throughout 
adulthood (Maisonpierre, et al., 1990; Friedman, et al., 1991; Timmusk, et 
al.,1993). Neurotrophic families, particularly the NGF family, have been 
extensively studied for their effects on neurodegenerative diseases of both central 
and peripheral nervous system like Parkinson’s, Alzheimer’s, Huntington’s and 
memory disorders as well as diabetic peripheral neuropathy, chemotherapy 
induced neurotoxicity and amyotrophic lateral sclerosis (Date, et al., 1997; O’Neill, 
2001; Haque and Isacson, 2000; Brewster, et al., 1994; Gao, et al., 1995; Yah, et 
al., 1994; Mitsumoto, et al., 1994). 
1.3.3 Hepatoma-derived growth factor and its related proteins  
1.3.3.1 Family-member overview 
Hepatoma derived growth factor (HDGF) and HDGF related proteins (HRPs) 
represent a polypeptide family of growth factors consisting of six members 
belonging to different subgroups according to their length and isoelectric points 
(Dietz, et al., 2002). According to the classification described before in table 2, 
HDGF family members can be classified as individual large peptide factors. Five 
HDGF homologous proteins have been identified up to now (Dietz, et al., 2002; 
Izumoto, et al., 1997; Ikegame, et al., 1999), four of them have been termed HRP-
1 to -4 (HDGF Related Proteins 1 to 4) and the fifth was termed p52/75 or LEDGF 
(Lens Epithelium-Derived Growth Factor). HDGF was the first member of this 
family to be identified. Although its sequence lacks a secretory leader sequence, 
HDGF was first isolated from the conditioned media of HuH-7 cells (Nakamura, et 
al., 1994; Ge, et al., 1998; Ikegame, et al., 1999; Izumoto, et al., 1997). HDGF and 
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its homologues display between 80% and 92% sequence identity among the 91 N-
terminal amino acids. Because of this similarity the amino-terminal region has 
been termed Homologue to Amino Terminus of HDGF or shortly HATH region
(Izumoto, et al., 1997). On the other hand, all the family members have no 
homology in the amino acid sequence of their specific C-terminal regions. All of 
HDGF family members show a putative nuclear localizing signal (NLS) in their self-
specific regions in addition to another NLS that is found in the HATH region 
(Nakamura, et al., 1994; Izumoto, et al., 1997; Ikegame, et al., 1999; Ge, et al., 
1998). For HDGF, this putative bipartite NLS in the self-specific region is 
responsible for its nuclear targeting. Any substitution of a single basic residue 
(lysine) in this region is sufficient to disturb nuclear targeting of HDGF.  
Up to now, not much is known about the function(s) of the different members of  
HDGF family. Nearly most studies addressed HDGF suggesting that it plays a role 
in renal vascular development (Oliver and Al-Awqati, 1998) and vascular lesion 
formation (Everett, et al., 2000; Nakamura, et al., 1989). Extracellular HDGF was 
shown to signal through signal transduction pathways from the cell surface 
(Everett, et al., 2004, Abouzied, et al., 2005) and to act as a mitogenic factor that 
promotes proliferation of fibroblasts and HuH-7 cells (Nakamura, et al., 1989), 
endothelial cells (Oliver and Al-Awqati, 1998) and smooth muscle cells (Everett, et 
al., 2000). It was also shown that the nuclear localization is a prerequisite for the 
mitogenic activity of intracellular HDGF (Kishima, et al., 2002; Everett, 2001). 
These effects suggest that HDGF may be involved in tissue damage response 
(Marubuchi, et al., 2006).  
It has also been speculated that HDGF plays a role in renal, liver, lung and heart 
development (Oliver and Al-Awqati, 1998; Cilley, et al., 2000; Enomoto, et al., 
2002; Everett, 2001). In addition, a growing number of studies reported a possible 
role of this growth factor in the development of different types of cancers (Okuda, 
et al., 2003; Huang, et al., 2004; Bernard, et al., 2003; Hu, et al., 2003). Recently, 
some research groups were able to detect a role for exogenously supplied HDGF 
as a neurotrophic factor for hippocampal as well as motor neurons (Zhou, et al., 
2004; Marubuchi, et al., 2006) when no mitogenic effect on post-mitotic neurons 
can be expected.  
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For the other members of HDGF family, very little -other than their growth factor 
activity- is known about their functions. HRP-1 was speculated to play a role in 
spermatogenesis (Kuroda, et al., 1999). LEDGF has been shown to function as a 
transcriptional activator that binds to and potentiates the activity of HIV integrase 
(Maertens, et al., 2003; Llano, et al., 2004; Cherepanov, et al., 2003 & 2004). This 
potentiation of HIV integrase activity has also been shown for HRP-2 
(Cherepanov, et al., 2004). 
1.3.3.2 Hepatoma-derived growth factor related protein –3 
Hepatoma derived growth factor related protein -3 (HRP-3) is a member of 
HDGF family of growth factors identified in 1999 by computer-aided expression 
sequence tag (EST) search for the homology to the HATH region (Ikegame, et al., 
1999). In addition to the NLS identified within the highly conserved HATH region in 
all family members, the deduced amino acid sequence for HRP-3 shows a putative 
bipartite nuclear localizing signal (NLS) sequence in its self-specific region in a 
similar location to that of HDGF and HRP-1 (Nakamura, et al., 1994; Izumoto, et 
al., 1997). By northern blot analysis, western blot analysis and 
immunohistochemistry, HRP-3 expression was shown to be restricted mainly to 
the central nervous system tissues and to a very low extent in the testis (Ikegame, 
et al., 1999; Abouzied, et al., 2004). In contrast to the other family members, no 
functional data other than the growth stimulating activity reported by Ikegame and 
co-workers is known for HRP-3. 
1.4 Aim of work 
This work aimed to investigate the tissue distribution of a not widely studied 
member of the HDGF related protein family, HRP-3, both in embryonic and adult 
mice nervous tissue by using immunohistochemistry. It was also of great interest 
to uncover the possible intracellular roles that HRP-3 could play in the nervous 
system. The role(s) of HRP-3 were investigated in different cellular models 
including neuronal primary and clonal cell models. This was achieved by utilizing 
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various experimental procedures including over-expression and down-regulation of 
the intrinsic protein level within the cells. Due to its unique characters discovered 
here including tissue distribution and intracellular roles, also the extracellular roles 
as a trophic factor and a substrate-bound neurite outgrowth promoting factor were 
investigated in primary mouse cortical neuron model.    
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2. Materials  
2.1 Instruments 
CO2 water jacketed incubator                 Forma Scientifics  
Water bath                                         1083 GFL 
Sterile bench                                      BDK 
Light microscope                                     TELAVAL 31 ZEISS 
Fluorescent microscope                          ZEISS 
Confocal laser microscope                       ZEISS 
Spectrophotometer DU 640 Beckman 
Centrifuge     5415C 
Labofuge 400e 
 Z233 MK                                                           
Eppendorf 
Eppendorf 
Hermle
Vibratome                                           Leica 
Digital pH meter Blue Line electrode SCHOTT 
Heating block  STAR LAB 
Microwave oven                                     Micro chef 3310 Moulinex  
Magnet stirrer                                     RCT Ikamag 
Ice maker                                          Ziegra 
Refrigerator  AEG 
Vortex device                                      Reox Top Heidolph  
Digital balance                                    CP 124S-OCE Sartorius balance 
Cold centrifuge                                    5810 R Eppendorf 
UV lamp                                            FAUS NU 6 KL 
Electrophoresis device electrophoresis power supply 
301 
Amersham 
Platform shaker                                    Rotamix 120 Heidolph 
PCR analyser                                       T3 thermocycler Biometra 
Sequencer   genetic analyser 310 ABI prism 
Protein electrophoresis cell Protean BioRad  
Semi dry blotting cell Trans-blot SD BioRad 
Magnetic plate  MaTRA 
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2.2 Equipments 
Cell culture dish                6 and 10 cm Φ    Falcon 
Cell culture T-flask 75 cm2 Falcon 
Cell culture plate 6 and 24 well Falcon 
Plastic tubes 15 and 50 ml Falcon 
Reaction mini tubes 0.5, 1.5 and 2.0 ml Eppendorf  
Freezing cryo-vials 2.0 ml Greiner  
Sterile filter 0.2 and 0.45 µm Sarstedt  
Disposable syringes         1, 2, 5 and 20 ml B. Braun 
Glass pipette                     5, 10 and 25 ml               Schott  
Glass Histobond slides 76*26 mm Marinefeld  
Pasteur pipettes 15 and 20 cm Brand  
Glass flasks 50, 100, 250, 400ml         Schott  
Filter paper            595 ½ Schleicher & Schuell 
Centriplus columns YM-30 KMWCO                                Amicon
X-rays films Fuji Medical X-Ray Film 
Nitrocellulose Transfer Membrane Schleicher & Schuell 
Hemocytometer Neubauer 
2.3 Reagents 
2.3.1 Chemicals 
Reagent  Supplier  
Agarose    
ABTS   
Alamar blue®
Avidin-Biotin complex kit (AB complex)                    
Bacto tryptone 
Bacto yeast extract 
β-mercaptoethanol 
BioRad DC protein assay kit 
Bovine serum albumin (BSA)  
Bromophenol blue 
Calcium chloride                                     
Crystal violet 
Gibco BRL 
Roche 
AbD serotec 
Vector 
DIFCO microbiology 
DIFCO microbiology 
Sigma  
BioRad 
Sigma 
Sigma  
Merck 
Sigma  
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DAB (diaminobenzidine HCl)                                   
DABCO (1,4-diazabicyclo(2,2,2)octan)
DAPI (4,6-diamidino-2-phenylindole)                       
Dibutyryl cyclic AMP (dBcAMP)                                                                         
Dimethyl sulfoxide (DMSO)      
DNA Mini preparation kit                                        
DNA Midi preparation kit                                                                        
DPX 
Ethanol                                                                     
Ethidium bromide                                                     
Ethylene diamine tetra acetic acid (EDTA)          
Exgen 500                                                                
Fetal calf serum (FCS)                                                      
Forskolin    
G418 
Gel extraction kit                                                                                             
Glacial acetic acid 
Glycerol   
Glycine                                                                   
HEPES 
Histogreen 
HPLC water                                                              
Hydrogen peroxide 30%                                           
Imidazole  
Isopropanol                                                               
Kaiser gelatine                                                          
L-glutamate                                                              
L-glutamic acid 
Lipofectamin 2000®
lysozyme 
Methanol  
MOPS 
Mowiol                                                                      
N2-supplement 
Sigma    
Roth 
Sigma  
Sigma                        
Sigma 
Qiagen 
Qiagen
Sigma  
Merck 
Sigma   
Fluka 
Fermentas 
Gibco BRL  
Sigma 
PAA 
Qiagen 
Roth  
Merck 
Sigma  
Roth  
Linaris-Biologische Produkte 
Merck 
Sigma 
Sigma  
Merck 
Merck 
Gibco BRL 
sigma 
Invitrogen 
Sigma  
Merck  
Roth  
Sigma 
Gibco 
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Nickel chloride hexahydrate 
Panceau-S 
Paraformaldehyde (PFA)                                         
PCR purification kit 
Penicillin                                                                   
Phalloidin 
Poly -D-lysine (PDL)       
Polyvinyl alcohol with DABCO®                                          
Potassium chloride   
Potassium dihydrogen phosphate                            
REDTagTM ready mixTM PCR reaction mix 
SilentFect®  
Sucrose  
Sodium acetate                                                        
Sodium azide 
Sodium chloride                                                       
Sodium citrate 
Sodium dodecyl sulfate (SDS) 
Sodium phosphate                                                 
Streptomycin                                                          
Talon resin®
Template suspending reagent (TSR)                  
Triethanolamine  
Tris (hydroxymethyl) aminoethane                         
Triton X-100                                                            
Trypsin solution 
Trypsin inhibitor                                                      
Fluka  
Roth 
Merck 
Qiagen 
Gibco BRL  
Sigma 
Sigma 
Fluka
Merck 
Merck 
Sigma 
BioRad 
Merck 
Merck 
Merck 
Merck   
Merck 
Serva  
Merck 
Gibco BRL 
Clontech 
Applied biosystems 
Sigma  
Invitrogen  
Fluka 
Gibco BRL 
Gibco BRL 
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2.3.2 Standard solutions and buffers 
Table 4: list of the standard solutions and buffers and their composition.  
Standard solution Composition  
150 mM NaCl 8.766 g NaCl/Liter H2O
Phosphate-buffered saline (1x 
PBS) 
150 mM NaCl, 10  mM Na-phosphate, pH 7.4       
2X HEPES buffer 
 0.28 M NaCl, 0.05 M HEPES, 1.5 mM 
Na2HPO4 in H2O, pH 7.13 
2.5 M CaCl2 277.35 gm/L CaCl2 in H2O 
4%PFA/10% sucrose 4 % w/v PFA in 10 % sucrose/PBS, pH 7.4   
Crystal violet staining solution 0.09% w/v crystal violet in 7 % alcohol 
Native lysis buffer 10 mM Na2HPO4, 1.8 mM KH2PO4 pH 7.4, 
140 mM NaCl, 2.7 mM KCl, 10 mM imidazol, 
0.5 mg/ml Lysozyme, 1 U/ml DNAse I, 1 mM 
PMSF, 2 µg/ml leupeptin, 2 µg/ml pepstatin 
Ni2+-immobilization buffer 20 mM Na2HPO4 pH 8.0, 100 mM Ni2+ (as 
NiCl2. 6 H2O) 
Ni2+-column equilibration buffer A 50 mM Na2HPO4 pH 7.4, 300 mM NaCl, 20 
mM imidazole  
Ni2+-column elution buffer B 20 mM Na2HPO4 pH 7.4, 150 mM NaCl, 250 
mM imidazole    
Ni2+-column stripping buffer 20 mM Na2HPO4 pH 7.4, 300 mM NaCl, 50 
mM EDTA 
Affigel 10® preservation buffer 100 mM MOPS pH 7.0, 0.02 % NaN3
Saline sodium citrate buffer (2x 
SSC) 
0.3 M NaCl, 0.03 M Na-citrate, pH 7.0
Sterile LB medium 1% (w/v) Bacto-tryptone, 0.5 % (w/v) Bacto-
yeast extract, 1% (w/v) NaCl, pH 7.0
DNA electrophoresis running buffer 
(50x TAE)  
2.5 M Tris base, 1 M sodium acetate, 0.1 M  
EDTA pH 8.0 
DNA electrophoresis sample buffer 50 % glycerol, 50 mM EDTA, 0.25 % (w/v) 
bromophenol blue 
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SDS-running buffer 192 mM glycine, 25 mM Tris, 0.1 % SDS, pH 
8.3
SDS-Blotting buffer 10 mM Tris, 100 mM glycine, pH 8.5 and 20 
% methanol
4x SDS-sample buffer 8 % SDS, 40 % Glycerol, 240 mM Tris-HCl 
pH 6.8, 4 % Bromphenolblue, 4 % β-ME 
Panceau S 0.2 % (w/v) ponceau-S in 3 % trichloroacetic 
acid 
Tris buffered saline (1x TBS) 20 mM Tris, 137 mM NaCl, pH 7.6                    
2.3.3 Media  
All media were purchased from Gibco BRL unless otherwise stated. 
• Dulbecco’s modified Eagle medium (DMEM) supplemented with 5 % foetal calf 
serum (FCS), 2 mM L-glutamate, 100 IU penicillin and 100 µg streptomycin.  
• Freezing medium: DMEM or DMEM Nut mix-F12 containing 20 % FCS and 10 
% dimethyl sulfoxide (DMSO) for storing the cells. 
• Neurobasal medium (NBM) supplemented with 2% B-27 supplement. 
• N2 medium: 75% DMEM + 25% Ham’s F12 + 3.9 mM L-glutamate 
supplemented with N2 supplement: 5 µg/ml insulin, 100 µg/ml transferrin, 20 nM 
progesterone, 100 µM putrescin, 30 nM sodium selenite (Bottenstein and Sato, 
1979).     
• Hank´s balanced salt solution (HBSS). 
• Opti-mem.
2.3.4 Antibodies 
Table 5: The primary antibodies used in immunocytochemistry and 
immunohistochemistry 
Specificity Host Producer/ supplier Used dilution 
HDGF Rabbit IBMB 1:300 of 2 µg/µl 
HRP-3 Rabbit IBMB 1:150 of 1µg/µl 
Calbindin (Purkinje cells) Mouse Vector 1:1000 
NeuN (Neurons) Mouse Chemicon 1:500 
GFAP(Active astrocytes) Mouse  Sigma 1:100 
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Map-2 (neurons) Mouse  Upstate 1 :200 
Β-III-tubulin (Tu -20) Mouse  Dianova 1:100 
β actin Mouse  Sigma 1:100 
Anti neurofilament H Chicken Chemicon 1:50 
Anti streptag Cheep  Frank Dietz 1:500 
Anti histag Mouse  Sigma  1:100 
Table 6: Secondary antibodies 
Specificity Host label Producer/ supplier Used dilution 
Anti-mouse Goat Cy2 Dianova  1:200 
Alexa fluor® 350 
anti-mouse 
Goat Blue  Invitrogen  1:100 
Anti rabbit Goat Biotin Vector 1:200 
Alexa fluor® 488 
anti-rabbit 
Goat  Green Invitrogen 1:200 
Anti rabbit Goat Cy3 Dianova  1:600 
Alexa fluor® 568 
anti-chicken 
Goat Red Invitrogen 1:100 
Anti-rabbit goat Peroxidase Jackson 1:10.000 
Anti-mouse goat Peroxidase Jackson 1:5.000 
IRDye  anti-rabbit goat Red LiCor 1:10.000 
IRDye anti-mouse goat Green LiCor 1:10.000 
2.3.5 Restriction enzymes 
All enzymes were purchased from Fermentas. 
Restriction enzymes: HindIII, SpeI, SspI, HpaI, NotI, PstI. 
Other enzymes: T4 DNA ligase.  
2.3.6 Bacteria, cell lines and animals  
Bacteria Genotype 
BL21 E. coli B F- dcm ompT hsdS(rB-mB-) gal 
XL-1 Bluer supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac 
F’[proAB+, laclq lacZ∆M15 Tn10 (tetr)] 
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The used cells in culture are:  
• B35 neuroblastoma cells 
• Human embryonic kidney cells (HEK293T)  
• Daoy medulloblastoma cells 
• Mouse primary cortical neurons   
• Mouse sensory neurons from dorsal root ganglia. 
Animals: NMRI mice at different stages of pregnancy.   
2.3.7 Primers 
Table 7: List of used primers  
HRP-3NLS1 
se (5’ end of 
the sequence 
5’-CTCGAGCTCAAGCTTGTCATGGCGCGTCCGCGG-3’ Cloning 
primer 
HRP-3NLS1 
As (5’ end of 
the sequence)
5’-GCTACGAATATTT mGAGTTTCCAAACTTGTCTTTG-3’ Cloning 
primer 
HRP-3NLS1 
se (3’ end of 
the sequence)
5’- CAGCAAGCTTAGCGTGTTAACCAGAACGGATTTAAT 
GAAGGAT-3’ 
Cloning 
primer 
HRP-3NLS1 
As (3’ end of 
the sequence 
5’- CTAGCATTTAGGTGACACTATAG-3’ Cloning 
primer 
HRP-3NLS2 
se (480 bp 
fragment) 
5’-CTCGAGCTCAAGCTTGTCATGGCGCGTCCGCGG-3’ Cloning 
primer 
HRP-3NLS2 
As (480 bp 
fragment) 
5’-TGCTGGACTAGTG TAGGACTTTTTCCGATTTGA-3’ Cloning 
primer 
HRP-3NLS2 
se (294 bp 
fragment) 
5’-ACGCCGACTAGTAAGAAGTCTTCTAATCAGTCCCGG 
AACTCTCCA-3’ 
Cloning 
primer 
HRP-3NLS2 
As (294 bp 
fragment) 
5’-CTAGCATTTAGGTGACACTATAG-3’ Cloning 
primer 
HRP-
3siRNA1 se 
5’-CACTGCAGCCCGGTGATAGAGTAGAAGATGTTCAAG 
AGACATCTTCTACT-3’ 
Cloning 
primer 
HRP-
3siRNA1 Ase
5’-TGGCGGCCGCTTTCCAAAAAGGTGATAGAGTAGAAG 
ATGTCTCTTGAACA-3’ 
Cloning 
primer 
HRP-
3siRNA2 se 
5’-CACTGCAGCCCGGAGTGAAATTTACTGGGTTTCAAG 
AGAACCCAGTAAAT-3’  
Cloning 
primer 
HRP-
3siRNA2 Ase
5’-TGGCGGCCGCTTTCCAAAAAGGAGTGAAATTTACTG 
GGTTCTCTTGAAAC-3’ 
Cloning 
primer 
T7 sense  5’-GGTAATACGACTCACTATAG-3’ Sequencing 
primer 
T3 ASe 5’-ATTAACCCTCACTAAAGGGA-3’ Sequencing 
primer 
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3. Methods 
3.1 Cell culture protocols 
3.1.1 Primary mouse cortical neuron culture 
Commonly used primary neurons in cultures are hippocampal, cerebellar, cortical 
and ganglionic neurons from rat, chicken, zebra fish and mouse. Cells are usually 
isolated during their developmental stage either from embryos or from newly born 
pups according to the cell type. In this work, cortical neurons derived from 
Embryonic day 14.5 mouse embryos, when undifferentiated neuron progenitors 
are predominant, were utilized in different experiments. For this purpose, E 14.5 
NMRI mouse embryos were harvested by caesarean section from anesthetized 
pregnant dams. The animal protocol was approved by the Animal Care and Use 
Committee of the Bezirksregierung, Köln. Cerebral cortices were isolated in ice 
cold Hank´s balanced salt solution (HBSS) and digested with 0.05 % trypsin/EDTA 
for 12 min at 37°C with gentle shaking after removi ng the meninges. Trypsin effect 
was stopped by adding an equal volume of trypsin inhibitor and 10 mg/ml BSA in 
PBS mixed in a ratio of 4 to 1. After a few minutes of incubation at room 
temperature, the supernatant was decanted carefully and the tissue pieces were 
dissociated with fire polished Pasteur pipette in Neurobasal medium (Life 
Technologies) supplemented with 2% B-27, 500 µM L-glutamine, 25 µM L-
glutamic acid, and 1X penicillin/streptomycin. High density cultures (9 x 106 cells), 
plated onto 100 mm poly-D-lysine (PDL)-coated tissue culture dishes, were used 
for Western blot analyses. Lower density cultures (6 x 105 cells), plated onto 12 
mm PDL-coated glass coverslips (introduced into 24 multi-well tissue culture 
plates) were used for immunocytochemical studies. Tissue culture dishes were 
pre-coated with 100 µg/mL PDL for 1 hour at 37°C or  overnight at 4°C. 
3.1.2 Protein coating of tissue culture vessels 
Sterile 12 mm glass coverslips were pre-coated for 1 hr with PDL (100 µg /ml in 
water) at 37°C then washed thoroughly with water. P re-coated coverslips (or 
uncoated bacterial plates in some experiments) were incubated with the purified 
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His-tagged protein of interest (HRP-3, HDGF or β-gal) in a concentration of 10 
µg/ml at 37°C. After two hours, excess protein solu tions were aspirated and 
vessels were washed once with water and allowed to dry before seeding the 
freshly prepared mouse cortical neurons onto them.
To estimate the amount of protein bound to the PDL-coated glass surface, protein-
coated, 12 mm glass coverslips as described previously were washed well to 
remove unbound proteins. Non-specific binding sites were blocked by incubating 
the coverslips with 2% BSA in PBS for 1 hr. Monoclonal antibody against His-tag 
diluted in the blocking solution was used to incubate the coverslips for 2 hrs. After 
being thoroughly washed, coverslips were incubated for 1 hr with peroxidase 
conjugated goat anti-mouse secondary antibody diluted in the blocking solution. 
Visualization of the bound peroxidase antibody was accomplished by incubating 
the coverslips with 2,2’-azino-di-[3-ethylbenzthiazoline sulfonate] (ABTS 
peroxidase substrate, Roche). The absorbance of the coloured reaction product 
was measured after 15-20 min using an ELISA plate reader at 405 nm according 
to manufacturer’s instructions. Absorbance values obtained from different 
conditions were compared using Excel program.  
3.1.3 Determination of neurite length  
Cells (primary mouse cortical neurons or B35) were fixed after different treatments 
in ice cold 4 % paraformaldehyde/ 10 % sucrose (4°C , 10 min) and immunostained 
using a neuronal cell marker (β-III-tubulin). Bound primary antibodies were 
visualized using fluorescently labelled secondary antibodies. Photos of the 
different cells were taken using fluorescence microscopy and the longest neurite 
arising from each positive cell in the captured images was measured. In some 
experiments also the branches arising from each positive cell were counted. Data 
were analysed using Excel programs and significance was calculated according to 
an unpaired t-test. 
3.1.4 Neuron rescue by the addition of purified proteins 
About 7 X 105 freshly prepared primary cortical neurons suspended in complete 
NBM + B-27 were seeded on PDL coated 12 mm coverslips. Twenty four hours 
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after seeding, neurons were washed three times with DMEM (containing 
penicillin/streptomycin) to remove any residues of B-27 supplemented NBM. 
Afterwards, cells were incubated with a medium consisting basically of DMEM 
supplemented with 100 ng/ml of affinity purified recombinant His-tagged HRP-3 as 
a test protein or recombinant β-gal as a negative control protein. Plain DMEM 
medium (without any added supplements) or 5 % FCS supplemented DMEM were 
used as negative and positive controls respectively. Neurons were fixed three 
days after treatment using ice cold 4 % paraformaldehyde/ 10 % sucrose in PBS 
(4°C, 10 min) and non-specifically stained using cr ystal violet (0.09 % w/v in 7 % 
ethanol, 5 min) before mounting to analyse the general culture morphology. 
3.1.5 Quantitative determination of cell survival using Alamar blue®
3.1.5.1 Principle 
Survival assays are bioassays attempting to determine the effect of an 
investigated factor(s) or condition(s) within a cell culture system on cell survival 
and/or proliferation. Colorimetric assays depending on a measurable change in the 
used reagent colour are reliable and easy methods to quantitatively estimate cell 
survival. Assays utilizing Alamar blue® incorporate an indicator dye that undergoes 
an oxidation-reduction (REDOX) reaction that can be photometrically measured in 
both forms. When it is applied to culture medium, cell growth or survival and hence 
respiration and electron transfer among the electron transport chain components 
cause a chemical reduction of Alamar blue®  producing a red fluorescent reduced 
form. Continued growth and respiration maintain that reduced form. Inhibited 
growth on the other hand allows the oxidation of Alamar blue® giving a blue non 
fluorescent form. The measured changes in fluorescence or  absorbance can be 
used for comparison reflecting an increased or decreased cell survival.   
3.1.5.2 Protocol 
Survival assays used in this work were performed in a 48-well tissue culture plate 
format. First, neurons were seeded on PDL-coated plates in a density of 60,000 
cells per well and allowed to adhere in complete NBM. After 2 hrs neurons were 
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washed once with warm DMEM and incubated with DMEM supplemented with the 
different test proteins (150 µl/well). Alternatively, neurons were seeded from the 
beginning in DMEM containing one of the proteins of interest. Three days after 
initiation of the treatment, Alamar blue® was added under aseptic conditions in a 
10% ratio of the total volume and fluorescence was measured for the first time 
immediately after addition. Fluorescence measurements were achieved at regular 
time intervals using an ELISA reader at 530-560 nm excitation wave length and 
590 nm emission wave length. The obtained mean fluorescence values were 
plotted against time and slopes of the resulting linear graphs were used for 
comparing the efficiency of the different supplements in promoting survival and/or 
cell growth. 
3.1.6 Antibody treatment of neurons 
Freshly prepared primary cortical neurons were seeded on PDL coated 12 mm 
glass coverslips in complete NBM+B27. Twenty four hrs after seeding neurons 
were washed 2x with N2 medium to remove the residual NBM. Neurons were then 
kept in either N2 medium alone, N2 containing 1 µg/ml polyclonal affinity purified 
antiserum raised against HRP-3 or N2 containing pre-absorbed anti-HRP-3. For 
antibody pre-absorption affinity purified antibody diluted in N2 medium (in 1 µg/ml 
end concentration) was incubated with an excess amount of purified recombinant 
His-tagged HRP-3 protein overnight at 4°C. A resin that binds to the His-tag of the 
protein (Talon® resin, Clontech) was then added to specifically bind the formed 
antibody-protein complex in the medium. By centrifugation, the medium was 
cleared from the resin-protein complex. After being sterile filtered, the different 
medium combinations were applied to neurons. Two days after treatment, neurons 
were fixed and non specifically stained using crystal violet solution to visualize the 
general morphology of cells. 
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3.1.7 Gene silencing 
3.1.7.1 Definition and types 
Gene silencing is a term that describes the “switching off” of a gene by a 
mechanism other than genetic modification within the organism aiming to regulate 
endogenous genes. This means, a gene which would be expressed (turned on) 
under normal circumstances is “switched off” by certain machinery in the cell. 
Mechanisms of gene silencing are a part of an ancient immune system protecting 
the organism's genome from infectious DNA elements (Plasterk, 2002) and it 
occurs at either the transcriptional or the post-transcriptional level.  
Transcriptional gene silencing is the result of histone modifications that make the 
gene inaccessible to transcriptional machinery like ribonucleic acid (RNA) 
polymerases and transcription factors.  
Post-transcriptional gene silencing is a result of destroying the messenger RNA 
(mRNA) of a particular gene and hence preventing its translation into an active 
gene-product (mostly a protein). RNA interference (RNAi) is considered one of the 
commonly used techniques for post-transcriptional gene silencing.
3.1.7.2 RNAi approach 
RNA interference (RNAi) is a highly conserved double stranded RNA (dsRNA)-
guided mechanism within living cells that helps controlling the activity level of 
different genes (Meister and Tuschl, 2004). There are two types of small RNA 
molecules controlling the process of RNA interference: microRNA (miRNA) and 
small interfering RNA (siRNA). MiRNAs are single-stranded RNA molecules (21-
23 nucleotides in length) which are partially complementary to one or more mRNA 
molecules, and function mainly to down-regulate gene expression. SiRNAs are 20-
25 nucleotide-long double-stranded RNA molecules (dsRNA) with symmetric 2 
nucleotide 3’-overhang that play a variety of roles like antiviral mechanisms and 
shaping chromatin structure of genomes. SiRNA is involved in the RNA 
interference (RNAi) pathway, where it interferes with the expression of specific 
gene(s) (Hannon, 2002; Hamilton and Baulcombe, 1999; Elbashir, et al., 2001). 
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SiRNA approach to gene silencing involves introducing an RNA sequence that is  
complementary to the mRNA transcribed from the target gene. As seen in the 
figure below dsRNAs are cleaved by RNAse-III-type enzymes (i.e. Dicer, Caf) into 
small interfering RNAs (siRNAs), probably in both the nucleus and the cytoplasm 
(Voinnet, 2002; Zamore, 2002).  
These siRNA fragments become incorporated into various protein factors forming 
RNA-induced silencing complex (RISC) which become then activated. When 
homologous mRNAs are present in the cytoplasm, the activated RISC guided by 
the antisense strand of the siRNA anneals to and serves as a guide for 
endonucleolytic cleavage of this homologous mRNA  leading to block of translation 
and hence blocking the production of an encoded protein (Hunter, 1999; Llave, et 
al. 2002; Kasschau, et al., 2003; Jana, et al., 2004). 
Figure 3: A schematic diagram presenting the steps of gene silencing achieved by 
introducing siRNA to the cell. 
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3.1.7.3 Transfection of neurons with siRNA oligos using lipofectamin 2000®
Transfection was done in 24 multiwell plates in triplicates using 150,000 neuronal 
cells per well suspended in 250 µl of culture medium. The transfection mixture per 
well was prepared by diluting 20 pmol siRNA (Ambion) + 5 pmol Cy3 labelled 
control siRNA in 50 µl Opti-mem (Gibco) in a sterile eppendorf tube. In another 
tube 1 µl Lipofectamin 2000® was diluted in 50 µl Opti-mem. Both solutions were 
mixed and allowed to stand for 20 min at RT before mixing them with the cell 
suspension. Afterwards, neurons suspended in transfection mix were seeded on 
PDL coated coverslips and final volume was filled up to 600 µl per well. Neurons 
were allowed to adhere to the coverslips and a medium change was done first 4-6 
hrs after seeding. Neurons were fixed for staining and neurite length analysis 48 
hrs after transfection.
3.1.7.4 Transfection of neurons with vector-based siRNA using MATra®
3.1.7.4.1 Principle 
Vector based siRNAs do not need the use of RNAse free chemicals and 
instruments. They have also other advantages including the ability to remove the 
untransfected cells by selecting the transfected cells using antibiotics resistance 
genes and the possibility to produce the vector easily by a simple transformation 
process (Chen, et al.,  2005). When these vectors are transported into the cells 
they start to express the short hairpin RNA under the control of an RNA 
polymerase III promoter. Afterwards they are processed by the cellular machinery 
into 19-21 nucleotide double stranded RNA.  
Magnet Assisted Transfection (MATra) approach is a new, easy-to-handle, very 
fast and highly efficient technology to transfect cells in culture. It can be used for 
all types of nucleic acids from plasmid DNA or siRNA to oligonucleotides. Using 
this new technique, nucleic acids are in a first step associated with specific 
magnetic nanoparticles (MagTag™). Exploiting magnetic force, the nucleic acid is 
then drawn towards and delivered into the target cells leading to efficient 
transfection without disturbing the membrane architecture and without causing 
chromosomal damage or leaving a hole in the cell membrane. 
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3.1.7.4.2 Protocol 
Freshly isolated mouse primary cortical neurons were seeded on PDL-coated 12-
mm glass coverslips in a 24 well plate and kept in 500 µl complete NBM per well. 
One day after seeding DNA-MATra mix was prepared by diluting 0.6 µg DNA into 
50 µl serum- and supplement-free medium. The diluted DNA was mixed by vortex 
with 0.6 µl MATra and the mixture was incubated for 20 min at RT before being 
applied to the cells. The mentioned amount of DNA-MATra mix was sufficient for 
one well of the 24 well plate so that a final volume of 550 µl/well (500 µl medium 
and 50 µl DNA-MATra mix) was reached. After adding the mixtures to cells, the 
supernatant was mixed thoroughly then the plate was placed immediately on the 
standard magnetic plate at 37°C for 15 min. One to two hours after tranfection, the 
medium was replaced with fresh medium to remove the excess transfection 
mixture from cells supernatant. 
3.1.8 Primary mouse sensory neuron culture 
Sensory neuron culture is derived from dorsal root ganglia (DRG) of embryonic 
mice. This kind of neurons belongs to the peripheral nervous system (PNS) and 
originates from the embryo’s migrating neural crest cells. Briefly, pregnant mice at 
14.5 dpc were anaesthetized and the uterus containing the embryos was extracted 
by caesarean section. Embryos were released from the uterus and the amniotic 
sacs and they were washed before removing head, upper and lower limbs, tail and 
gut under a dissecting microscope. Vertebral columns from all embryos were 
transferred to a new Petri dish and the cartilage vertebrae were carefully removed 
after being opened from the ventral side using fine forceps. After exposing the 
neural tube and the attached DRG as seen in figure 4, an ultra fine forceps pair 
was used to draw the DRG away from the neural tube. Harvested DRG were 
transferred into HBSS in a 50-ml falcon tube using a sterile glass Pasteur pipette. 
To prevent adherence of the tissue pieces to the glass inner surface of the pipette, 
it was previously coated with 0.1 % BSA/PBS by drawing the solution up and down 
several times before using it for transferring the tissue. 
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Figure 4: A photograph showing an overview of the exposed neural tube of E14.5 
mouse embryo where the attached DRG can be seen on both sides. 
To dissociate the cells, collected DRG were digested for 5 min at 37°C using 
dispase/HBSS (5 mg/ml), suspended shortly with a BSA/PBS coated pipette then 
further incubated for another 8 min. The enzymatic reaction was stopped by 
adding 10 x volume of BSA/PBS solution before the suspension was centrifuged at 
4,000 rpm for 5 min. After aspirating the supernatant, the cell pellet was re-
suspended in NBM supplemented with 2 % B-27 and 25 ng/ml NGF and cells were 
counted using a haemocytometer. Cells in the needed density (about 30,000 cells/ 
12-mm coverslip) were seeded on coated glass coverslips (0.1 mg/ml PDL/ 2 
ng/ml laminin) and allowed to adhere. When DRG were needed in an intact form 
(undissociated) the step of dispase digestion and the later steps were omitted and 
the tissue pieces were directly seeded after isolation on PDL coated coverslips. 
After the required times in cultures cells were fixed in 4 % PFA/ 10 % sucrose at 
4°C and immunostained.      
3.1.9 B35 neuroblastoma cells  
3.1.9.1 B35 cells in culture 
B35 neuroblastoma cells represent an inducible neuronal cell line that produce a 
neuronal phenotype upon inducing their differentiation and can provide an 
alternative for primary neuron cultures. It is one of the commonly used cell lines for 
studying the effect of different factors on neurite outgrowth. In 1974, a panel of 
neuronal cell lines was derived from the neonatal rat central nervous system 
tumours including B35 (Schubert, et al., 1974). These cell lines offer a number of 
Neural tube
DRG 
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advantages for CNS neurons research as they are simple to cultivate, differentiate, 
and to transfect. Under normal culture conditions with serum-containing medium, 
neuroblastoma cells proliferate rapidly but they have the ability to respond to 
serum withdrawal and increased cAMP levels by producing neuronal phenotypes 
bearing neurites. A known cell-permeable cAMP analog is dibutyryl cAMP 
(Bt2cAMP, dBcAMP) which preferentially activates cAMP-dependent protein 
kinase (Meyer and Miller, 1974;  Boukhelifa, et al., 2001) and hence regulates 
neuronal differentiation, axonal guidance, neuronal survival and neurite outgrowth 
(Fujioka, et al., 2004; Song, et al., 1997; Hanson, et al., 1998; Meyer-Franke, et 
al., 1998; Neumann, et al., 2002; Cai, et al., 1999). 
3.1.9.2 Transient transfection of B35 cells with HRP-3 constructs 
B35 cells were kept in culture under proliferative conditions using DMEM Nut mix-
F12 + 5 % FCS + Penicillin/streptomycin. For transfection, about 2.5 x 104 - 3.0 x 
104 cells suspended in culture medium were seeded on 12 mm PDL-coated glass 
coverslips. Twenty four hours later, Exgene 500 transfection mixtures were 
prepared according to the manufacturer’s instructions using the different cDNA 
constructs. Briefly, for each well 1µg DNA was diluted in 100 µl of 150 mM NaCl 
before 3.3 µl Exgene 500 were added and mixed well. After 10 min of incubation at 
room temperature, the transfection mix was added to the cells and volume was 
filled up to 1 ml with culture medium. Cells were switched to fresh medium four 
hours after transfection. Three days later, cells were fixed and immunostained 
against streptag to visualize the cellular localization of the different constructs. 
When differentiation was required, cells were induced to differentiate 24 hrs after 
transfection using 1mM dBcAMP and fixed three days after induction.
3.1.10 Daoy medulloblastoma cells  
3.1.10.1 Transient transfection of Daoy cells using calcium phosphate 
The calcium phosphate transfection method depends on introducing DNA to the 
cells via a precipitate that adheres to the cell surface. A HEPES buffer was used to 
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form calcium phosphate-DNA precipitate that is directly layered onto the cells. This 
method may be used for both transient and stable transfection of adherent cells. It 
introduces large amounts of DNA into the cells that pick up the DNA. One million 
cells were seeded 24 hrs before transfection into 10 cm plate in complete medium. 
For transfection, 10 µg DNA were suspended in 450 µl H2O and mixed gently with 
50 µl of 2.5 M CaCl2. While creating air bubbles in a tube containing 500 µl of 2 X 
HEPES buffer using electronic pipette, the DNA-CaCl2  mixture was added drop 
wise to allow formation of a fine precipitate. The formed DNA-Calcium phosphate 
precipitate was incubated for 15-20 min at room tepmerature (RT) before adding it 
to the cells. After about 20-24 hrs of incubation at 37°C in a humidified water 
jacketed incubator, the culture medium was exchanged with fresh medium to 
remove the excess precipitate from the cells. 
3.1.10.2 Stable transfection and selection of Daoy cells 
One to two days after transfecting cells with the resistance gene-encoding plasmid 
using calcium phosphate method, they were washed once with PBS and incubated 
with the selection medium. To prepare selection medium, geneticin® (G418) was 
diluted in the normal growth medium to a final concentration of 300 µg/ml. 
Selection medium was replaced every other day with fresh selection medium 
containing the same concentration of G418. After one week, the concentration of 
G418 in the medium was increased up to 400 µg/ml and cell supernatant was 
changed every other day for another week. Finally the concentration was 
increased up to 500 µg/ml and cells were kept under this concentration for one to 
two weeks until cell aggregates started to appear in the culture plates. For a mixed 
clone culture, all the colonies growing in the vessel were trypsinized together and 
re-plated on fresh tissue culture vessel. For single clone cultures, single clones 
were carefully picked up and trypsinized separately before being seeded on fresh 
vessels. Cells from both cases were allowed to proliferate until being semi-
confluent before they were frozen and stored in liquid nitrogen for later use.
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3.1.10.3 Proliferation assay of Daoy cells using MTS 
3.1.10.3.1 Principle 
Promega cellTiter® 96 AQueous Non-Radioactive cell proliferation assay is an assay 
to estimate cell proliferation utilizing MTS. MTS is a standard colorimetric assay 
(an assay which measures changes in colour) for measuring the activity of 
enzymes that reduce MTS + PMS to formazan, giving a purple colour. It can also 
be used to determine cytotoxicity of potential medicinal agents and other toxic 
materials which cause metabolic dysfunction and therefore decreased 
performance in the assay. MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), in the presence of 
phenazine methosulfate (PMS), produces a water-soluble formazan product that 
has an absorbance maximum at 490-500 nm in phosphate-buffered saline (Cory, 
et al., 1991). The reduction takes place only when reductase enzymes are active, 
and therefore conversion is often used as a measure of viable (living) cells.
3.1.10.3.2 Protocol 
To compare the viability of Daoy cells transfected with different constructs, cells 
were seeded into 96 well plates at a density of 5000 cells per well in 120 µl culture 
medium. Three days after seeding assay reagent was prepared by mixing MTS 
with PMS in a ration of 20:1 before 30 µl of the reagent mix were added to each 
well of the 96 well plate (1:5 ratio of MTS/PMS to total volume per well). Four 
hours later, the absorbance of the produced formazan was measured at 495 nm 
and the values obtained from each condition were compared. 
3.1.11 Freezing of cells 
Healthy cells growing in log phase were washed carefully with warm PBS solution 
then treated with trypsin solution and incubated at 37°C. After 2-3 min tissue 
culture plates were rocked gently to allow cell detachment then trypsin effect was 
stopped by diluting it with FCS containing medium. Cell suspension was placed 
into a sterile falcon tube and centrifuged at 3,000 to 4,000 rpm for 5 min. Under 
aseptic conditions supernatant was removed and cells were resuspended in ice 
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cold freezing medium (10 % DMSO, 20 % FCS and 70 % medium of choice) at a 
concentration of 2*106 cells/ml. About 1-1,5 ml of cell suspension were filled into 
labelled cryovials and stored for one day at -80°C before storing it in the liquid 
nitrogen tank. 
3.1.12 Thawing of cells 
About 10 ml of the required growth medium were placed into a 15 ml falcon tube 
and kept on ice while the rest of medium was warmed at 37°C. Cryovials 
containing the frozen cells were taken out of liquid nitrogen and thawed rapidly by 
swirling in a 37°C water bath for 1-2 min. After de contaminating their outer 
surface, vials were taken under the laminar air flow hood and the contents were 
applied to the top of the previously prepared falcon tube with the cold medium. 
Cell suspension was centrifuged at 3,000 to 4,000 rpm for 5 min before removing 
the supernatant and re-suspending the cell pellet in the suitable growth medium. 
Cells were seeded onto 10 cm tissue culture plates and incubated at 37°C, 5 % 
CO2 in a humidified water jacketed incubator to allow cell growth. 
3.2 Immunolocalization protocols 
   
3.2.1 Immunolocalization of interest proteins in mouse tissues 
To obtain brains from adult mice, animals were deeply anaesthetized then they 
were perfused with 37°C warm PBS to wash out the bl ood from the brain. After 
that animal tissues were fixed by perfusing it with a 37°C warm solution of 4 % 
PFA in PBS. After that, heads were cut off, skulls were opened and the brains 
were extracted and post fixed in 4 % PFA overnight. To prepare embryonic 
tissues, pregnant mice at different time points of pregnancy were anaesthetized 
and mice embryos were extracted by caesarean section. After several washes in 
37°C warm PBS, embryos were fixed in 4 % PFA in PBS  for 24 hrs. After fixation 
both brains and embryos were washed thoroughly in PBS before they were 
dehydrated through a series of increasing concentrations of ethanol (50, 60, 70, 
80, 90, 100 %) using one-hour incubation in each concentration. After that, tissues 
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were cleared with three 60-minutes incubations in xylene before embedding in 
warm paraffin (56°C) overnight. Embedded tissue blo cks were allowed to solidify 
before being sectioned at 5-10 µm thick sections onto Histobond® glass slides 
(Marinefield). Slides with sections were kept at 37°C for 24 hrs to allow for good 
adhesion on the glass then they were stored at 4°C.  For staining, sections were 
deparaffinized (3 x 5 min) in xylene then rehydrated in a series of decreasing 
alcohol concentrations starting from 100 % down to 70 % and finally in PBS in 3 x 
5 min repeats. Antibody binding sites were retrieved by heating the sections in 
antigen retrieval buffer (2 x SSC, pH 7.0) for 2 x 5 min using microwave oven at 
600 watt. After cooling down to room temperature in the retrieval solution, sections 
were washed 1 x 10 min in PBS and endogenous peroxidase activity was 
quenched using 1 % H2O2 in PBS for 10 min. Afterwards section were 
permeabilized for 10 min in 0.5 % Triton X-100/PBS and washed for 3 x 5 min in 
PBS before blocking the non-specific binding sites with 2 % BSA/PBS for 2 hours 
at RT. Sections were incubated with the primary antibody diluted in the blocking 
solution in a humidified chamber at 4°C overnight t hen the excess unbound 
antibody was washed out with PBS (3 x 5 min). Secondary antibody was diluted 
similarly in the blocking solution and incubated on the sections for 2 hrs at RT after 
which sections were washed thoroughly. For colour development of non 
fluorescently stained sections, tissues were further incubated with Avidin-biotin 
complex kit (Vector labs) for 1 hr according to manufacturer’s instruction followed 
by Histogreen for 1 to 5 min until a suitable colour signal with minimal 
background was obtained. After dehydration in xylene, sections were embedded in 
DPX® (Distyrene-Plasticizer-Xylene) and pictures were taken at an Axiovert zeiss 
microscope. When fluorescently labelled secondary antibodies were used, the 
peroxidase activity quenching step was omitted and direct visualization of bound 
antibody was possible after mounting the sections in polyvinyl alcohol with 1,4-
diazabicyclo(2,2,2)octan (DABCO, Fluka) after washing for 5 min in water. 
3.2.2 Immunolocalization of interest proteins in neuron cultures 
Neurons (cortical or sensory) were fixed at different time points in ice cold 4 % 
paraformaldehyde/ 10 % sucrose in PBS (4°C, 10 min) , and permeabilized using 
0.5 % Triton X-100 for 5 min. Non-specific binding sites were blocked using 2 % 
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BSA in PBS for 1 hr at room temperature after which neurons were incubated for 2 
hrs with the different primary antibodies diluted in the blocking solution. After three 
washes in PBS, neurons were incubated with the fluorescently labelled secondary 
antibodies diluted in the blocking solution for 1 hr in the dark to avoid signal 
quenching. A nuclear counter staining with 4,6 diamidino-2-phenylindole (DAPI) 
was done for 2 min when required. Coverslips were finally washed 1 x PBS and 2 
x H2O to remove excess salt before embedding in polyvinylalcohol with DABCO. 
Images were captured with an Axiovert 100M instrument (Zeiss, Jena, Germany) 
or by laser scan microscopy using a Leica TCS SP2 instrument (Leica, Wetzlar, 
Germany). 
3.3 DNA protocols  
3.3.1 Cloning of HRP-3 variants 
Expression vectors coding for mutations in the nuclear localization signals (NLS) 
of HRP-3 were cloned via a two-step polymerase chain reaction (PCR) approach 
using a pCDNA3 vector containing the HRP-3 coding sequence as a template. For 
mutation of the second NLS (NLS2) as a first step, bases located 5’ of the NLS 
site were amplified using primers 5’-CTC GAG CTC AAG CTT GTC ATG GCG 
CGT CCG CGG-3’ and 5’-TGC TGG ACT AGT GTA GGA CTT TTT CCG ATT 
TGA-3’ to produce a 480 bp fragment. This fragment was digested by HindIII/SpeI 
and cloned into a pBSK(-) vector. Bases located 3’ of the NLS were amplified 
using primers 5’-ACG CCG ACT AGT AAG AAG TCT TCT AAT CAG TCC CGG 
AAC TCT CCA-3’ and 5’-CTA GCA TTT AGG TGA CAC TAT AG-3’ to produce a 
294 bp fragment which was digested by SpeI and cloned into the pBSK(-) vector 
produced above (containing the 480 bp fragment).  
HRP-3 mutated in its NLS1 was cloned using the primer set 5’-CTC GAG CTC 
AAG CTT GTC ATG GCG CGT CCG CGG-3’ and 5’-GCT ACG AAT ATT TGA 
GTT TCC AAA CTT GTC TTT G-3’ for the 5’-part of the sequence (HindIII/SpeI 
digest) and the primer set 5’- CAG CAA GCT TAG CGT GTT AAC CAG AAC GGA 
TTT AAT GAA GGA T-3’ and 5’- CTA GCA TTT AGG TGA CAC TAT AG-3’ 
(HpaI/NotI digest) for the 3’-part of the construct. Integrity of all construct were 
confirmed by cycle sequencing. The vector coding for the double mutant (NLS1+2) 
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was constructed by cutting a PstI fragment from the NLS2 mutant containing 
pBSK(-) vector (25 bp) and cloning it into the vector containing the NLS1 mutant. 
Expression vectors were constructed by subcloning into the pCDNA3 vector 
containing the CMV promoter for eukaryotic expression and a C-terminal signal 
coding for a StrepTag® peptide. 
3.3.2 Construction of HRP3siRNA pSilencer vectors 
DNA-vector-based siRNA technology, in contrast to synthetic siRNA, involves 
cloning of a small DNA insert of about 70 bp into a commercially available vector. 
This vector can be transfected into the cell by the usual transfection methods, 
where the DNA insert expresses a short hairpin RNA. The hairpin RNA is rapidly 
processed by the cellular enzyme machinery into functional double-stranded 
siRNA. The use of vector based siRNA provides certain advantages over 
chemically synthesized siRNAs, including the lower costs and the possibility of 
regeneration. One of the problems concerning the synthetic siRNA is the non 
continuous gene suppression which can be effectively overcome by using vector 
based siRNA. In the latter case the untransfected cells can be easily removed by 
selecting the transfected cells with antibiotic resistant genes. Depending on the 
synthetic siRNA oligos against HRP-3, two sets of oligonucleotides were designed. 
To amplify HRP-3siRNA1 the following set of the oligos 5´-CAC TGC AGC CCG 
GTG ATA GAG TAG AAG ATG TTC AAG AGA CAT CTT CTA CT-3´ and 5´-TGG 
CGG CCG CTT TCC AAA AAG GTG ATA GAG TAG AAG ATG TCT CTT GAA 
CA-3´ was used. To amplify HRP-3siRNA2 the following set of the oligos  5´-CAC 
TGC AGC CCG GAG TGA AAT TTA CTG GGT TTC AAG AGA ACC CAG TAA 
AT-3´ and 5´-TGG CGG CCG CTT TCC AAA AAG GAG TGA AAT TTA CTG GGT 
TCT CTT GAA AC-3´ was used. For annealing each set, five hundred picomols of 
each oligonucleotide in 1x ligase buffer were hybridized using the following 
program.  95°C /5 min (90, 85, 80, 75, 70, 65, 60, 55°C) each for 2 min and 50°C 
for 5 min. Hybridized fragments were klenow filled using 50 mM Tris-HCl (pH 7.2), 
10 mM MgSO4, 0.1 mM DTT, 40 µM of each dNTP, 20 µg/ml acetylated BSA and 
1 unit of Klenow Fragment per microgram of DNA. The samples were incubated at 
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room temperature for 10 minutes then the reaction was stopped by heating the 
mixture for 10 minutes at 75°C.
Klenow-filled-in fragments and pSilencer vector were digested using the restriction 
enzymes Pst1 and Not1 according to manufacturer’s recommendations. The 
correct size of the digested vector and annealed inserts was confirmed using 2.5 
and 1% agarose gel electrophoresis respectively. The digested samples were 
ligated, transformed and positive clones having the insert were identified using 
colony screening. DNA preparation was performed on larger scale after confirming 
the correct sequence of insert and promoter by sequencing with the sense (T7) 
and antisense (T3) primers. 
3.3.3 Ligation of DNA 
DNA ligation is the process of joining linear DNA fragments together with covalent 
bonds. The process of ligation is catalysed by bacteriophage T4 DNA ligase, an 
enzyme that joins two pieces of DNA together via the formation of phosphodiester 
bonds between adjacent 3´-hydroxyl and 5´-phosphate termini in DNA. The 
enzyme catalyses ligation of DNA fragments with both blunt and single (sticky) 
stranded termini ends. The reaction is performed with small volumes (10-15 µl) to 
facilitate the annealing of two DNA fragments with compatible termini. This 
protocol is optimised for single strand termini ligation reactions (Sambrook, et al., 
1989). The formula below is used to estimate the amount of the vector and insert 
needed for optimal ligation. 
Generally, vector and insert were mixed in an Eppendorf tube and T4 DNA ligase 
was added to them together with ligase buffer according to the manufacturer’s 
instruction. After an incubation period that ranges from 4 hrs (at RT) to overnight 
(at 16°C) a small volume of the mixture was used to  confirm a successful ligation 
by running it on an agarose gel against a suitable DNA ladder. 
vector)inbp(total
vector)ng(50insert)bp(YinsertngX ⋅=
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3.3.4 Transformation 
3.3.4.1 Principle 
Transformation is a process in which free DNA plasmids are introduced to 
bacterial cells (here E. coli were used). These bacterial cells take up the plasmids 
from solution and amplify them in order to produce them in large quantities 
because plasmids replicate by themselves by acting as extra chromosomal 
genomes. Only the transformed cells have to be selected from the other cells in 
the transformation mixture. To ensure this, plasmids containing a gene encoding a 
resistance to an antibiotic are usually used. Only cells containing these plasmids 
are able to live and multiply in a growth medium containing the same antibiotic 
against which a resistance gene exists. To minimise the possibility for picking cells 
transformed with an incorrectly inserted vector, the transformed cells were 
selected by the use of the α-complementation system (Sambrook, et al., 1989). 
3.3.4.2 Protocol 
About 1 ng of DNA was mixed with 100 µl competent XL-1 blue bacteria and the 
mixture was kept on ice for 30 minutes. A heat shock was performed by heating 
the mixture for 30 seconds at 42°C and suddenly cooling it on ice for 2 minutes. 
This heat shock enables the plasmids to enter the bacterial cells through pores in 
the bacterial cell wall. 900 µl of pre-warmed LB medium were added to the 
bacteria–DNA mix and the mixture was incubated in a shaker at 37°C for 1 hr.  
Afterwards, 100 to 500 µl of the DNA-bacterial cells mixture were spread on agar-
LB medium plates (1.5 % w/v agar in LB medium) containing the same antibiotic 
used for selection and incubated at 37°C over night. Single clones arising from 
single bacterial cells were picked and inoculated each in 5 ml LB medium 
containing antibiotic (50 µg/ml penicillin) and incubated at 37°C over night. 
Plasmid DNA was isolated by mini prep isolation kit (Qiagen®) according to 
manufacturer’s instructions, digested with the suitable restriction enzymes and the 
correct insert size was verified by agarose gel electrophoresis in comparison to a 
DNA standard ladder.  
                                                           Methods  
41
3.3.5 Colony screening 
The correct clones containing the insert were verified by PCR technique using the 
following reaction mixture: 10 µl REDTagTM ready mix PCR reaction mix, 10 pmol 
of each forward and backward primers and volume was filled up to 20 µl with water 
in 250 µl PCR tubes. Using sterile tooth pickers very small amounts of the colonies 
to be tested were introduced into the reaction mixture. After PCR amplification 
using the program: [95°C for 3 min, (95°C for 30 se c, 55°C for 45 sec, 72°C for 1 
min) x 30-40 cycles, 72°C for 3 min], PCR products were separated using 
electrophoresis against standard DNA ladder. Clones having the correct insert size 
were used further for DNA isolation.  
3.3.6 Separation of DNA by agarose gel electrophoresis 
3.3.6.1 Principle 
Agarose gel electrophoresis is a method to separate DNA molecules migrating 
through an agarose matrix. The separation process depends here on the size of 
the migrating molecules under the effect of an electric field. Large molecules 
migrate slower because they have greater difficulties migrating through the pores 
in the gel than smaller molecules. At physiological pH, DNA is negatively charged 
and migrates towards the anode. DNA molecules are visualised by ethidium 
bromide, which intercalates between the bases in double stranded DNA so that 
the complex becomes fluorescent when exposed to ultraviolet light (Sambrook, et 
al., 1989). 
3.3.6.2 Protocol 
Agarose gel (1 or 2,5 %) was prepared by suspending the needed amount of 
agarose in 1 x TAE buffer and heating in a microwave oven until the solution 
became clear. After cooling the solution down to about 55°C, ethidium bromide 
was added in a final concentration of 1 µg/ml and the mixture was allowed to 
polymerize in a prepared casting tray with a suitable comb size. After being 
completely polymerized, the gel was placed into an electrophoresis chamber filled 
with 1xTAE buffer. DNA samples were mixed with sample buffer and slowly loaded 
                                                           Methods  
42
into the wells before the electric current was applied (3-10 V/cm2). Finally, DNA 
fragments were detected using a UV detector or  a fluorimager. 
3.3.7 DNA sequencing 
The following reagents (all from ABI) were  mixed and briefly centrifuged to spin 
down the droplets on the tube walls: 1 µl of 5 pmol forward or reverse primer, 2 µl 
Big dye and 2 µl cycle sequence buffer and the volume was filled up to 10µl with 
HPLC grade water. About 300-500 ng DNA were added to the previous mixture 
and a PCR was performed using the following protocol: 96°C for 3 min, 30x [96°C 
for 10 sec, 50°C for 5 sec, 60°C for 4 min].  
For DNA precipitation, 10 µl HPLC-grade water, 2 µl of 3 M sodium acetate pH 5.2 
and 50 µl absolute ethanol were added to PCR products, mixed well and left for 10 
min at RT. After 10 min of centrifugation at 18.000 x g the supernatant was 
carefully removed and the DNA pellet was carefully washed with 250 µl 70 % 
ethanol. DNA pellets were allowed to air dry for 20 min then they were re-
suspended in 25 µl of Hi Dye. Samples were applied to an ABI 310 automatic 
sequencer (Applied Biosystems) to verify their sequence after being denatured by 
heating up to 80°C for 3 min followed by cooling do wn to 4°C. 
3.3.8 Gel extraction of DNA (Qiagen®) 
DNA fragments separated by agarose gel electrophoresis were extracted from the 
gel using a DNA gel extraction kit (Qiagen) according to manufacturer’s 
instructions. Briefly, DNA bands were cut out and completely melt in 3 volumes of 
QG buffer at 50°C. One gel volume of isopropanol wa s added to the melted gel 
piece and the mixture was applied to a spin column and centrifuged for 1 minute. 
DNA bound to the column was washed with 750 µl of washing buffer before eluting 
it with 30-50 µl of elution buffer (10 mM Tris.HCl, pH 8.5) or water using a desk 
top-centrifuge.   
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3.3.9 Mini and midi plasmid DNA preparation (Qiagen®) 
The purification was performed using Qiagen® kits according to the manufacturer’s 
instructions. 
3.4 Protein chemistry protocols 
3.4.1 Purification of His-tagged proteins 
3.4.1.1 Ni2+-affinity chromatography 
Purification of His-tagged molecules is based on the ability of histidine to form 
complexes with transition metal ions, combined to a resin with a high affinity for 
the same transition metal ion. The high affinity of the resin for 6x His-tagged 
proteins or peptides is due to both the specificity of the interaction between 
histidine residues and immobilized metal ions and to the strength with which these 
ions are held to the resin. The most often used metal ions are cupric ions (Cu2+) 
and nickel ions (Ni2+) (Hi-Trap chelating column user guide, Pharmacia Biotech). 
3.4.1.2 Choice of lysis buffer 
The native lysis buffer system recommended for the High-Trap column from 
Pharmacia was used for the lysis of bacterial cells induced to express the required 
proteins (see table of standard solutions and buffers). Tris-buffer is not 
recommended because it interferes with the metal-chelating system. Reagents 
with secondary or tertiary amines will reduce the nickel ions, and thus reduce or 
even eliminate the specific binding between the bound metal ion and the His-tag 
molecule. Other reagents that interfere with the ionic binding are HEPES, MOPS, 
EDTA, EGTA, DTT, SDS, Gly, Gln, Asp, His, NH3. 
3.4.1.3 Isolation of the recombinant proteins 
A Hi-Trap chelating column (1 ml column volume, from Amersham pharmacia 
Biotech) was charged with Ni2+ immobilization buffer as recommended by the 
manufacturer and equilibrated with 5 column volumes (CV) of Ni2+-column 
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equilibration buffer A. After applying the bacterial lysate to the column, unbound 
material was washed out with 5 CV of Ni2+-column equilibration buffer A. 
Specifically bound recombinant proteins were eluted from the column with 5 CV 
Ni2+-column elution buffer B and were dialysed against PBS overnight at 4°C.  
Purity and correct molecular weight of the eluted proteins was proved by 
Coomassie staining of SDS-PAGE gels and western blotting using specific 
antibodies against the N-terminal histidine residue. Protein concentration was 
estimated by comparison to known concentrations of bovine serum albumin on 
Coomassie gels and with BioRad DC protein assay kit ® (BioRad). 
3.4.2 Antibody purification protocol  
Polyclonal antibodies were isolated from animal anti-sera by affinity 
chromatography. The bacterial protein purified by affinity Hi-Trap chelating column 
was dialysed against 100 mM 3-(N-morpholino) propanesulfonic acid (MOPS) 
buffer pH 7.0 and calcium chloride (CaCl2) was added to the protein solution to 
reach an end concentration of 80 mM CaCl2. About 2 ml of affigel 10®  slurry were 
washed with 10 bed-volumes of 100 mM MOPS buffer pH 7.0 and mixed with the 
His- or GST-tagged protein. After the gel had settled down a 50 µl aliquot from the 
supernatant was taken as sample 1. The gel-protein mix was left on a shaker 
overnight at 4°C to allow coupling of tagged protei n to gel beads and after settling 
of the gel another 50 µl aliquot was taken from the supernatant (sample 2). 
Coupling efficiency of protein molecules to the gel beads was approved by 
comparing protein content in sample 1 and 2. After the slurry was washed with 10 
bed-volumes of 100 mM MOPS pH 7.0 to remove unbound protein molecules, it 
was incubated on a shaker with 1 M ethanolamine HCl pH 8.0 (0.1 ml/ml gel) for 1 
hr. The produced matrix was applied to a prepared column and washed with 10 
column volumes (CV) of 100 mM MOPS pH 7.0 followed by 10 CV of 100 mM 
MOPS pH 7.0 + 0.2 % NaN3 as a preservative buffer and keep at 4°C for later  use.  
Directly before using the column, it was equilibrated by washing with 10 CV of 
each of the following buffers respectively: 1M NaCl phosphate buffer, 100 mM 
glycine pH 2.5, 10 mM Tris pH 8.8, 100 mM triethanolamine pH 11.5, and 10 mM 
Tris pH 7.5. Animal anti-serum containing the antibodies was diluted 1:10 in 10 
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mM Tris pH 7.5 and centrifuged at 5,000 rpm before applying the supernatant 
slowly to the equilibrated antigen column. After collecting the flow through, the 
column was washed with 10 CV of 10 mM Tris pH 7.5 followed by 10 CV 10 mM 
Tris pH 7.5 + 0.5 M NaCl to remove any non-specifically bound proteins. Bound 
antibodies were first acidic-eluted with 5 CV of 100 mM glycine pH 2.5 and 
collected in 0.5 CV 1M Tris pH 8.5. In the next step, the column was washed with 
10 mM Tris pH 8.8 until the pH of the column reach 8.8, the remaining antibodies 
were basic-eluted using 10 CV of 100 mM triethanolamine pH 11.5 and collected 
in 0.5 CV of 1M Tris pH 8.0.  
The eluted antibody fractions from acidic & basic elutions were pooled and 
concentrated using spin concentrator (Centriplus YM-30 KMWCO millipore corp, 
Amicon) before being dialysed against 100-volumes PBS buffer three times. 
Dialyzed antibodies were stored in 50% glycerol and kept at –20°C. After elution of 
antibody, used columns were washed with 10 mM Tris-HCl pH 7.5 until pH value 
of 7.5 was reached and stored in the preservation buffer at 4°C. 
3.4.3 Western blot analysis 
3.4.3.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Proteins possess charges as a result of acidic and basic amino acids, and in 
PAGE, the migration depends on the protein charge. However, in sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) proteins are separated 
primarily according to their molecular weights because the negatively charged 
SDS molecules bind along the polypeptide chain and mask the charges in the 
molecule. During electrophoresis, migration distance of the reduced SDS-protein 
complex is proportional to its molecular weight and does not dependent on protein 
charge.  
Separating gel of different percentages of acrylamide were prepared regarding the 
molecular weight of the separated protein according to the following table (table 8). 
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Table 8: Ingredients for preparing separating SDS polyacrylamide gels. 
Solutions  6% 7,5% 10% 12,5% 15% 
H2O 5,79 ml 5,42 ml 4,79 ml 4,17 ml 3,54 ml 
40% Acrylamide 1,50 ml 1,88 ml 2,50 ml 3,13 ml 3,75 ml 
1,5 M Tris-HCl pH8.8 2,50 ml 2,50 ml  2,50 ml 2,50 ml 2,50 ml 
10% SDS 0,10 ml 0,10 ml 0,10 ml 0,10 ml 0,10 ml 
10% APS 0,10 ml 0,10 ml 0,10 ml 0,10 ml 0,10 ml 
TEMED 0,01 ml 0,01 ml 0,01 ml 0,01 ml 0,01 ml 
Stacking gel of 5%  acrylamide was prepared according to the following table 
(table 9) 
Table 9: Ingredients for preparing 5% stacking SDS polyacrylamide gel.
Solutions Volumes (in ml) for 10 ml 
H2O 6,04 
40% Acrylamide 1,25 
0,5 M Tris-HCl pH6.8 2,5 
10% SDS 0,1 
10% APS 0,1 
TEMED 0,01 
Using the Biorad gel casting system, the separating gel solution was filled in 
between the assembled glass plates. After the separating gel was polymerized, 
the stacking gel was poured on top and a comb with the required lane size was 
inserted between the glass plates then the gel was allowed to fully polymerize. 
polymerizaed gels were assembled in the electrophoresis cells according to 
manufacturer’s instructions and combs were removed.  Appropriate amount (30-50 
µg of total protein extract) of the protein samples to be analysed were mixed with 1 
volume of 2 x sample buffer containing SDS and β-mercaptoethanol. Samples 
were boiled for 5 min to denature the proteins. After a brief centrifugation, the 
samples were loaded into the lanes of the SDS-gel assembled in an 
electrophoresis cell (Protean, BioRad®) containing running buffer. A constant 
voltage of 80 V was applied to the gel until the tracking dye entered the separating 
gel then the voltage was increased to 120 V until the dye reached the bottom of 
the gel. 
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3.4.3.2 Semi dry protein transfer (blotting) 
Following SDS-PAGE, separated proteins were transferred to nitrocellulose 
membrane having 0.45 µm pore size (Schleicher & Schuell) in a semi-dry blotting 
apparatus (BioRad) at 0.8 mA/cm2 for 90 min using Tris/glycine/methanol blotting 
buffer. After transfer, the membrane was washed twice with 1 x TBS and stained 
with Ponceau-S to ensure proper loading and blotting as recommended by the 
supplier. Free protein binding sites on the membrane were blocked by incubation 
in 5 % skimm milk in TBS containing 0.05 % Tween-20 (TBS-T) at RT for 1 hr or 
over night at 4°C. After washing three times with T BS-T, the membrane was 
incubated with affinity purified primary antibody diluted in TBS-T containing 0.5 % 
skimm milk for 1 hr at RT. Unbound antibodies were removed by triple wash in 
TBS-T. Membrane was then incubated for 1 hr at RT with a peroxidase labelled 
secondary antibody against rabbit diluted similarly in TBS-T containing 0.5 % 
skimm milk. After three washings in TBS, bound antibodies were visualized by the 
ECL system (Amersham Pharmacia Biotech) according to manufacturer's protocol. 
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4. Results 
Part I: Cellular localization of HRP-3 
I.1 Expression of HRP-3 under physiological conditions 
I.1.1 HRP-3 expression in adult mouse nervous system 
I.1.1.1 HRP-3 expression in adult mouse brain  
In the work done before (diploma thesis, Eltahir) the immunolocalization of 
different HDGF related proteins was shown using vibratome free floating brain 
sections of adult mice. Immunostaining using affinity purified polyclonal antibodies 
raised against the investigated proteins showed a different expression pattern for 
each protein. Whereas HDGF was widely expressed throughout all brain areas, 
HRP-3 showed more restricted expression mostly in the cerebellum and 
hippocampus. 
Starting with the cerebellum, the schematic diagram represented in figure 5 shows 
the cellular organization and architecture of a cerebellar lobe. It consists basically 
of three layers that differ in their cellular content including the molecular cell layer, 
Purkinje cell layer and internal granular layer arranged starting from outside. The
molecular cell layer
 (MCL) contains two types of inhibitory interneurons: the 
stellate cells
 and basket cells. It also contains the dendritic arbours of Purkinje 
neurons and parallel fibre tracts from the granule cells in addition to axons of Golgi 
cells. Both stellate and basket cells form GABAergic synapses onto Purkinje cell 
dendrites.  
The middle layer, Purkinje cell layer (PCL), contains only one type of neuronal cell 
bodies, that of the large Purkinje cell. Purkinje cells are primary GABAergic 
integrative neurons of the cerebellar cortex having dendrites that are large arbours 
with hundreds of spiny branches reaching up into the molecular layer and exist in 
one plane (flat). Both basket and stellate cells (found in the cerebellar molecular 
layer) provide inhibitory (GABAergic) input to the Purkinje cell, with basket cells 
synapsing on the Purkinje cell axon initial segment and stellate cells onto the 
dendrites. Purkinje cells send inhibitory projections to the deep cerebellar nuclei, 
and constitute the sole output of all motor coordination in the cerebellar cortex. 
The third, innermost, layer is the granular cell layer which consists of two cell 
types: the numerous and tiny granule cells and the larger Golgi cells. Granule cells 
are glutamatergic neurons that account for nearly half of the neurons in the central 
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nervous system and are found in cerebral cortex, olfactory bulb, dentate gyrus and 
hippocampus in addition to the cerebellum. They send their T-shaped axons -
known as parallel fibres- up into the superficial molecular layer where they form 
hundreds of thousands of synapses with Purkinje cell dendrites. Golgi cells on the 
other hand are GABAergic neurons providing inhibitory feedback to granule cells, 
forming a synapse with them and projecting an axon into the molecular layer (Fine, 
et al., 2002; Muller and O'Rahilly, 1990). 
Figure 5: Schematic diagram of a lobe of the cerebellum.
 The mammalian cerebellum 
consists of three layers ordered from the outer to the inner: the molecular cell layer which 
contains basket and stellate cells, the dendritic arbors of Purkinje cells and the parallel 
fibers of the granule cells, Purkinje cell layer which contain the largest neuronal cells 
(Purkinje cells) and the nuclear (internal granular) layer which contains the small granule 
cells and the larger Golgi cells (Grey’s anatomy, 1918).   
Sagittal sections of paraffin embedded brains obtained from adult mice were used 
to immunolocalize HDGF and HRP-3. To proof the identity of the different cell 
types specific neuronal markers were used for double staining and bound 
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antibodies were visualized by different fluorescently labeled secondary antibodies. 
First, brain sections were stained against HDGF or HRP-3 together with a granular 
cell marker (NeuN, figure 6) to examine if both proteins were expressed by this cell 
population or with calbindin as a Purkinje cell marker to test for their expression in 
Purkinje cells (figure 7). Analysis using laser scan microscopy showed that most of 
the cells were expressing HDGF including granular cells and Purkinje cells of the 
cerebellum in addition to cells in the molecular cell layer (figures 6A, 7A). On the 
other hand, a very restricted expression pattern was detected in HRP-3 stained 
sections. HRP-3 was expressed in the Purkinje cell layer similar to HDGF but 
surprisingly only few NeuN negative cells were expressing it in the granular cell 
layer. These HRP-3 positive cells are most likely Golgi cells (arrow heads in 
figures 6F, 7D). 
Figure 6: Expression of HDGF and HRP-3 in granular cells of the mouse cerebellum. 
Antibodies against HDGF (A) or HRP-3 (G) together with NeuN (B, E) were used to 
detect the expression of both proteins in paraffin embedded brain slices from adult mice. 
Double staining of HDGF or HRP-3 with NeuN demonstrated that in contrast to HDGF 
which was widely expressed in most of the cells, HRP-3 was not expressed in NeuN 
positive granular cells of the cerebellum. Only few distinct NeuN negative cells in the IGL, 
most likely Golgi cells, were detected to be HRP-3 positive (F, arrowheads). HRP-3 was 
also clearly expressed in the PCL and weakly in some cells of the MCL (F). MCL: 
D: HRP-3 E:
E: 
F:
E: 
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molecular cell layer; PCL: Purkinje cell layer; IGL: internal granular cell layer; WM: white 
matter. Bars are 80 µm.  
Figure 7: Expression of HDGF and HRP-3 in Purkinje cells of mouse cerebellum.
Antibodies against HDGF (A) or HRP-3 (D) together with Calbindin (B, E) were used to 
detect the expression of the respective proteins in paraffin embedded brain slices from 
adult mice. Double staining of either proteins together with Calbindin (Purkinje cell 
marker) demonstrated that both members were expressed in nuclei of Calbindin positive 
cells of the cerebellum (arrowheads in A and D). Arrows in C indicate HDGF positive cells 
in the white matter. Arrows in F point to HRP-3 expressing cells in the IGL. MCL: 
molecular cell layer; PCL: Purkinje cell layer; IGL: internal granular cell layer; WM: white 
matter. Bars are 40 µm. 
Detecting HDGF positive cells in white matter tracts was behind a more detailed 
investigation about the expression of HDGF and HRP-3 in glial cells. So that, the 
specific antisera directed against both proteins together with a monoclonal 
antibody recognizing glial fibrillary acidic protein (GFAP) were applied to sections 
from adult mouse brain. Immunostaining showed that cells with HDGF positive 
nuclei also expressed GFAP (arrowheads, figure 8). In contrast, HRP-3 did not 
localize to GFAP positive cells. Therefore, astrocytes express HDGF but no HRP-
3. To investigate the expression of HDGF and HRP-3 in oligodendrocytes a co-
immunostaining on brain stem sections was performed for both proteins together 
E:
E: 
F:
E: 
D: 
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with an antibody against 2,3-cyclonucleotid-phosphodiesterase (CNPase, Figure 
9).  
Figure 8: Expression of HDGF and HRP-3 in astrocytes. Antibodies against HDGF 
(A), HRP-3 (D) and GFAP (B & E) were used to detect the respective proteins in the 
hippocampal region of adult mice brain. Double immunfluorescence demonstrates that 
HDGF (C, arrows) was expressed in cells positive for GFAP. On the other hand, no GFAP 
positive cells could be detected as HRP-3 positive (F). Bars are 40 µm.
D: HRP-3 E: GFAP F: Overlay 
D: HRP-3 E: CNPase F: Overlay 
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Figure 9: Expression of HDGF family members in oligodendrocytes. Antibodies 
against HDGF (A), HRP-3 (D) and CNPase (B & E) were used to detect the respective 
proteins in fibre tracts in the brain stem of adult mice brain. Double immunfluorescence 
demonstrates that HDGF (C, arrowheads) was strongly expressed by cells also positive for 
CNPase. In contrast HRP-3 was only very weakly expressed by this cell type (F, 
arrowheads) when compared to other HRP-3 positive cells which most likely represent 
brain stem neurons (F, asterisks). Bars are 25 µm. 
Also in this staining HDGF was strongly expressed by CNPase positive cells 
(arrowheads in Figure 9) whereas these cells showed only very limited HRP-3 
expression when compared to cells most likely representing neuronal cells of the 
brain stem that are strongly HRP-3 positive. 
To examine whether beside the described differences there were also cell 
populations that simultaneously express both proteins, double staining of paraffin 
embedded adult brain sections using sheep antiHDGF together with rabbit 
antiHRP-3 was performed. A set of two different fluorescently labelled goat anti 
sheep and goat anti rabbit secondary antibodies was used to visualize the bound 
primary antibodies. Using laser scan microscopy, the expression of both proteins 
in cerebellum showed a low degree of co-localization. HRP-3 was expressed only 
in Purkinje cells and Golgi cells of the IGL but not in the white matter or in the rest 
of granular cells (figure 10E). Although HDGF was expressed in most of IGL cells, 
some of the possibly Golgi cells did (arrow heads) and some did not express 
HDGF (asterisk) as shown in figures 10B & C.  
Figure 10: Simultaneous expression of HDGF and HRP-3 in adult mouse brain 
cerebellum.
 Antibodies against HDGF (A) and HRP-3 (B) were used to detect both 
proteins in the cerebellum of an adult mouse brain. Comparison of the double 
immunfluorescence demonstrated a low degree of co-expression. Whereas HRP-3 was 
A CB
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only expressed in Purkinje cells and in Golgi cells of the IGL (B), HDGF was expressed in 
most of cerebellum cells (A) including some of the HRP-3 positive Golgi cells (D-F, 
arrowheads). Some of HRP-3 positive Golgi cells did not express HDGF (B+C, asterisks). 
EGL: external granular layer; MCL: molecular cell layer; PCL: Purkinje cell layer; IGL: 
internal granular cell layer; WM: white matter. Bars are 40 µm. 
The simultaneous expression of HDGF and HRP-3 was tested in two other brain 
structures: hippocampus and cortex. Hippocampus is a part of the forebrain that 
plays an important role in short term memory. It can be divided mainly into three 
structures: the dentate gyrus (DG), subiculum (Sub) and Cornu ammonis (CA). DG  
consists of three cell layers: a molecular, a granular and a polymorphic layer. Sub
is composed of tightly packed pyramidal neurons (striatum pyramidale) which 
extend their dendrites into the second layer of subiculum, the striatum moleculare. 
The third structure, CA, consists of five layers: Stratum lacunosum-moleculare (I), 
Stratum radiatum (II), Stratum pyramidale (III), Stratum oriens  (IV) and Alveus (V, 
only axons = white matter) mentioned from inside to outside as seen in figure 11 
(Amaral, 1978; Amaral and Lavenex, 2006; Andersen, et al., 1971). 
Double staining against HDGF and HRP-3 in the hippocampus area demonstrated 
that neurons in the different hippocampal structures co-expressed both HDGF and 
HRP-3 in varying degrees. Whereas HDGF was more evenly expressed in the 
whole hippocampal structures (figure 12A), HRP-3 showed a weak expression 
signal in the DG when compared to its signal in the rest of the hippocampus 
including sub and CA1 (figure 12B). In addition, the cells lining the ventricular wall 
of the hippocampus showed a lack of HRP-3 expression in the same time they 
expressed HDGF clearly (arrow in figure 12C).  
Figure 11: A Schematic diagram showing the laminar structure of the hippocampus.
The hippocampus consists of three regions: the dentate gyrus, cornu ammonis CA1-3 and 
the subiculum. The dentate gyrus can be divided into lamina molecularis (I), lamina 
granularis (II) and hilus (III); and the cornu ammonis into: stratum lacunosum-moleculare 
(I), stratum radiatum (II), stratum pyramidale (III), stratum oriens (IV) and Alveus (V).  
Fimbria hippocampi
Dentate gyrus 
Subiculum 
Sulcus hippocampi 
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Figure 12: Comparison of HDGF and HRP-3 expression in mouse hippocampus.
 An  
antibody against HDGF raised in sheep (A) was used together with the rabbit raised 
antibody against HRP-3 described before (B) to detect both proteins in the hippocampus of 
adult mouse brain. Cells covering the ventricular wall of the hippocampal region (arrow in 
C) did not express HRP-3, whereas HDGF was clearly expressed in this cell type. 
Hippocampal neurons co-expressed both family members. Whereas HDGF was almost 
evenly expressed in all neurons of the hippocampus (A), neurons of the DG showed only 
weak expression of HRP-3 compared to the rest of the hippocampus (B). Arrow heads in D 
(D is a higher magnification of C) show cells that predominantly expressed HRP-3 
whereas arrows show a cell layer that was only positive for HDGF. CA: cornu ammonis; 
Sub: subiculum; DG: dentate gyrus; Bar in C is 80 µm; bar in D is 40 µm. 
Arrow heads in figure 12D show cells that predominantly expressed HRP-3 
whereas arrows show a cell layer that was only positive to HDGF. The Pia mater 
represents the innermost layer of the meninges enveloping and protecting the 
brain and is derived from neural crest cells on the surface of the neocortex.  
Immunostaining demonstrated that cells forming the Pia mater (PM, figures 13A & 
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C), expressed HDGF but not HRP-3. Some cells in layer I were HRP-3 negative 
whereas cells in the rest of the cortex showed a high degree of co-expression of 
both HDGF and HRP-3 (figures 13A-C).  
Figure 13: HDGF and HRP-3 expression in adult mouse brain cortex.
 Antibodies 
against HDGF (A, D) or HRP-3 (B, E) were used to detect both proteins in the neocortex 
of an adult mouse. Comparison of the double immunfluorescence demonstrated the lack of 
expression of HRP-3 in cells building the pia mater at the surface of the cortex (PM in C) 
and some cells in layer I (C, arrows). Cells in the rest of the cortex showed a high degree 
of co-expression of HDGF and HRP-3. PM: Pia Mater; I+II: layer I and II. Bars are 40 µm. 
As it was shown before in fluorescently stained free floating sections from adult 
brain, HRP-3 was expressed in the processes of hippocampal neuron. To have a 
more detailed view, a better structure preservation was required. So that paraffin 
blocks  prepared from PFA perfused and fixed adult mouse brain were used to 
prepare 5 to 10 µm thick sagittal sections. These sections were deparaffinized and 
immunostained as mentioned in the Methods part using a biotin labelled anti-rabbit 
secondary antibody. Bound antibodies were visualized with Histogreen as a 
substrate (chromogen) for the Avidin-biotin reaction. This method of staining 
provided a very good structure preservation. Examination by light microscopy 
interestingly demonstrated a cytoplasmic localization of HRP-3 in addition to the 
expected nuclear signal in some brain regions. Arrows in figures 14A & D point to 
cells in the cerebral cortex that beside the nuclear signal also showed a signal in 
some of their processes. These cells represented most probably neuronal cells of 
the third cortical layer (layer III) which are usually characterized by the vertically-
oriented intracortical axons. In the Sub and CA (in hippocampus) also, 
extranuclear expression signals for HRP-3 were detectable (figure 14B & E) .  
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Figure 14: Extranuclear expression of HRP-3 in different areas of adult mouse brain.
  
Five to ten micrometer-thick paraffin embedded adult mouse brain sections were 
immunostained against HRP-3 using biotin labelled secondary antibody. Avidin biotin 
complex kit followed by Histogreen as a chromagen were used to visualize the 
immunreaction. Examination under a light microscope showed an expression of HRP-3 in 
the nuclei as well as in the cytoplasm including cell body and/or cell processes in the 
deeper layers of the cortex (A), stratum pyramidale and stratum radiatum layers of the 
hippocampus (B) and in Purkinje cells in the cerebellum (C). Arrows point to areas of 
cytoplasmic expression whereas arrowheads point to nuclear signal of HRP-3. D, E and F 
are higher magnifications of the 20x  photos A, B and C. CA 1: cornu ammonis 1; Sub: 
subiculum; IGL: internal granular cell layer; PCL: Purkinje cell layer; MCL: molecular cell 
layer. St. radiatum: stratum radiatum; St. pyramidale: stratum pyramidale; St. oriens: 
stratum oriens. Bars are 20 µm.
In the different hippocampal structures, HRP-3 was expressed in the nuclei of the 
pyramidal cells (stratum pyramidale, layer III) and possibly in the nuclei of some 
cells of striatum oriens (layer IV) as seen in figures 14B & E. In addition, an 
A: Cortex D: Cortex 
E: HippocampusB: Hippocampus
Sub 
CA 1 
St. radiatum
St. pyramidale
St. oriens 
F: Cerebellum C: Cerebellum
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extranuclear expression of HRP-3 in the Stratum radiatum was detected, which 
contains septal and commissural fibers (arrows in figure 14E) together with some 
interneurons (basket cells, bistratified cells, and radial trilaminar cells).   
In a third region, the cerebellum, also a cytoplasmic signal for HRP-3 was clearly 
detected in the largest neurons found there, Purkinje cells. These cells which have 
characteristic highly branched processes showed a very impressing HRP-3 
staining in their dendritic trees. In the same way, this extranuclear expression 
pattern was accompanied by a more prominent nuclear HRP-3 signal as shown by 
the arrows in figures 14C & F. 
I.1.1.2 HRP-3 expression in adult mouse spinal cord  
The spinal cord is a long, thin tubular bundle of nerves that represents an 
extension of the central nervous system arising from the brain. Its main function is 
to transmit neural inputs and outputs between the brain and the periphery. It 
consists mainly of an outer envelope called the white matter and an inner core 
named the grey matter which can be distinguished by the naked eye due to the 
color difference. The white matter consist mainly of the myelinated nerve axon 
fibers traveling long distances from the spinal cord to the brain and vice verse in 
addition to a minor population of cells, some astrocytes, oligodendrocytes and 
endothelial cells from blood vessels. On the other hand, the grey matter is made 
up mainly of different types of neuronal cell bodies together with their dendrites. 
Grey matter can be divided roughly into two ventral and two dorsal horns.  
Figure 15: Schematic diagram of the adult spinal cord in mammals. Spinal cord 
consists of white matter (the outer part, white in diagram) and grey matter (inner core, grey 
in diagram). Numbers represent the following structures: 1 ventral horn, 2 dorsal horn, 3 
5
6
7
8
9
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Gray’s commissure, 4 white matter, 5 central canal, 6 ventral root, 7 dorsal root, 8 dorsal 
root ganglion, 9 spinal nerve. 
Motor neurons are located in the ventral horns on the ventral side of the spinal 
cord (structure 1, figure 15) giving rise to the ventral roots (structure 6, figure 15) 
which are bundles of nerve axons innervating target muscles. The sensory 
neurons (projection- and interneurons), on the other hand, exist in the dorsal horns 
of the spinal cord (structure 2, figure 15) and deal with the sensory perception 
signals from allover the body transmitted to them through the dorsal roots 
(structure 7, figure 15). 
Along their length, these dorsal roots show cell aggregations named the dorsal 
root ganglia (DRG, structure 8 in figure 15). DRG consist of afferent (receptor) 
spinal neuron cell bodies that send their dendrites to the periphery to take up the 
sensory signals and send their axons in a bundled form called the dorsal roots to 
the spinal cord to conduct the received signals. In the intermediate area between 
both horns, the autonomic neurons which innervate muscles and glands are 
located (Nolte, 2002). As a part of the nervous system, it was interesting to know if 
HRP-3 was expressed in the spinal cord. To check for HRP-3 expression in this 
organ, paraffin embedded transverse sections from adult mouse spinal cord were 
stained against HRP-3 using a non fluorescent avidin-biotin based immunostaining 
technique. A moderate expression signal was detected in many areas including 
both white and grey matter. As mentioned above, HRP-3 was expressed in the 
adult mouse brain in both nuclear and extranuclear patterns in some cell 
populations. Similarly, adult spinal cord showed nuclear and extranuclear 
expression patterns. Here, HRP-3 was distributed between nuclei in the majority of 
cells on one side as shown by arrows in the figures 16D & E, and the cytoplasm 
and cell processes in a minority of cells on the other side as shown by arrow 
heads in these figures. It can also be noticed that the expression level of HRP-3 
was higher in motor neurons area in the ventral horn (figures 16D & E) than in the 
sensory neurons area in the dorsal horn (figure 16C). Also axons in the white 
matter showed a fibrous staining pattern for HRP-3 as seen in figure 16E. No 
significant signal for HRP-3 expression was detected in the ependymal cells 
surrounding the central canal through which the cerebrospinal fluid runs in the 
middle of the grey matter (figure 16B). No immunoreactivity was observed when 
only the secondary antibody was used for immunostaining. 
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Figure 16: Expression of HRP-3 in adult mouse spinal cord.
 Transverse sections from 
adult mouse spinal cord were stained against HRP-3 using avidin-biotin system followed 
by Histogreen®. Figure A represents a mosaic overview of the whole section assembled 
from multiple, low magnification pictures (10x, A). C, D and E represent shots from three 
different areas taken at a higher magnification. A clear expression signal was detected for 
HRP-3 in the areas D and E (motoneuron areas) in the nuclei of many cells (arrows) as 
well as in the cell cytoplasm and processes of other fewer cells in the grey matter (arrow 
heads). A fibrous expression pattern for HRP-3 was also noticed in the white matter, WM 
(E). The area of sensory neurons (C) showed a weaker HRP-3 signal detected in fewer 
cells compared to motoneuron areas. Ependymal cells surrounding the central canal did not 
express HRP-3 (B). GM: grey matter, WM: white matter. Bars are 50 µm.   
I.1.1.3 HRP-3 expression in adult mouse sciatic nerve  
HRP-3 expression up to this point was detected in the central nervous system 
(CNS) but whether it is expressed in the peripheral nervous system (PNS) needed 
further examination. The sciatic nerve is a part of this PNS and is the largest and 
thickest nerve in the body emerging from the spinal cord at the lumbar part. It 
represents the main nerve supply for the lower limb and consists of a large 
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number of myelinated fibers (myelinated nerve axons). Myelination process of the 
peripheral nerves includes the enwrapping of the axons with layers of special, lipid 
enriched membranes (myelin) which act as an insulator for the transmitted signals. 
In the periphery, myelin production is taken over by Schwann cells that lie among 
the nerve axons. Each single axon (fiber) is individually wrapped with a very 
delicate layer of connective tissue called the endoneurium produced by fibroblasts. 
These individual fibers are collected into numerous bundles and each nerve 
bundle is surrounded by a layer of connective tissue known as the perineurium 
separating it from other bundles. These wrapped bundles are then collected all 
together to form the nerve by an external layer of connective tissue: the 
epineurium.  
To examine for HRP-3 expression in the PNS, sciatic nerve was prepared from the 
lower limb of an adult mouse and cut into longitudinal sections. These sections 
were stained against HRP-3 and HDGF for comparison using immunofluorescent 
staining technique. As expected from a protein expressed by axons, HRP-3-
stained nerve sections showed a fibrous staining along the nerve as shown by 
arrow heads in figure 17A. In contrast, HDGF-stained sections showed only a 
nuclear pattern of staining (figure 17B) probably corresponding to the nuclei of 
Schwann cells present along the nerve fibers. 
Figure 17: Expression of HRP-3 and HDGF in adult mouse sciatic nerve.
 Paraffin 
sections obtained from adult mouse sciatic nerve cut along its length were stained against 
HRP-3 or HDGF using specific primary antibodies and fluorescently labelled secondary 
antibody. Boxes in A and B represent a higher magnification of the original pictures. A 
fibrous pattern of staining was observed in the sections stained for HRP3 as shown by the 
arrow heads in box 1. On the other hand, a staining of what is likely to be Schwann cell 
nuclei was observed in case of HDGF stained sections with a complete absence of axonal 
staining as seen in box 2. Bars are 20 µm. 
A: Anti HRP-3 Box 1 B: Anti HDGF Box 2
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I.1.2 HRP-3 expression in the embryonic mouse  
I.1.2.1 General expression of HRP-3 in mouse embryo
All the previously presented data showed that HRP-3 was expressed in both adult 
CNS and adult PNS. The expression signal was detected primarily in cell nuclei 
but in some cell populations HRP-3 was also expressed in the cell cytoplasm. 
To check for a possible expression of HRP-3 during the development of the 
nervous system, immunhistochemistry was performed on sections prepared from 
mouse embryos at different developmental stages. First, transverse sections in the 
neck region of an E11.5 mouse embryo were stained against HRP-3. Staining 
showed a strong expression signal that was highly restricted to nervous tissues 
(Figure 18A). At this time point of the embryonic life, the neural plate had already 
folded itself into a neural tube. This tube can be distinguished into a dorsal part 
and a ventral part. The dorsal part contains the sensory neurons which receive 
sensory inputs from the different organs through axon bundles known as the 
posterior or dorsal roots (these axons develop from the cells of the neural dorsal 
ganglia). The ventral part contains the motor neurons which extend their axons in 
the form of bundles known as the anterior or ventral roots to the different organs 
as seen in the schematic diagram (figure 18B). Immediately beyond the dorsal root 
ganglion (DRG, neural ganglion), both ventral and dorsal roots join to form a spinal 
nerve which later on is split into anterior, posterior, and visceral divisions (Kandel, 
et al., 2000).  
Immunostaining against HRP-3 in figure 18 shows that the motor neurons (MN) 
and their axons (anterior nerve root, ANR)  expressed higher amounts of HRP-3 
than the sensory neurons (SNC) which resembles the pattern represented before 
in the adult spinal cord. In the posterior nerve root (PNR), a much weaker signal 
was detected, however, the oval bundle (OB) which is the area where the PNR 
penetrates the neural tube showed a comparatively high expression signal. The 
expression was also high in the spinal nerve (SN) and its visceral branch (VB). 
Comparing the expression in the sympathetic ganglia (SG) and in the dorsal root 
ganglion (DRG) showed that the former ones, SG, expressed higher amounts of 
HRP-3 than the latter, DRG. A weaker signal was detected in the rest of the neural 
tube cells including the roof and floor plates (RP & FP, respectively) and the 
neuroepithelium forming the major mass of the neural tube. In the same time, no 
detectable expression signal for HRP-3 was found in the other structures 
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comprising the rest of the embryonic tissue seen in these sections other than 
those related to the nervous system. Similar observations in the neural tube were 
obtained from free floating, PFA fixed transverse sections using fluorescent 
secondary antibody (see supplementary data, figure S1). 
  
Figure 18: Expression of HRP-3 in transverse section of E11.5 mouse embryo. Picture 
A represents a transverse section from an E11.5 mouse embryo in the neck area showing 
the neural tube immunostained against HRP-3 using avidin-biotin technique. A strong 
expression signal for HRP-3 was detected in most of the neural tube structures including 
oval bundle (OB), sympathetic ganglion (SG), anterior nerve root (ANR, Efferent motor 
neuron axons), spinal nerve (SN) and motor neuron (MN) cell bodies. A weaker HRP-3 
signal was detected in neural ganglion (NG), floor and roof plate (FP, RP), posterior nerve 
root (PNR) and neuroepithelium (NE). B: schematic diagram represents the different 
structures in the neural tube (Grey’s anatomy). A: aorta, CC: central canal, SNC: sensory 
neurons cell bodies, EL: ependymal layer, VB: visceral branch of the spinal nerve. Bar is 
100 µm. 
Staining of sagittal section near the middle line of an E15.5 whole mouse embryo 
against HRP-3 underlined the results regarding the restriction of HRP-3 
expression to nervous tissue (Figure 19). All brain divisions, prosencephalon (I), 
mesencephalon (II) and rhombencephalon (III) were positive for HRP-3. In 
addition,  a signal was detected in the exposed parts of the spinal cord (arrows in 
figure 19A) and in the dorsal root ganglia (DRG, figure 19B) together with the 
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fibres connecting them to the spinal cord (dorsal roots, posterior nerve roots) as 
pointed out with arrow heads in figure 19B. 
Figure 19: Expression of HRP-3 in E15.5 mouse embryo.
 Sagittal section in E15.5 
paraffin embedded mouse embryo was stained against HRP-3 using a red fluorescent 
secondary antibody together with the blue fluorescent DNA stain 4,6-diamidino-2-
phenylindole (DAPI). HRP-3 expression was restricted to the nervous tissue including 
brain, spinal cord and dorsal root ganglia. A fibrous staining of HRP-3 in posterior nerve 
roots at DRG level (B) can be seen. Other fibrous structures representing mainly organ 
innervations were recognized as HRP-3 positive structures in A. Red signal in liver was 
not considered to be a positive HRP-3 expression signal as the same signal was obtained 
when the secondary antibody was used alone. I, II and III represent the three brain 
divisions: prosencephalon, mesencephalon and rhombencephalon, respectively. White 
triangles represent brain ventricles. 
In addition to these tissues, some fibrous structures in many organs were detected 
to be strongly HRP-3 positive as shown by the asterisks in figure 19A. From the 
previously represented HRP-3 expression pattern it can be speculated that these 
structures probably represent nerve fibers (innervations) supplying these organs. 
On the other hand, positive HRP-3 signal was neither detected in the skin and 
muscles of the embryo nor in the inner organs except for some background 
staining detected in liver which was also detected in similar sections incubated 
with the secondary antibody only. 
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I.1.2.2 HRP-3 expression in embryonic mouse DRG 
Dorsal root ganglia (DRG) are collections of nerve cells on the posterior roots of 
the spinal nerves and consist mainly of spinal neurons from which the fibers of the 
posterior root take origin and travel to the spinal cord. As mentioned before, 
directly beyond the ganglion both the anterior and posterior roots join to form the 
spinal nerve.  
Staining of sagittal sections cutting through the DRG from embryos at different 
developmental stages (E10.5, E11.5, E13.5 and E15.5) against HRP-3 showed 
that the protein was strongly expressed in DRG (as shown by arrow heads in 
figures 20A, B, C and D) and in the spinal nerves (as shown by arrows in figure 
20B & C) in all time points examined.  
B: E 11.5A: E 10.5
C: E 13.5 D: E 15.5
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Figure 20: HRP-3 expression in embryonic mouse dorsal root ganglia. Sagittal sections 
in the DRG area from paraffin embedded mouse embryos at E10.5, E11.5, 13.5 and E15.5 
were stained against HRP-3 (A-E) or HDGF (F). HRP-3 signal was strong in all time 
points in both: DRG (arrow heads A-D) and connected nerves (arrows in B & C). E and F 
represent higher magnification of DRG at E13.5 stained against HRP-3 or HDGF 
respectively. HRP-3 showed a strong signal in the cytoplasm and processes of a cell 
population bearing a single process (arrows in E). HDGF expression was restricted to the 
nuclei of some cells in the ganglion (arrow heads in F). Bars are 20 µm. 
When higher magnification was used to examine HRP-3 expressing cells within 
the DRG of E13.5 mouse embryos, many cells with minor morphological 
differences (representing mostly the same cell population) were detected to be 
HRP-3 positive. These cells showed a prominent cytoplasmic signal that extended 
to a single cell process as shown by arrows in figure 20E giving the outline of 
unipolar-looking cells. In contrast, tissue sections stained for comparison against 
HDGF -which is the parent member in this protein family- demonstrated an 
exclusive nuclear signal for HDGF (figure 20F, arrowheads). Comparing the 
pictures E and F in figure 20 indicates a clear and basic difference in the 
subcellular distribution of both proteins. Whereas HRP-3 showed a characteristic 
intense signal in the cytoplasm in addition to the positively stained fibers, only a 
nuclear expression signal was detected for HDGF suggesting different functions 
for both growth factors.
I.1.2.3 HRP-3 expression in the developing mouse cerebral cortex  
Taking a closer look into the embryonic brain, it was noticed that HRP-3 at the 
early life stage exists in nearly all cortical cells including neurons, radial glial cells 
and their progenitors as both types exist at this age (Choi, 1988). In these cells, 
HRP-3 localized mainly in the cell cytoplasm including cell body and cell 
F:HDGFE:HRP-3 
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processes (figure 21E, arrows). When this pattern was compared to the 
expression pattern in adult mouse brain, a clear difference in the pattern of HRP-3 
expression between both cases could be noticed. HRP-3 in the adult brain cortex 
was expressed by a limited number of cortex cells and the expression signal was 
predominantly restricted to nuclei of these cells (arrow heads in figure 21F). The 
gradual change in the pattern of expression through the examined time points 
points to a possible developmentally regulated role for HRP-3. In the same time, 
this may also underline an initial importance of HRP-3 for most cell populations in 
the developing mouse cerebral cortex and a more specific role(s) for HRP-3 in 
certain populations of mature neural cells. 
Figure 21: A comparison of HRP-3 expression pattern between developing and adult 
mouse brain cortex.
 Sagittal paraffin E15.5, P1, P12 and adult mice brains were stained 
against HRP-3 using avidin-biotin based technique. Under light microscope, pictures were 
taken of an area of the neocortex above the hippocampal structure. During the embryonic 
and early postnatal stages (E15.5 and P1, A and B) cortical neurons showed an 
extranuclear HRP-3 signal that was strongly reduced at later time points (P12 and adult, C 
and D). Numbers on the right side refer to the different cortical layers in adult mice. E and 
F represent higher magnification of E15.5 and adult cortex demonstrating the cellular 
changes in HRP-3 expression during development. Arrows in E point to cytoplasmic signal 
of HRP-3 and arrow heads in F point to nuclear signal of the protein. Bars are 40 µm in A-
D and 20 µm in E & F. 
A DCB
FE
Results 
68
I.2 Expression of HRP-3 under pathological conditions 
I.2.1 HRP-3 expression in medulloblastoma tumor 
The high level of HDGF expression in the EGL of the cerebellum and the fact that 
HDGF was found to be over-expressed in a number of cancer types (Okuda, et al., 
2003; Huang, et al., 2004; Bernard, et al., 2003; Hu, et al., 2003) raised the 
question whether tumors in this layer would show an increased level of HDGF. To 
answer this question, a mouse model with medulloblastoma tumor was used. 
Serial paraffin sections of the cerebellar tumor were deparaffinized, rehydrated 
and immunostained against HDGF or HRP-3. Tumor tissue was visualized by 
hematoxylin staining (figure 22A).  
Figure 22: Expression of HDGF and HRP-3 in medulloblastoma tissue. Serial paraffin 
sections from cerebellum of a medulloblastoma mouse model were stained against HDGF 
or HRP-3. Shown is a part of the cerebellum with a massive rosette shaped 
medulloblastoma pointed out with the white dotted lines. Tumor cells showed an intense 
signal for HDGF in the area of granular cells (EGL) as seen in B compared to the healthy 
surrounding areas. No increase in the signal of HRP-3 was detected in the tumor tissue 
compared to the healthy surrounding tissue in C. Tumor area was identified with the 
intense hematoxylin staining of the cancerous cells (A). PC: Purkinje cells, MCL: 
molecular cell layer, EGL: External granular layer. Bar is 100 µm. 
Immunostaining revealed an increased signal for HDGF in tumor cells (figure 22B) 
whereas the signal for HRP-3 was unchanged compared to its expression signal in 
the neighboring healthy part of the tissue (figure 22C).  
This pattern of staining points to a possible relation between the increased HDGF 
expression and tumorigenesis or increased rate of cell proliferation. For many cell 
types like fibroblasts, HuH-7 cells (Nakamura, et al., 1994), aortic endothelial cells 
(Oliver and Al-Awqati, 1998), and vascular smooth muscles (VSM) (Everett, 2000) 
a mitogenic effect for HDGF was already shown. To test the mitogenic effect of 
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Tumor 
C:HRP-3
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HDGF on tumor cells, Daoy medulloblastoma tumor cells were stably transfected 
with HDGF-GFPC3, HRP-3-GFPC3 or GFPC3 and seeded into a 96 well plate 
(10.000 cells per well) in normal culture medium using 24 wells for each stable cell 
line. After three days, cell proliferation of the different stable lines was estimated 
using Cell titer 96® AQueous non radioactive cell proliferation assay (Promega) 
according to the manufacturer’s instructions. The mean absorbance at 490 nm 
was measured using an ELISA plate reader and the results were compared for the 
different cases. It was found that HDGF over-expressing cells showed a 
significantly higher proliferation (P≤ 0.0001, unpaired t-test) compared to the 
control-transfected cells (figure 23).  
   
Figure 23: Increased proliferation of Daoy medulloblastoma cells over-expressing 
HDGF. Daoy medulloblastoma cells were transfected with HDGF-GFPC3, HRP-3GFPC3 
or GFPC3 and kept under genticin-containing medium to select for the positively 
transfected cells. The expression of the respective genes in mixed clones prepared from 
each condition was controlled by fluorescence microscopy. Cell proliferation was 
determined three days after seeding 10.000 cells /well in 96 well plates, using Promega 
non-radioactive cell proliferation assay. Light absorbance of the colorimetric reaction was 
measured on an automated ELISA plate reader at 490 nm. A significant increase in the 
proliferation of HDGF over-expressers compared to both HRP-3 over-expressers and the 
control transfected cells was detected. Bars on the columns represent the standard error. 
Asterisks represent p<0.0001.
On the other hand, HRP-3 over-expressers did not show a significant increase in 
proliferation compared to the control cells, a finding that can be expected from the 
immunohistochemistry staining of tumor tissue done before.  
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I.2.2 HRP-3 expression in crushed sciatic nerve 
Another type of pathological changes in the nervous system is nerve injury which 
is usually accompanied by many sub-cellular changes. From the previous data it 
was found that HRP-3 was expressed in mouse sciatic nerve and DRGs under 
physiological conditions. So that it was interesting to investigate any possible 
changes in its expression after injury and during the healing process. In 
cooperation with professor H. W Müller and Dr. Frank Bosse, Molecular 
Neurobiology institute, University of Duesseldorf, the sciatic nerve of adult mice 
was exposed using surgical procedures under anesthesia and crushed before re-
suturing the animal skin (trans). As a control (sham), the animal was exposed to 
the same surgical procedures of cutting and suturing but without the step of nerve 
crushing. Seven days after the procedures animals were sacrificed and the sciatic 
nerves were extracted together with the attached ganglia, fixed and paraffin 
embedded before they were cut in transverse sections. Section were cut so that 
the sections contained both, the ganglion and the nerve as shown in the schematic 
diagram in figure 24.  
Figure 24: A schematic diagram for a transversely cut nerve with part of an adjacent 
ganglion. Nerve bundles (represented as green colored areas) which consist of many axons 
(represented as dark green circles) are normally separated by a layer of connective tissue 
(yellow). All nerve bundles and the separating connective tissue are enwrapped with a 
layer of connective tissue named the epineurium (thick black outline). The ganglion is 
shown as a brown structure adjacent to the nerve.  
Sections from both conditions, trans and sham, were stained against HRP-3 using 
avidin-biotin technique and histogreen® as a chromogen. Examining the control 
sections under transmitted light microscope showed that HRP-3 was strongly 
expressed in the nuclei of nearly half of the ganglion cells adjacent to the 
Ganglion
Axons 
Epineurium 
Connective 
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undamaged nerve (sham, arrow heads in figure 25B). This was in addition to a 
signal for HRP-3 in the cytoplasm of a population of bigger cells ranging from very 
intense to much lighter expression signal (arrows in 25B). Also in the transversely 
cut nerve fibers, a strong HRP-3 signal was clearly detectable (figure 25C).  
Figure 25: Changes in HRP-3 expression pattern after sciatic nerve injury.
 Transverse 
sections from either control treated (sham, A-C) or crushed (tarns, D-F) adult mice sciatic 
nerve seven days after the surgical manipulation were stained against HRP-3. Sections 
showed a part of the ganglion (blue dotted line) adjacent to the nerve (red dotted line) as 
explained in figure 22. In the control treated nerve, ganglion cells showed an intense 
nuclear signal for HRP-3 in almost half of the positive cells. A population of significantly 
bigger cells showed varying degrees of a cytoplasmic signal of HRP-3. Seven days after 
nerve damage, almost no nuclear signal for HRP-3 was detected and a comparatively 
weak, structured cytoplasmic signal was detected in nearly all ganglion cells (E). However, 
three weeks after damage initiation the nuclear HRP-3 signal was partially retained beside 
its cytoplasmic signal (H). Although not many differences were detected in the expression 
pattern of HRP-3 in nerve fibers between sham and trans models, a relative reduction in 
A: Sham 10x B: Sham 40x 
E: Trans 40x F: Trans 100x
H: Trans 40x I: Trans 100xG: Trans 10x, 21 days
D: Trans 10x, 7 days
C: Sham 100x
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signal intensity in damaged nerve axons was detected (compare C+F). Bars are 100 µm in 
A, D and G, 25µm in B, E and H and 10 µm in C, F and I.    
                  
Interestingly, however no change in its pattern was seen, the expression signal of 
HRP-3 in the crushed nerve fibers (axons) showed a relative reduction in its 
intensity compared to undamaged nerve expression signal (figures 25C, F & I). To 
determine if this decrease in intensity was resulting from a down regulation of 
protein expression or because of the wallerian degeneration of the nerve needs 
further investigations. On the other hand, a clear difference in the expression 
pattern of HRP-3 in ganglion cells was observed between the control and the 
damaged nerve. It was found that the cell population expressing HRP-3 in their 
nuclei before nerve damage (arrow heads in 25B) either disappeared or 
remodeled its expression pattern after damage leaving the bigger cells with a 
significantly weaker cytoplasmic signal and almost HRP-3 negative, eccentric 
nuclei (arrows in 25E). By the time, the missed nuclear signal of HRP-3 started to 
appear in a small sized cell population as pointed out with arrows in figure 25H.   
I.3 HRP-3 expression in vitro  
I.3.1 HRP-3 expression in mouse primary DRG (sensory) neurons 
As described before, HRP-3 was found to be expressed very early in mouse 
embryo and due to the intense and interesting signal detected in the embryonic 
DRG, it was important to investigate the expression of HRP-3 in DRG neurons in 
vitro. Therefore, primary cultures of these sensory neurons were prepared from 
embryonic DRG isolated from E 14.5 mouse embryos as described in the Methods 
part and were allowed to proceed in culture in the form of aggregates (explants). 
After about three days some cells had already migrated away from the main 
cellular aggregation and started to differentiate. Starting from this time point cells 
were fixed at three days intervals in ice cold 4% PFA/ 10% sucrose and stained 
against HRP-3. To prove the neuronal identity of the fixed cells, a neuron specific 
marker (β-III-tubulin) was used and nuclei were visualized using the DNA-stain 
DAPI. Under fluorescence microscope, it was very interesting to observe that 
HRP-3 was expressed in the DRG neurons at all examined time points. However, 
a clear change in the expression pattern of HRP-3 was observed. While in the 
young DRG neurons (three to six days in culture) the expression signal was 
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almost cytoplasmic as seen in figure 26A and D, a strong nuclear expression 
signal  was noticed in older neurons (figure 26E & F). It was also noticed that the 
intensity of the cytoplasmic signal was decreasing with time. In three days old 
neurons, HRP-3 was detected along the whole neuronal cell processes and in the 
growth cones (arrow heads, figure 26B & C) whereas the older neurons showed a 
weaker signal in cell soma as well as a much weaker signal for HRP-3 that was 
hardly detectable in cell processes. 
Figure 26: HRP-3 expression in mouse primary sensory neurons at different time 
points.
 Sensory neurons obtained from DRG of E14.5 mouse embryos were brought into 
culture as aggregates and kept under complete NBM + 20 nM NGF. Neurons were fixed at 
different time points (3, 6, 9 and 12 days) and immunostained against HRP-3 (red channel) 
and the neuronal cell marker β-III-tubulin (green channel) together with the DNA-stain 
DAPI (blue channel). Figure A represents the predominant cytoplasmic signal of HRP-3 in 
β-III-tubulin positive neurons after three days in culture whereas B and C represent 
expression signals of HRP-3 in neuronal processes and growth cones (arrow heads) at the 
same time point. A nuclear expression signal for HRP-3 started to appear after 9 days in 
culture (E) and was also detectable after 12 days (F). Bars are 20 µm.   
I.3.2 HRP-3 expression in mouse primary cortical neurons 
It was also very interesting to investigate whether HRP-3 was still expressed in 
cortical neurons kept in vitro and whether its expression in these neurons exhibited 
changes over the time similar to which was noticed in vivo. For this purpose, 
primary cortical neurons were prepared from mouse embryos and taken into 
culture in Neurobasal medium (NBM) containing B27 supplement as a standard 
A: 3 DIV
D: 6 DIV E: 9 DIV F: 12 DIV
C: 3 DIVB: 3 DIV 
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culture medium (Brewer, 1995). After trying to prepare neurons from embryos of 
different ages, E14.5 gave the best results regarding cell yield and survival in 
culture.  
Neurons obtained after enzymatic and mechanical dissociation were plated onto 
thoroughly washed PDL coated vessels in standard NBM. As early as four hours 
after plating many cells were starting to differentiate showing filopodia or even 
minor processes. For the various experiments neurons were fixed at different time 
points and immunostained using antibodies against HRP-3, MAP-2 and 
neurofilament-H or with the DNA-stain DAPI to visualize cell nuclei when needed. 
Figure 27 demonstrates HRP-3 expression in dendrites stained for MAP-2 (arrows 
heads, figure 27B)  as well as axons stained for neurofilament-H (arrows, figure 
27C) of mouse cortical neurons. 
Figure 27: HRP-3 expression in both axonal and dendritic compartments of mouse 
primary cortical neurons. Cultured cortical neurons were stained for HRP-3 (red), MAP-
2 (blue) as a dendritic marker, and neurofilament-H (red) as an axonal marker. Staining 
showed that HRP-3 at this time point was expressed in cell bodies, dendrites (MAP-2 
positive processes) and axons (neurofilament positive processes). Bar is 20 µm.    
This staining showed that HRP-3 was expressed in cultured cortical neurons and 
also resolved the question about HRP-3 expression in both types of neuronal cell 
processes, dendrites and axons. This triple immunostaining was able to confirm 
that HRP-3 (green signal in figure 27A) was expressed in both, Map-2 positive 
dendrites as shown by arrow heads in figure 25B and neurofilament positive axons 
as shown by arrows in figure 27C. 
When primary neurons are grown in culture, they undergo a sequence of 
morphological changes that have been well documented (Dotti, et al., 1988). After 
dissociation and within a few hours after plating, cortical neurons look rounded and 
exhibit lamellipodia. After about five hours in culture, the neurons start to extend 
minor processes. After one day in culture, the axons elongate and the dendrites 
B:Map-2 C:Neurofilamen
t
A:HRP-3
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start to develop, and both acquire large growth cones at their tips. After four days 
in vitro (DIV), cortical neurons reach morphological maturation, with numerous 
dendrites, synaptic contacts, and axonal branches. To investigate HRP-3 
localization during neuronal differentiation stages in culture, immunofluorescence 
staining and imaging were performed using cultured cortical neurons fixed after 
different periods of time starting from 9 hrs up to 12 DIV.  
The interesting pattern of expression of HRP-3 shown before in mouse embryonic 
and postnatal brain cortices was behind the idea of a detailed, time point based 
series of cultured cortical neuron immunocytochemical analysis. For this purpose, 
primary cortical neurons were prepared as mentioned before and seeded on PDL 
coated glass coverslips in a 24-well tissue culture plate in the complete culture 
medium. At different time points (9 hrs, 24 hrs, 48 hrs, 72 hrs, 5 DIV and 12 DIV), 
neurons were fixed in ice-cold 4% PFA/ 10% sucrose solution. Neurons were 
immunostained against HRP-3 together with Map-2 as a marker for neuronal cells. 
Fluorescently labelled anti-rabbit and anti-mouse secondary antibodies were used 
to visualize bound primary antibodies. Pictures taken for the stained neurons at 
each stage showed that HRP-3 expression in cortical neurons in vitro started as 
early as 9 hrs after seeding showing a clear signal in their cytoplasm as seen in 
figure 28A. By this time, some neurons had already started to be polarized and 
extend some minor processes, of which a single one should grow rapidly to form 
the future axon. After 24 hrs in culture, most of neurons were extending a long 
axon and shorter dendrites. HRP-3 signal at this time was highly concentrated in 
the cell body and along all the extending processes (figure 28B) and no signal was 
detected in the cell nucleus (arrow head, figure 28B). A stronger signal was also 
noticed at this time at the base of the longest process representing probably the 
axonal hillock as shown by the arrow in figure 28B. By the time neurons were two 
days in culture, an intense nuclear signal started to appear in some cells in 
addition to the cytoplasmic one which remained with an unchanged intensity until 
this time point (figure 28C). From this time onwards, the intensity of the nuclear 
HRP-3 signal increased until five DIV (arrow heads in figures 28D and E). In the 
same time, HRP-3 expression signal started to fade out gradually in the 
cytoplasmic compartments but it did not completely disappear, as the axons 
remained clearly HRP-3 positive until five days in culture (arrows in 28D & E). 
After 12 days in culture, neurons were fully mature and the process network was 
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highly developed as proved by the clear immunopositivity for MAP-2 (green signal 
in figure 28F). However, at this time point it was noticed that only the nuclear 
signal for HRP-3 was detectable (arrow heads in figure 28F). 
Figure 28: HRP-3 expression dynamically changed over time in cultured primary 
cortical neurons. Primary mouse cortical neurons prepared and fixed at different time 
points (9 hrs, 24 hrs, 48 hrs, 72 hrs, 5 DIV and 12 DIV) were stained against HRP-3 (in 
red) together with a DNA stain (DAPI, in blue) or MAP-2 (in green). At 9 and 24 hrs HRP-
3 signal was exclusively cytoplasmic including cell processes (A & B). After two to five 
days of culture in vitro, neurons showed a nuclear signal for HRP-3 in addition to the 
cytoplasmic signal that started to fade out. Older neurons (12 DIV) expressed HRP-3 only 
in their nuclei however the neurite network was still intact. Box in F indicated a neuron 
culture with an intact processes network after 12 days. Arrows in B point to HRP-3 signal 
at the axonal hillock and arrow head points to an HRP-3 negative nucleus at day 1 and to 
an HRP-3 positive nucleus at 3 and 12 days in D and F respectively. Arrows in D point to 
an HRP-3 positive axon. Bars are 20µm.   
These results were similar to data obtained from immunolocalization of HRP-3 in 
mouse brain neocortex in vivo at different developmental stages. In these tissues, 
almost a nuclear HRP-3 expression signal was found in the adult animal brain (in 
which the cortical neurons were already mature, much resembling the 12-days old 
neurons in culture) whereas a predominant extranuclear signal for HRP-3 was 
detectable in various regions of the cortex in the embryonic and early postnatal 
stages (in which the cortical neurons were still developing, resembling the neurons 
in earlier time points of the cortical neurons culture, figure 28). Interestingly, the 
changes in HRP-3 expression pattern in cultured cortical neurons was also very 
similar to the changes observed in the cultured primary DRG neurons except for a 
B: 24 hrs
E: 5 DIV D: 72 hrs 
A: 9 hrs C: 48 hrs
F: 12 DIV
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slight time shift in the onset of the nuclear expression signal that appeared earlier 
in primary cortical neurons.   
The expression of the structurally related growth factor of the same family, HDGF, 
was also examined in cultured cortical neurons and compared to HRP-3 
expression by immunocytochemistry. Using specific antibodies raised against 
either one of them together with the neuronal marker MAP-2 to prove neuronal cell 
identity, the expression patterns of both proteins were compared.  
Figure 29: Comparison between HDGF and HRP-3 expression patterns in cultured 
mouse cortical neurons after 1 and 5 days in vitro. Primary mouse cortical neurons were 
A: HDGF
C: HDGF
B
B: HDGF/MAP-2
1 DIV
5 DIV
D
D: HDGF/MAP-2
1 DIV
5 DIV
G: HRP-3 
G
E: HRP-3 
F
F: HRP-3/MAP-2
H
H: HRP-3/MAP-2
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fixed after one or five days and immunostained against HDGF or HRP-3. MAP-2 was used 
to prove the neuronal identity. A set of fluorescently labeled secondary antibodies was 
used to detect bound antibodies (red labeled for HDGF or HRP-3 and green labeled for 
MAP-2). Under fluorescence microscope, HDGF was expressed only nuclear at both time 
points (A & C) but HRP-3 was showing a dynamic change, being expressed in the 
cytoplasm after one day (E) and started to be expressed in the nuclei after five days (G). 
Bars are 40 µm.  
As can be expected from the previous immunohistochemistry of brain sections, 
both factors were also expressed in the primary cortical neurons in culture. But 
interestingly, HRP-3 showed, as previously mentioned, a dynamic change in the 
expression pattern over the time. Neurons showed only a cytoplasmic signal for 
HRP-3 in the early time point (24 hrs) but in the later time points an additional 
nuclear signal was detectable (figure 29E & G). On the other hand, HDGF was 
expressed at both time points (one day and five days after seeding) only inside cell 
nuclei showing no changes in its localization (figure 29A & C). 
Results 
79
Part II: Possible roles of HRP-3 
II.1 Intracellular roles 
II.1.1 Knockdown of endogenous HRP-3 protein level 
After detecting the developmentally regulated expression pattern of HRP-3 in vivo 
in the different mouse nervous tissues and in vitro in primary sensory and cortical 
neurons culture it was very interesting to get an idea about the possible functions 
of this protein inside neuronal cells in vitro. One of the most useful tools used 
today to determine the possible roles and importance of a certain gene are the 
approaches depending on post-transcriptional gene silencing using small 
interfering RNA (siRNA, Fire, et al., 1998). They produce their selective effects on 
the target gene by destroying the gene’s mRNA and hence preventing its 
translation into an active protein. To knock down the expression of HRP-3, three 
different siRNAs targeting three different regions of the coding sequence of HRP-
3mRNA were designed:  
siRNA1: 5’GGTGATAGAGTAGAAGATG-3’ 
siRNA2: 5’GAGTGAAATTTACTGGGT-3’ 
siRNA3: 5’GGGAGAAGGTGGAAATACT-3’ 
These oligos were tested first on HEK293T cells. As these cells do not express 
HRP-3, first, cells were stably transfected with HRP-3-GFPC3. After that, the 
resulting HRP-3-GFPC3 stable clones were seeded in 24 well plate and 
transfected with 50 nM of siRNA solution per well using Silentfect reagent 
according to manufacturer’s instructions. For the pooled siRNA mixture 20 nM of 
each siRNA were used to give a total of 60 nM of siRNAs. Three days after 
transfection cells were collected and lysed in ice cold RIPA buffer and equivalent 
protein amounts were used to estimate the knock down efficiency by Western blot 
analysis. Separated proteins were blotted onto a nitrocellulose membrane and 
probed with specific antibodies against HRP-3 and β-actin as a quantitative control 
for the loaded protein amounts. Using two different fluorescently labelled 
secondary antibodies, bound primary antibodies were detected using a LiCor 
fluorescent scanning system. The signals obtained for HRP-3 under the different 
conditions were normalized against the intensity of the corresponding β-actin 
bands. Quantitative analysis of the obtained bands showed that in HRP-3siRNA 
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transfected cells the expression level of HRP-3-GFPC3 was reduced (band at ≈63 
kDa, lanes 1, 2, 3 and 4 in figure 30A) by a ratio of about 40 to 50% (figure 30B) in 
comparison to cells transfected with a scramble siRNA (an RNA that is not 
directed against any known gene, lane 5 in figure 30A).      
Figure 30: HRP-3siRNAs reduced HRP-3 level in HEK293T cells. HEK293T cells 
stably expressing HRP-3-GFPC3 seeded into a 24 well plate were transfected with either 
the different siRNA targeting HRP-3 or a control siRNA. Three days after transfection 
cells were lysed and protein contents were separated by SDS-PAGE. (A) represents a 
Western blot analysis of the cell lysate of the different conditions using an HRP-3 specific 
antibody recognizing the HRP-3-GFPC3 fusion protein (upper band, 63 kDa) and a β-actin 
specific antibody (lower band, 42 kDa). Lanes are: 1: HRP-3siRNA1, 2: HRP-3siRNA2, 3: 
HRP-3siRNA3, 4: pooled HRP-3siRNA, 5: scramble siRNA. (B) Quantification of the 
detected protein bands using the Odyssey quantification system shows that HRP-3siRNAs 
decreased HRP-3 expression level within the selected stable HRP-3 GFPC3 clone to 
various degrees.  
After proofing the ability of the chosen HRP-3siRNA sequences to reduce HRP-3 
protein content in HEK293T cells, they were used to transfect primary cortical 
neurons to test for possible effects. Neurons were transfected using Lipofectamin 
2000® at the same time of seeding in a 24 well plate-format. A red fluorescent 
(Cy3) control siRNA was co-transfected to label targeted cells. Two days after 
transfection, neurons were fixed and immunostained against HRP-3 and β-III-
tubulin using green and blue fluorescently labelled secondary antibodies. Under a 
fluorescence microscope more than 200 labelled cells were randomly 
photographed from each condition. The length of the longest neurite arising from 
each cell was measured and the number of neurites arising from single neurons 
was counted and the obtained data were analysed in a blind way. Interestingly, 
cortical neurons transfected with the specific HRP-3siRNAs exhibited significantly 
shorter neurites compared to control siRNA transfected neurons (figure 31A). In 
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addition to the shorter neurites, reduced HRP-3 levels resulted in neurons bearing 
less number of neurites as shown by the accumulation curve in figure 31B. 
Figure 31: Reduction of the intracellular HRP-3 level resulted in neurons bearing 
shorter and fewer neurites. Primary cortical neurons were transfected with different 
HRP-3siRNAs directly before seeding. A scramble, Cy3 labelled siRNA (ctrl siRNA) was 
used as a negative control. Two days after transfection cells were fixed and immunostained 
against HRP-3 and β-III-tubulin to verify the identity of the transfected cells. More than 
200 randomly chosen neurons were analysed from each condition in a blinded way. Data 
analysis showed a highly significant reduction in both the mean neurite length (A) as well 
as the number of neurites arising from the cell body (B) of HRP-3siRNA positively 
transfected neurons compared to control transfected neurons (represented by two asterisks 
in A). The experiment was repeated four times with similar results every time (see 
supplementary data, S2). ** p<0.0001
Repeating the experiments resulted each time in the same results with minor 
variations related to the culture-to-culture differences (see supplementary data, 
figure S2). 
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II.1.2 Increasing the endogenous HRP-3 protein level 
There are many neuronal cell lines that provide many properties similar to in vivo 
neuronal tissues like B35 (rat neuroblastoma cells), PC12 (rat pheochromocytoma 
cells) and P19 (mouse teratocarcinoma cells). Most of these cell lines have the 
ability to differentiate into a neuronal phenotype after certain treatments. Rat B35 
neuroblastoma cell model (Schubert et al., 1974) is one of these lines which 
proliferates normally under serum supplemented medium. As soon as the serum is 
withdrawn and culture medium is supplemented with 1 mM of dBcAMP which is a 
membrane permeable analogue of cAMP, cells start to differentiate into a neuron-
like phenotype with extended neurites (Boukhelifa et al., 2001). Due to the ease of 
transfecting this cell line in comparison to primary cortical neurons and  in addition 
to its rapid proliferation rate and easy differentiation procedures, B35 cell line was 
chosen as a convenient cellular model for studying the possible roles of increasing 
the intracellular expression of HRP-3. Under normal culture conditions in 
DMEM:F12 medium supplemented with 5 % FCS and 2 mM L-glutamate, B35 
cells were allowed to grow and proliferate.  
Figure 32: B35 neuroblastoma cells differentiated into a neuronal phenotype induced 
by an increased cAMP level. B35 cells treated with 1mM dBcAMP in serum free medium 
showed neurite outgrowth and a neuron-similar morphology after three (A) and six days 
(B) compared to cells treated with the vehicle alone for the same period of time (C & D). 
Bars are 100 µm.  
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Cell differentiation was started in culture by keeping cells under serum-free 
medium supplemented with 1 mM of dBcAMP. Shortly after treatment, cells started 
to show longer cell processes and after 3 days nearly all cells showed a neuronal 
morphology (figure 31A). After a further three-days interval the extended 
processes were much longer forming a network of extensions (figure 32B). 
To check for the endogenous HRP-3 expression of these cells, normally 
proliferating undifferentiated B35 cells cultured on glass cover-slips were fixed in 
ice-cold 4% PFA for immunostaining. Immunocytochemistry analysis was done by 
shortly permeabilizing the fixed cells with 0.5% Triton X-100 solution then blocking 
the non specific antibody binding sites before incubating the cells with specific 
antibody against HRP-3. Bound antibodies were visualized by a second incubation 
with a Cy3 fluorescently labeled secondary antibody. Under normal proliferation 
conditions no endogenous HRP-3 expression signal could be detected by 
microscopic examination (figure 33A). Interestingly, a positive HRP-3 expression 
signal could be detected within B35 cells when they were exposed to 
differentiating conditions for three or six days before being stained against HRP-3 
(examined using the same exposure time figures 33B & C). A change in HRP-3 
protein distribution was observed during the differentiation process.  
Figure 33: Endogenous HRP-3 expression in B35 cells.
 B35 rat neuroblastoma cells 
were either untreated for 6 days (A, kept under 5% FCS supplemented DMEM:F12) or 
treated for three (B) or six days (C) with 1mM dBcAMP supplemented, FCS free 
DMEM:F12. At these time points cells were fixed and immunostained for their 
endogenous HRP-3 content using a specific antibody against HRP-3. A fluorescent 
secondary antibody was used to visualize bound antibody. Cells were examined using the 
same exposure time under a fluorescence microscope. Undifferentiated proliferating cells 
(A) did not express HRP-3. Early after differentiation, B35 cells showed an HRP-3 signal 
distributed over the whole cytoplasm (B). Three days later a strong nuclear signal was 
detected in addition to the cytoplasmatic signal (C). Bars are 20 µm. 
Whereas B35 cells allowed to differentiate for three days showed a clear 
cytoplasmic signal for HRP-3 (arrows in figure 33B), most of the cells allowed to 
B: Three days treatment C: Six days treatment 
days
A: Untreated B35 cells 
DAPI
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differentiate for longer time showed a visible nuclear signal of endogenously 
expressed HRP-3 as shown in figure 34C in addition to the cytoplasmic signal. 
These observations mean that only differentiating B35 cells expressed HRP-3 and 
that the expression pattern of the protein was dependent on the differentiation 
stage in which the cells were.  
Interestingly, also B35 cells transfected with a streptagged wild type HRP-3 
showed a change in the expression pattern over time when they were allowed to 
differentiate. When HRP-3 transfected B35 cells were kept under proliferating 
conditions, HRP-3 signal remained nuclear after three or six days in culture 
(figures 34C & D). But when HRP-3 transfected cells were allowed to differentiate, 
HRP-3 signal showed a change in its distribution pattern. Three days after 
inducing differentiation, the signal of transfected HRP-3 was seen both nuclear 
and cytoplasmic (figure 34A). As differentiation continued, the cytoplasmic signal 
faded out leaving a more prominent nuclear signal after six days (figure 34B).  
Figure 34: Expression pattern of wild type HRP-3 transfected into B35 showed a 
differentiation-dependent distribution pattern. B35 neuroblastoma cells were 
transfected with cDNA encoding wild type HRP-3 with a streptag. Cells were either 
allowed to proliferate or induced to differentiate into a neuron phenotype using dBcAMP. 
Comparing the streptag signal after three and six days in both conditions showed that 
proliferating cells expressed transfected HRP-3 only in their nuclei (C & D). 
Differentiating cells on the other hand showed both nuclear and cytoplasmic signals after 
three days (A) but almost only a nuclear signal after six days (B). Bars are 20 µm.  
After three days After six days 
Transfected, 
treated cells 
Transfected, 
untreated cells 
BA
C D
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Expression of transfected wtHRP-3 in proliferating B35 nuclei can be due to the 
nuclear localizing signals in its sequence. HRP-3 has -like the other HDGF family 
members- two nuclear localization signals (NLS). One is located in the conserved 
N-terminal HATH region (NLS1) and one in the non conserved C-terminal part of 
the protein (NLS2). In this aspect HDGF was shown to achieve its proliferative 
activity by the nuclear translocation of the protein through its NLS2. To investigate 
which of the two NLSs was responsible for the nuclear localization of HRP-3 in 
B35 cells, they were mutated by exchanging the Lysine residues in the NLS to 
Asparagine residues. 
Polymerase chain reaction (PCR) technique was utilized to introduce three point 
mutations at Lys74, Lys77 and Lys79 (lysines) changing them to Asn (asparagines) 
in NLS1 to produce the construct HRP-3mutNLS1.The same strategy was used to 
construct HRP-3mutNLS2 where the three amino acids Lys144, Lys156 and Lys160 
were replaced by Asparagine. To produce the double mutated NLS HRP-3 
construct, all six Lysines in both NLS1 and NLS2 (Lys74, Lys77, Lys79, Lys144, 
Lys156 and Lys160) were replaced with Asparagine (figure 35).  
Figure 35: Schematic diagram of NLS mutant HRP-3 constructs. Schematic diagram 
showing the position of the different NLSs and positions of the created point mutations in 
HRP-3 molecule. In HRP-3mut NLS1 or HRP-3mutNLS2 three lysine amino acids in 
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either NLS1 (74, 77 and 79) or NLS2 (144, 156 and 160) respectively were replaced by 
three asparagines. In the double mutant construct (HRP-3mutNLS1&2) all six lysines (of 
both NLS1 and NLS2) were replaced by asparagines using a primer based PCR technique. 
All constructs were cloned into a vector coding for a C-terminal StrepTag. The 
integrity of the constructs was confirmed by cycle sequencing before they were 
transfected into proliferating B35 neuroblastoma cells seeded on glass cover-slips. 
Three days after transfection, cells from each transfection condition were fixed 
using ice-cold 4% PFA, permeabilized, blocked with 2% BSA and immunostained 
against Streptag. A red fluorescently labeled secondary antibody was used to 
visualize the bound antibody and nuclei were counter stained with DAPI. Under 
microscope, it was found that immuno-positive B35 cells were able to completely 
translocate wtHRP-3StrepTag to the nucleus (arrow heads in figures 36A, B & C).   
Figure 36: Subcellular localization of wild type or NLS-mutant HRP-3 constructs 
transfected into B35 neuroblastoma cells. B35 neuroblastoma cells under normal 
A: HRP3 pCDNA
D: HRP-3 mutNLS1 pCDNA
G: HRP-3 mutNLS2 pCDNA
J: HRP-3 mutNLS1&2 pCDNA 
Streptag DAPI Overlay 
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proliferation conditions were transfected with the wild type or the different NLS-mutant 
HRP-3 constructs (cloned in streptag pCDNA3 vector) using Exgen 500 reagent. Three 
days after transfection, cells were fixed and immunostained using an antibody against 
streptag. DAPI was used as a nuclear counter stain. Both wild type HRP-3 and HRP-
3mutNLS1 were able to localize to the nuclei of positively transfected cells (arrow heads in 
A & D) whereas HRP-3mutNLS2 and HRP-3mutNLS1&2 failed to target the nucleus and 
localized only to the cytoplasm in most of the cells (arrows in G & J). Bars are 20 µm. 
This observation was found to be in accordance with the data shown by Ikegame 
concerning the nuclear translocation of transfected HRP-3 (Ikegame, et al., 1999). 
Interestingly, whereas cells expressing HRP-3mutNLS1 were indistinguishable 
from the wtHRP-3 expressing ones, most cells failed to translocate HRP-
3mutNLS2 into their nuclei showing a streptag signal only in the cytoplasm (arrows 
in figures 36G, H & I). This last finding was similar to the behavior of 
NLS2mutHDGF which failed to target the nucleus when transfected into 293 cells 
(Kishima, et al., 2002) indicating the importance of the NLS2 in the nuclear 
targeting ability of at least HRP-3 and HDGF within this protein family. As 
expected, constructs mutated at both NLSs were unable to translocate to the 
nucleus most probably due to the deficient NLS2 (figures 36J, K & L).  
The data presented before showed that reducing the level of endogenous HRP-3 
resulted in negative effects on neurite length and sprouting ability of cells. In 
addition, data from previous experiments on the same cell line (see diploma 
Thesis, El-Tahir) showed that increasing the intracellular level of HRP-3 in B35 
cells had a neurite outgrowth promoting effect upon dBcAMP-induced 
differentiation. To investigate whether localization of HRP-3 could be responsible 
for these effects, B35 cells were transfected with the different NLS mutant 
constructs of HRP-3 described before. WtHRP-3 transfected cells were used as a 
positive control and cells transfected with the empty vector (pCDNA3) as a 
negative control. Twenty four hours after transfection, cells were induced to 
differentiate using 1 mM dBcAMP and they were fixed 3 days after induction. Cells 
were co-transfected with an eGFPC3 plasmid in a ratio of 10% of total DNA 
amount of the different constructs used so that transfected cells could be detected 
under the fluorescence microscope by their GFP signal. Randomly chosen 
pictures were taken under the microscope from the different conditions. The length 
in micrometer of the longest neurite arising from about 100 randomly chosen 
positive transfected cell in each condition was recorded. Analysis of the obtained 
data showed as expected a highly significant increase in the mean neurite length 
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in wtHRP-3 transfected cells compared to the negative control. Interestingly, also 
HRP-3mutNLS2 transfected cells which failed to translocate the protein into their 
nuclei showed a nearly equal and significant increase in the mean neurite length 
(p<0.001, unpaired t-test) when compared to the negative control cells. 
Surprisingly, however located to cell nuclei similar to the wild type HRP-3, no 
significant increase in the neurite length was observed over the negative control 
when B35 cells were transfected with HRP-3mutNLS1 (p=0.9) or the double 
mutant construct HRP-3NLS1&2 (p=0.1; figure 37). The same observations were 
obtained when the experiment was repeated under the same conditions (see 
supplementary data S 3).  
Figure 37: NLS1 is responsible for the neurite outgrowth promoting effect of HRP-3 
in B35 cells. B35 neuroblastoma cells were transfected with different NLS mutant 
constructs, wild type HRP-3 or the empty vector together with eGFPC3 in a DNA ratio of 
10 to 1 to detect the positively transfected cells under a fluorescence microscope. Twenty 
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four hours after transfection, differentiation was induced with 1 mM dBcAMP and cells 
were fixed and stained three days later. The length of the longest neurite arising from about 
100 randomly chosen positively transfected cells was estimated in a blind assay. Repeating 
the experiment under the same conditions resulted in the same tendency. In the first graph 
bars represent the standard error and asterisks indicate a significant mean over the control. 
**p≤0.001.
II.2 Extracellular roles 
II.2.1 Role of HRP-3 in neuronal cell survival 
Zhou and co-workers reported that in the central nervous system HDGF was 
produced mainly in neurons and retained in their nuclei. They found that this 
protein was released by cultured primary hippocampal neurons under 
physiological conditions and that its release was accelerated under necrosis 
conditions. They reported also a similar observation concerning the secretion of a 
well known neurotrophic factor, HMG1 (Zhou, et al., 2004). From the data shown 
here before, beside the structural similarity of HRP-3 and HDGF, cortical neurons 
expressed both proteins in parallel. Therefore it was interesting to know if neurons 
release HRP-3 into their supernatant in a similar way to that observed for HDGF. 
For this experiment, neurons were freshly prepared from mouse embryos and 
seeded onto PDL coated 10 cm cell culture plates. Thirty to sixty minutes after 
seeding cells were washed twice with DMEM then NBM/B27 medium was 
replaced by DMEM medium supplemented with 200 ng/ml affinity purified 
recombinant HDGF. Neuron supernatant was collected after 3 or 5 days. After 
being concentrated by centrifugation through a filter with MWCO 10 kDa, 
supernatant contents were separated by SDS-PAGE. Medium not incubated with 
cells was used as control. Western blot analysis using a polyclonal antibody 
against HRP-3 detected HRP-3 in supernatant (figure 38A) indicating that it was 
released by primary cortical neurons into the supernatant similar to HDGF. Control 
medium (medium without cells) showed no immunoreactivity against HRP-3 (figure 
38A, lane 8). Bands obtained at 72 kDa were identified using mass spectrometry 
as bovine serum albumin (BSA) which was used in relatively large amounts during 
the preparation of primary cortical neurons as a trypsin inhibitor.  
Neurons in primary cultures are very sensitive to the absence of nutrients and they 
may show survival difficulties under these conditions. It was shown before by 
many research groups that many proliferating and/or differentiating factors affect 
the survival of neurons (Oppenheim, 1996; deLapeyrier and Henderson, 1997; 
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Giehl, 2001). Zhou and Marubuchi and their co-workers reported that the addition 
of HDGF (the structurally similar to HRP-3) to the culture medium of mouse 
hippocampal neurons (Zhou, et al., 2004) or rat motor neurons (Marubuchi, et al., 
2006) was able to promote cell survival and neurite extension in an equivalent way 
to those of well known neurotrophic factors like CNTF and BDNF (Arakawa, et al., 
1990; Sendtner, et al., 1990, 1992a & 1992b; Oppenheim, et al., 1991 & 1992; 
Yan, et al., 1992; Henderson, et al., 1993; Koliatsos, et al., 1993; Mitsumoto, et al. 
1994). To investigate whether HRP-3, like HDGF, was involved in neuronal 
survival, the protein released by the neurons into their supernatant was blocked 24 
h after seeding by adding a specific antiHRP-3 antibody. Pre-absorbed antibody 
was used as a negative control. After 48 hrs of treatment, neurons were fixed and 
visualized by an unspecific crystal violet staining to analyze general cell 
morphology (figure 38B) by transmitted light microscopy.  
Figure 38: Endogenous HRP-3 promoted primary cortical neurons survival after 
being released into the cell culture supernatant. (A) supernatants from primary cortical 
neurons were collected at different time points (3 and 5 days after seeding) and 
concentrated. One eighth of the total supernatant volume from both time points was 
separated by SDS-PAGE and separated proteins were detected using specific polyclonal 
antiHRP-3 antibodies. A protein migrating at a molecular weight of ≈ 30 kDa was detected 
as HRP-3. No immunoreactivity was detected in the cell-free medium. Lane 1 & 3: 
supernatant collected after 3 and 5 days respectively, 5: mouse brain lysate, 7: affinity 
purified bacterially expressed HRP-3, 8: cell free medium, 2, 4 and 6 are free lanes. Bands 
17
24
34
44
52
72
1 2 3 4 5 6 7 8 A
BSA 
HRP-3
B: AntiHRP-3 C: Pre-absorbed antiHRP-3 D: Untreated cells 
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at 72 kDa were identified as BSA using mass spectrometry. (B) One day old primary 
cortical neurons were treated for 48 hrs with 1 µg/ml of the affinity purified HRP-3 
antibody (AntiHRP-3) or the antibody pre-absorbed against recombinant HRP-3 protein 
(Pre-absorbed antiHRP-3) or an equivalent amount of the vehicle used for diluting the 
antibody (Untreated cells). Antibody treated neurons showed a massive loss of the neurite 
network compared to the cells treated with the blocked (pre-absorbed) antibody or those 
treated with the vehicle alone. Bars are 100 µm.   
It was noticed that neurons treated with the medium supplemented with an 
equivalent amount of the antibody-diluting vehicle (50 % glycerol/PBS) alone did 
not show any change in their morphology and proceeded normally like untreated 
neurons (figure 38D). On the other hand, blockage of HRP-3 in neuron 
supernatants resulted in time dependent deterioration of neurite network of the 
neurons and finally led to cell death within three to four days of HRP-3 depletion 
indicating its importance for maintaining culture health (figure 38B). The specificity 
of HRP-3 survival promoting effect was proved by the possibility to completely 
block the effect of the added antiHRP-3 antibody by pre-absorbing it before being 
applied to neurons. Neurons under this condition were not distinguishable from 
those incubated with the vehicle supplemented medium (figures 38C & D). 
Taking in consideration the previous experiment’s results and the possible 
neurotrophic effect of HRP-3, it was interesting to test the ability of HRP-3 to 
rescue neurons kept under nutrient deficient conditions. In the preliminary trials to 
configure this effect cells were cultured in complete N2 medium. Culture medium 
was daily exchanged with fresh medium which was either complete N2 medium, 
His-tagged HRP-3 supplemented N2 medium (100 ng/ml) or β-gal supplemented 
N2 medium (100 ng/ml). As an additional control for comparison, neurons in some 
wells were kept under unchanged complete N2 medium for the whole period of the 
experiment. Under these conditions only a little difference between the test protein 
and the different controls (β-gal supplemented or un-supplemented medium) was 
obtained probably due to the nutrient-rich medium used (complete N2). To get a 
clearer difference, a nutrient-free Dulbecco’s Modified Eagle Medium (DMEM, 
GIBCO) with neither serum nor growth factors was used as the basal medium 
(negative control). Plain DMEM was supplemented either with 100 ng/ml of affinity 
purified recombinant His-tagged HRP-3, 100 ng/ml of affinity purified recombinant 
β-gal or 5% FCS. Having the experiment done in this way resulted in significant 
differences between HRP-3 treated cells on one hand and β-gal treated or 
nutrients free medium treated cells on the other hand regarding neurons survival 
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and consequently integrity as well as the degree of complexity of neurite network. 
As expected, keeping neurons under nutrient-free medium resulted in 
degeneration and loss of neurite network over time and finally cell death within 3-4 
days (figure 39D). Surprisingly, neurons kept under HRP-3 as the only supplement 
in culture medium (figure 39A) looked as healthy as those under 5% FCS 
supplemented DMEM during the whole period of experiment (figure 39B).  
Figure 39: Exogenously-supplemented HRP-3 rescued mouse primary cortical 
neurons cultured under supplement-free conditions. Primary cortical neurons were 
seeded on PDL coated glass coverslips in complete NBM medium. One day later cells 
A: HRP-3 His, 100ng/ml
C: β-gal, 100ng/ml
B: 5% FCS 
D: Plain DMEM
Viability of primary cortical neurons under different supplements
0
5000
10000
15000
20000
25000
30000
0 2 4 6 8 10
time in hrs
flu
o
re
sc
en
ce
HRP-3
0%FCS
5%FCS
E
Results 
93
were thoroughly washed and incubated in supplement-free DMEM or DMEM 
supplemented with 100 ng/ml HRP-3, 100 ng/ml β-gal or 5% FCS. After three days of 
treatment cells were fixed and non-specifically stained using crystal violet. Pictures taken 
using light microscopy demonstrated the ability of recombinant HRP-3 to rescue primary 
cortical neurons (A). Neither another recombinant protein similarly purified from bacterial 
culture (C) nor DMEM medium alone (D) were able to rescue neurons from death. FCS 
supplemented DMEM was used as a positive control (B). E represents a quantitative 
estimation of the survival promoting effect of HRP-3 on cortical neurons compared to the 
other supplements using Alamar blue®. Bars are 50 µm. 
Unlike HRP-3, The presence of a control protein, like β-gal, purified after bacterial 
expression using the same protocol was unable to protect the neurons from cell 
death when used under the same conditions (figure 39C). Quantitative estimation 
of this effect was achieved using colorimetric Alamar blue® proliferation assay 
three days after keeping neurons under the different conditions. Measuring the 
fluorescence of the reduced form of the added dye (which is in a direct relationship 
with the cell viability) showed that neurons under HRP-3-supplemented medium 
were surviving better compared to those under no supplement (figure 39E). The 
results of the quantitative estimation were reproducible when the experiment was 
repeated (see supplementary data, figure S 5). These data together with the data 
obtained from depleting the medium from secreted HRP-3 suggested that HRP-3 
either secreted by the neurons themselves or artificially added to their 
supernatants exerted a neurotrophic effect on mouse primary cortical neurons. 
These experiments point to an important role played by HRP-3 in neuronal cell 
survival.  
II.2.2 Role of HRP-3 in neuritogenesis 
II.2.2.1 Effect of soluble HRP-3 on neuritogenesis 
After detecting a role for HRP-3 in supporting neuronal cell survival, it was 
important to determine whether this growth factor in addition to its survival 
promoting effect also has an influence on neuritogenesis. To answer this question, 
the protein in its soluble form was applied to neuron supernatant. For this purpose 
neurons seeded in complete NBM culture medium were supplemented with 1.5 
µg/ml of either affinity purified recombinant HRP-3 or β-gal. After 48 hrs, neurons 
were fixed and immunostained against the neuronal marker β-III-tubulin to label 
neuronal processes. Using fluorescence microscopy, pictures were taken for 
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neurons under both conditions. The length of the longest neurite arising from 
randomly chosen β-III-tubulin positive neurons was measured and the number of 
processes (branches) arising from these cells were counted. Blind analysis of the 
data obtained from both conditions showed that the addition of HRP-3 in its 
soluble form to the culture medium did not result in a statistically significant 
enhancement neither in the mean neurite length nor in the number of branches 
produced by these neurons when compared to those produced by neurons treated 
by adding β-gal (figure 40). 
Figure 40: Soluble HRP-3 did not show a neurite outgrowth promoting effect on 
cultured primary cortical neurons.
 Primary cortical neurons were seeded on PDL coated 
glass coverslips in complete NBM medium. The complete growth medium was 
supplemented with recombinant HRP-3 or β-gal as a control protein (1.5µg/ml). After 48 
hours cells were fixed and immunostained against β-III-tubulin. Random pictures were 
taken from each condition under a fluorescence microscope. The neurite length (A) and 
number of branches arising from β-III-tubulin positive neurons (B) were analyzed 
independently. HRP-3 was unable to induce any significant increase regarding both 
parameters when compared to the control protein. n = 200. 
II.2.2.2 Effect of substrate-bound HRP-3 on neuritogenesis
  
As HRP-3 in its soluble form proved not to play a role in neuritogenesis, it was 
important to exclude the possibility that it may bind the substrate and exert other 
effects. It was shown before that some molecules like HB-GAM or 
chondroitin/dermatan sulfate were able to promote neurite outgrowth under 
conditions when they were coated on a cell culture dish surface but not when they 
were used in soluble form (Rauvala, et al., 1994; Kinnunen, et al., 1996; Raulo, et 
al., 2005;  Li, et al., 2007). To test whether this case would apply also for HRP-3, 
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two questions were investigated. The first question was to know if HRP-3 helped 
the cells at all to adhere to an unfavourable substrate coated only with HRP-3. The 
second question was to find out the consequences of this adherence if it exists at 
all. To get an answer for these questions, primary mouse cortical neurons were 
seeded onto an unfavourable substrate for cells, non adhesive sterile bacterial 
plates. These plates do not provide an appropriate surface for cell adhesion and 
cell growth, resulting in the inability of neurons to start differentiation due to the 
lack of a supporting substrate. Before seeding, plates were pre-treated for 1 hr 
with the purified recombinant His-tagged proteins HRP-3, HDGF or β-gal (10 
µg/ml). The amount of bound proteins was estimated using an ELISA based 
enzymatic assay (supplementary data, figure S 6). Equal numbers of freshly 
prepared neurons were seeded on the different substrates after being washed and 
incubated in complete NBM. A few hours after seeding cells showed nearly the 
same number of neurons  adhering on the different protein coats. After 48 hrs on 
the bacterial plates, neurons were fixed and stained using crystal violet.  
Figure 41: Surface-immobilized HRP-3 promoted neurite outgrowth of primary 
cortical neurons seeded on bacterial plates. Freshly prepared primary cortical neurons 
C: β-gal
B: HDGF A: HRP-3 
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were seeded on bacterial plates pre-coated for 1 hr at 37°C with 10 µg/ml of affinity 
purified recombinant His-tagged HRP-3, HDGF or β-gal. Morphological examination 
initially revealed a similar amount of cells attached to the different coated culture 
substrates. Only on HRP-3 coated plates a substantial amount of cells started to 
differentiate compared to HDGF or β-gal (A-C). Quantitative analysis of cells producing 
neurites longer than their cell bodies underlined the neurite outgrowth promoting effect of 
HRP-3 on cultured primary cortical neurons. Bars in A, B, C are 100 µm.  
Plates were examined under transmitted light microscope for morphological 
differences of neurons on the different substrates. It was found that the presence 
of any of the three proteins as a substrates was enough to allow the adherence of 
nearly the same number of cells in all conditions. But interestingly, only in case of 
HRP-3 matrix a significant number of neurons was able to sprout and began to 
produce neurites (figure 41A). On the other hand, neurons that were seeded on 
HDGF coat were not distinguishable from those on the control protein coat (β-gal). 
In both cases (HDGF and β-gal coats) very few cells were able to spread their 
processes and differentiate (figures 41B & C). Statistically, about 100 randomly 
chosen cells in different shots from each condition were analyzed concerning the 
production of at least a single cell process that was equal to or longer than the cell 
body. A highly significant increase in the number of differentiating cells was 
observed when HRP-3 was used as a coat (4-time increase) compared to HDGF 
or β-gal coats (figure 41D). An effect that may be explained by a facilitated 
penetration of the growing processes only on HRP-3 matrix. 
To compare the proteins effect on neurons, two days after seeding on the protein-
coated PDL-coated coverslips, neurons were fixed and immunostained against β-
III-tubulin to visualize their morphology. Using fluorescence microscopy more than 
200 positively stained cells from each condition were randomly chosen, 
photographed and analysed. Analysis parameters were the length of the longest 
neurite arising from neurons and the number of neurites arising from each neuron. 
The analysis revealed that HRP-3 as an extracellular matrix exerted a significantly 
stronger neurite outgrowth promoting effect compared to the other coats. Data 
showed a highly significant increase in the mean length of the processes produced 
by the neurons seeded on HRP-3 coat as well as in the number of neurites 
produced by these cell (figure 42A & B). On the other hand, neurons seeded on 
HDGF and β-gal coats did not show significant differences regarding both 
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parameters (mean length of longest neurite and number of produced neurites per 
neuron) when compared to each other or to neurons seeded on PDL coated 
coverslips.  
Figure 42: Surface-immobilized HRP-3 promoted neuritic outgrowth and cell 
sprouting of primary cortical neurons. Mouse primary cortical neurons were seeded on 
PDL-coated glass coverslips coated with His-tagged HRP-3, His-tagged HDGF, His-
tagged β-gal. After 48 hours neurons were fixed and immunostained against a neuronal 
marker (β-III-tubulin). Random pictures were taken for each condition under a 
fluorescence microscope. The mean neurite length (A) and number of neurites arising from 
β-III-tubulin positive neurons (B) were analyzed independently. HRP-3 as a coat increased 
the mean neurite length as well as the number of neurites arising from neurons when 
compared to other substrates. Pre-incubating the HRP-3 coated coverslip with specific 
antiHRP-3 antibodies before seeding neurons on them was able to block the positive 
effects of this protein regarding the previously mentioned morphological characters (C + 
D). Number of cells examined per condition ≈200; **p<0.0001 
Although the amount of HDGF adhered to glass was significantly higher than the 
amount of adhered HRP-3, the neurite outgrowth on the latter protein coat was 
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significantly higher. This indicated that the neurite outgrowth promoting effect of 
HRP-3 was a specific effect for this protein when used as an extracellular matrix 
and could not be related to an improved adhesion to the substrate. This effect was 
a specific reproducible effect (see supplementary data S 6) not achieved even by 
the closely related family member HDGF.  
As a further control for the specificity of this effect, HRP-3 coated coverslips were 
blocked with a specific antiHRP-3 antibody before using them as a substrate for 
seeding cortical neurons. Comparing the mean neurite length produced by these 
neurons with the values obtained from neurons seeded on unblocked HRP-3 coat 
as well as β-gal coat demonstrated that the antibody blocking of the protein was 
able to completely inhibit the positive effect of HRP-3 on neuritogenesis (Figure 
42C & D). 
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5. Discussion 
5.1 HRP-3 expression in vivo and in vitro 
The family of Hepatoma-Derived Growth Factor related proteins comprises six 
members: HDGF, HDGF related protein -1 to 4 and lens epithelial-derived growth 
factor (LEDGF) all of which show homology in the N-terminal 98 amino acids 
(Nakamura, et al., 1994; Izumoto, et al., 1997; Ikegame, et al., 1999; Ge, et al., 
1998). Whereas HDGF is expressed in a wide variety of tissues, the expression of 
HRP-3 is restricted to the nervous tissue. Previous data indicated that both HDGF 
and HRP-3 are expressed by differentiated neurons with different expression 
patterns (Abouzied, et al., 2005). Western blot analysis of protein extracts of 
different brain regions demonstrated a rather ubiquitous expression of HDGF 
family members in different brain regions. HDGF is almost evenly distributed 
(Abouzied, et al., 2005; Zhou, et al., 2004) whereas HRP-3 expression level varies 
between the different brain regions (El-Tahir, et al., 2006). On the cellular level 
within the rodent brain, HRP-3 showed a more restricted expression when 
compared to HDGF. Purkinje cells in the cerebellum and neurons within the 
subiculum and cornu ammonis of the hippocampus were strongly HRP-3 positive 
whereas cerebellar granular cells appeared to be HRP-3 negative. The term 
granular cell is used to describe major cell populations of tiny neurons found in the 
cerebral cortex, olfactory bulb, granular layer of the cerebellum and the dentate 
gyrus. These cells are similar in being born late during development and 
expressing at least one common molecular marker, termed RU49. This has led to 
the suggestion that these diverse kinds of granule cells are of a common 
developmental origin (Yang, et al., 1996). Interestingly, granular cells having these 
common origin and characteristics show a weak expression signal of HRP-3 in the 
dentate gyrus and a lack of its expression in the cerebellum. Beside the correlation 
between HRP-3 expression and neuronal origin, the expression pattern of this 
protein in cerebellar neuron subtypes correlates also with the transmitter 
phenotype of these cells. Whereas granule cells are mostly glutamatergic 
(excitatory), almost all the other neurons in this brain structure use gamma amino 
butyric acid (GABA, inhibitory) as a neurotransmitter. In a similar way, Ptf1a, which 
was reported to be a lineage determinator in the cerebellum, is also exclusively 
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expressed by GABAergic neurons of the cerebellum (Hoshino, et al., 2005; Sellick, 
et al., 2004). At least in the cerebellum, HRP-3 might be a marker distinguishing 
between excitatory and inhibitory neuronal subpopulations. Except for neurons, 
very low amounts of HRP-3 could be detected in oligodendrocytes located in the 
brain stem and in glial cells. On the other hand, white matter tracts of the 
cerebellum contained no HRP-3 expressing cells. Studies on the place and time of 
birth of oligodendrocytes have demonstrated heterogeneity inside this cell 
population. It is possible that HRP-3 expression in oligodendrocytes is also 
dependent on their time of birth similar to the observations for granule neurons. 
Unlike oligodendrocytes which contained limited amounts of the protein, astrocytes 
in vivo could not be detected as HRP-3 positive cells. In contrast to the restricted 
expression of HRP-3, HDGF was found in neurons, astrocytes and 
oligodendroglia, in meningeal fibroblasts and ependymal cells. Immunostainings 
presented in this work indicate that both proteins, HDGF and HRP-3, were 
expressed in the majority of neurons in adult mouse brain. The overlapping 
expression pattern of HDGF and HRP-3 in neuronal cell nuclei in vivo and in vitro 
suggests different functions for both proteins that may include proliferation, 
differentiation as well as cell survival in addition to other unknown functions. On 
the other hand, the almost neuron-specific expression pattern of HRP-3 points to 
special function(s) for this protein that may include cell polarization and/or 
maintaining of the newly produced cell processes.  
HRP-3 expression during mouse embryogenesis showed that its expression is not 
only restricted to the developing brain but rather expressed in the whole nervous 
tissue. Interesting in its embryonic expression was the early detected signal within 
both the central and the peripheral nervous system. Directly after the three germ 
layers: ectoderm, mesoderm and endoderm have taken their positions within the 
embryo (gastrulation phase), neurulation begins and the neural tube is developed 
from the ectoderm. The stimulation of ectoderm to form the neural tube is 
mediated by some morphogenic factors released by the notochord, like e.g. sonic 
hedgehog (SHH) which regulates organogenesis and signals for the development 
of motor neurons (Echelard, et al., 1993). The rostral (apical) part of the formed 
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neural tube will form the brain with its divisions and the caudal (lower) part will 
form the spinal cord. 
HRP-3 was expressed in the whole neural tube which will form the nervous tissue 
early after its closure. However, HRP-3 expression levels varied strongly within the 
different parts of the neural tube. Looking from a transverse view, HRP-3 showed 
an intense signal in the oval bundle and motor neurons and a weaker signal in rest 
structures. These discriminate expression levels within the different structures of 
the neural tube point to possibly different roles or a variable degree of importance 
of the protein in the different cell types. Both sympathetic and dorsal root ganglia 
which originate from the migrating neural crest cells and are parts of the peripheral 
nervous system were expressing HRP-3 as well. Dorsal root ganglia consist of 
neuronal cells of different subtypes. The strongest HRP-3 signal in embryonic 
DRG neurons was detected in the cytoplasm as well as in the single processes 
arising from some neurons having a unipolar outline. In a differently looking 
neuronal cell population, only a weak nuclear signal for HRP-3 was detected. The 
strong signal for HRP-3 detected in E10.5 dorsal root ganglia remained through 
out all the later embryonic time points as developmental neurogenesis was still 
going on. Looking at the embryo from a sagittal view, it was detected that HRP-3 
was expressed also within the whole embryonic brain.  
Brain neocortex is composed mainly of neurons named the cortical neurons. 
These neurons are generated by the asymmetric division of progenitor cells within 
the ventricular zone next to the lateral ventricles. At first, progenitor cells divide 
asymmetrically, producing glial cells and neuronal cells (Noctor, et al., 2001). The 
fibres of the glial cells produced in the first divisions of the progenitor cells become 
radially oriented, spanning the thickness of the cortex from the ventricular zone to 
the outer pial surface. Some other progenitor cells begin to divide asymmetrically 
producing a postmitotic cell (a cortical neuron) and a daughter progenitor cell 
(Rakic, 1988). The radially oriented fibres of the glial cells function as a scaffold for 
the produced postmitotic neurons migrating outwards from the ventricular zone. 
The layered structure of the mature cerebral cortex is formed in an inside out 
manner as the newly born cells always migrate through the older layers during 
development (Brazel, et al., 2003; Jessell and Sanes, 2000) as shown in figure 43. 
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Figure 43: Generation and migration of neurons in the mammalian cerebral cortex.
Cortical neurons are generated in an inside-first, outside-last order. Neurons born within 
the ventricular zone at early stages migrate to the deepest layers of the cortical plate. 
Neurons generated at later stages migrate past the earlier-generated neurons to form the 
more superficial layers of the cortex.  
HRP-3 showed a widespread and early expression in the murine developing 
cerebral cortex cells which implies a possible role for this protein in developmental 
patterning and neurogenesis. From embryonic stages to the adulthood, HRP-3 
showed dynamic variations in the subcellular localization as well as the number of 
cells expressing the protein. During the prenatal development of the mouse brain 
cortex, a huge number of homogenously distributed neurons expressed HRP-3. 
During this time, cortex was still developing and neurons were migrating along 
their way to their final destinies so that it is difficult to recognize the layered 
structure of the neocortex. On the other hand, postnatal and adult mouse brain 
neocortex showed a well-defined, layered structure. Directly after birth, the number 
of cells expressing HRP-3 in the neocortex seemed to be down regulated. In 
addition to that, these HRP-3 positive neurons were not homogenously distributed 
all over the neocortex like in embryonic stages, rather they were enriched in 
certain cortical layers. For example, layers I, IV and V showed the lowest number 
of HRP-3 positive neurons whereas layers II, III and VI were rich in HRP-3 positive 
neurons (according to the layers numbers mentioned in the introduction and 
results).  
Another major difference between the developing and mature mouse brain was 
the subcellular localization of the protein within neurons. Whereas in the 
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embryonic brain mainly an extranuclear signal was detected in the developing 
cells, this signal gradually disappeared leaving almost only a nuclear signal in the 
well differentiated adult cortical neurons. 
There are some proteins that are expressed, similar to HRP-3, in the early 
embryonic stage like fibroblast growth factors (FGFs) and heparin binding growth 
associated molecule (HB-GAM). Both FGFs and HB-GAM share some characters 
with the closely related family member HDGF, as they are heparin-binding proteins 
that exert mitogenic effect on many cell types and are also actively secreted 
proteins (Asahina et al., 2002; Burgess and Maciag, 1989). FGFs participate in 
many developmental, plasticity and repair processes including neurogenesis, cell 
survival, axonal growth, neuroprotection, learning and memory and are expressed 
in early embryonic stages (Reuss and von Bohlen und Halbach, 2003). In a similar 
way, HB-GAM is a protein that is strongly and widely expressed during embryonic 
and early postnatal stages and fades in adult rat brain (Rauvala, et al., 1994; 
Rauvala, et al., 1989).  
The localization change of HRP-3 signal observed in tissue could also be detected 
in cultured primary neurons. In vitro, cultured mouse embryonic DRG (sensory) 
neurons showed an extranuclear expression signal for HRP-3 in young neurons 
which decreased by aging making place for the increasing nuclear HRP-3 signal in 
the mature sensory neurons. However both HRP-3 and HDGF were expressed in 
cortical neurons nuclei, only HRP-3 showed an additional and prominent 
expression signal in neurites of in vitro cultured mouse cortical neurons which was 
similar to that observed for cultured rat cortical neurons (Abouzied, et al., 2004).
As the expression pattern of HDGF in mouse cortical neurons remained 
unchanged over time, HRP-3 showed a dynamic change regarding its expression 
pattern. Similar to the change in its localization observed in DRG neurons, young 
immature cortical neurons were showing a predominating cytoplasmic signal that 
was fading out by getting older. In the same time, a predominating nuclear signal 
was observed in older mature neurons. This developmental, stage-dependent 
change in localization was not only observed in primary neurons, but also in an 
inducible cell model, B35 neuroblastoma cells. These cells were expressing no 
HRP-3 during their proliferating stages but shortly after being induced to 
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differentiate, B35 cells showed a cytoplasmic HRP-3 expression signal. 
Interestingly, mature differentiated B35 cells were showing a strong expression 
signal for HRP-3 within their nuclei. Such a switch between cytoplasmic and 
nuclear pattern of expression may be explained by a possible need for a high level 
of HRP-3 in the cytoplasm of immature neuronal cells to promote differentiation 
and consequently reaching structural maturity. As soon as the neuronal cell has 
acquired its final mature structure and the neurite network is already established, 
there should be -according to this postulation- no need for HRP-3 in the 
cytoplasm. Thus, it can be speculated that the presence of HRP-3 within the cell 
nucleus could be a character of structural maturity in neurons expressing it. These 
findings regarding the dynamic change of the localization of HRP-3 between 
developing and mature cortical and sensory neurons in vivo as well as in vitro spot 
more light on the importance of this protein during the maturation steps in a 
neuron’s life. This developmentally regulated expression pattern was also reported 
for another family member, LEDGF. LEDGF is expressed in the eye as a nuclear 
protein in the well-differentiated cells of ciliary body, iris and the photoreceptor 
cells of retina. On the other hand, it is expressed as a cytosolic protein in 
differentiating lens fibre cells and superficial corneal epithelial cells. In other words, 
the differentiation of lens epithelial cells is associated with a progressive change 
towards a nuclear LEDGF signal (Kubo, et al., 2003).  
This hypothesis regarding the connection between the developmental stage and 
the cellular localization of HRP-3 signal can also be utilized to explain the 
extranuclear HRP-3 expression signal noticed in some areas of adult mouse brain. 
HRP-3 was detected as a cytosolic protein in areas like hippocampus, a region 
that is important for learning and memory (Van Praag, et al., 2002; Altman & Das, 
1965; Kaplan & Hinds, 1977; Kuhn, et al., 1996; Kornack & Rakic, 1999; Eriksson, 
et al., 1998). Also in cerebral cortex, Purkinje cell layer and the ventral horns of the 
adult mouse spinal cord HRP-3 was detected as a cytosolic protein. These 
mentioned areas in addition to the lateral subventricular and subgranular zones of 
the dentate gyrus (hippocampus), optic nerve, olfactory bulb, caudate nucleus, 
spinal cord and many brain stem and forebrain structures have been shown to 
contain mitotic cells undergoing adult neurogenesis (Altman & Das, 1965; Altman 
& Das, 1966; Altman, 1969a & 1969b; Abrous, et al., 2005; Luzzati, et al., 2006; 
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Gage, 2007). To date, the function of this cell genesis in the normal intact adult 
brain and spinal cord is not known but researchers suggest that some of the new 
cells can become neuronal or glial cells (Horner, et al., 2000). Some others 
suggest that the newly born, young neurons provide a greater degree of plasticity 
to the mature brain (Biebel, et al., 2000) or function to replace dying neurons as a 
latent mechanism for brain repair (Mitchell, et al., 2004). Detecting an extranuclear 
HRP-3 signal which refers mostly to a differentiating neuron within the areas 
where adult neurogenesis is expected makes it reasonable to conclude a possible 
function(s) for this protein during cell maturation or in cell regeneration and repair 
processes. On the other hand its expression in the adult PNS axons (adult mouse 
sciatic nerve) may suggest a role for HRP-3 in impulse conduction or in 
maintaining axonal integrity. 
5.2 Intracellular roles of HRP-3  
As mentioned before, HRP-3 was expressed in primary cortical neurons early after 
seeding. An important finding was that the expression pattern of HRP-3 at this 
time point reflected an uneven, polarized distribution within the cytoplasm where 
its expression showed a local increase at the point where neuritogenesis would 
begin. At the areas of beginning neuritogenesis, tubulin units polymerize to form a 
strong core of microtubules. This polymerization regulates the events of cellular 
polarity and initiation of differentiation through sets of microtubules stabilizing and 
destabilizing proteins (Dehmelt & Halpain, 2004). Microtubules together with 
neurofilaments and actin constitute the elements of a neuron cytoskeleton 
(Hughes, 1953; Nakai, 1956). The local (polarized) increase in HRP-3 expression 
at the point where a process starts to elongate within the cytoplasm of very young 
neurons may point to the involvement of HRP-3 in neuron polarization process and 
a possible interaction with cytoskeleton element(s).  
Both actin filaments and microtubules are necessary for axon extension. Actin 
filament polymerization drives the forward-extension of both filopodia and 
lamellipodia. Additionally, actin network of the cell cortex tends to resist gross 
shape changes. Consequently, actin-destabilizing drugs facilitate neurite outgrowth 
(Edson, et al., 1993; Knowles, et al., 1994; Bradke and Dotti, 1999). On the other 
hand, microtubule polymerization and transport of organelles mediate the 
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engorgement process and provide the core for a growing cell process. 
Microtubules must be dynamically unstable to allow growth cone formation. 
Therefore, both microtubule-stabilizing and -destabilizing poisons (drugs) can 
inhibit neurite outgrowth (Baas and Ahmad, 1993; Rochlin, et al., 1996; Liao, et al., 
1995; Tanaka, et al., 1995; Jordan and Wilson, 1998; Kaverina, et al., 1998; 
Waterman-Storer and Salmon, 1999; Goode, et al., 2000; Kabir, et al., 2001).  
The facts of stabilization and destabilization of the cytoskeleton elements could be  
successfully employed to explain the inability of cultured primary neurons to 
extend neurites, and fibroblasts and trophoblasts to loose their stress fibres when 
the expression of palladin or synapsin II was attenuated (Boukhelifa, et al., 2001; 
Ferreira, et al., 1994; Parast and Otey, 2000). Both proteins were identified as 
cytoskeleton-associated proteins. Whereas palladin was shown to play a possible 
role in establishing the polarized neuronal morphology and to maintain the integrity 
of organized cytoskeleton (Boukhelifa, et al., 2001; Parast and Otey, 2000), 
synapsin II regulates neurotransmitter release and plays a role in the formation of 
nerve terminals (Chilcote, et al., 1994).  
An important finding was the close and direct relation between the cellular 
expression level of HRP-3 and neurite length. A reduction in the endogenous 
HRP-3 level within cortical neurons resulted in a significant reduction in the length 
of the produced neurite whereas increasing cellular level of HRP-3 resulted in a 
significant increase in neurite length.  
Wild type HRP-3 transfected into cells was shown before to localize to cell nuclei  
(Ikegame, et al., 1999). It was also found that this nuclear translocation of wild 
type HRP-3 after transfection was related to the nuclear localising signals, NLSs 
and more precisely to NLS2 rather than NLS1 in a similar way to HDGF 
(Nakamura, et al., 1994; Ikegame, et al., 1999; El-Tahir, et al., 2009). The basic 
lysine residues of the nuclear localizing signal included in the carboxyl terminal 
(NLS2) were identified, for both HDGF and HRP-3, as a prerequisite for directing 
the protein into the nucleus.  
Although excluding HRP-3 from the nucleus did not hinder its neurite outgrowth 
promoting effect on the cells, excluding HDGF from cell nucleus was enough to 
block its effect as a mitogen for Vascular Smooth Muscle cells (VSM, Everett, et 
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al., 2001). In other words, the nuclear localizing signal in the amino terminus 
(NLS1) is the one involved in promoting the neuritogenesis however not important 
for nuclear localization. This can be explained by the fact that HRP-3 interacts with 
the microtubules through its HATH region (where NLS1 is located) not through its 
C-terminus (where NLS2 is located, El-tahir, et al., 2009).   
In brief, the direct relation between the cellular expression level of HRP-3 and 
neurite length in addition to the redistribution of HRP-3 from the cytoplasm to the 
nucleus during the maturation process strongly suggests a role for this protein 
during neuritogenesis. Recently, it has been reported that these neuritogenetic 
effects of HRP-3 are mediated through its interaction with tubulin dimers and 
assembled microtubules and its ability to promote the bundling of microtubules (El-
tahir, et al., 2009). 
5.3 Extracellular roles of HRP-3 
Other than the tissue expression pattern and the subcellular localization in the 
adult mouse brain (Abouzied, et al., 2004; El-Tahir, et al., 2006), not much data 
regarding the functions and importance of HRP-3, were known up to now. In this 
study it was possible to uncover some of its extracellular roles in primary mouse 
cortical neurons. Primary rodent cortical neurons were shown before to have a 
high expression level of HRP-3 (Abouzied, et al., 2004; El-Tahir, et al., 2009). 
They have been long ago utilized as a tool for studying the effect of different 
proteins and growth factors like neurotrophins, HB-GAM, and also HDGF (Yuen, et 
al., 1996; Raulo, et al., 1992; Kinnunen, et al., 1996; Zhou, et al., 2004) as they 
are very sensitive to the absence of nutrients and growth factors. They may show 
survival difficulties in the absence of many proliferating and/or differentiating 
factors that affect their survival (Oppenheim, 1996; deLapeyrier, 1997; Giehl, 
2001). Many proteins were shown to exert a neurotrophic effect on neurons like 
HMG1 (Zhou, et al., 2004), CNTF (Sendtner, et al., 1992 & 1994) and HB-GAM 
(Raulo, et al., 1992 & 1994). Among HDGF family members, LEDGF exerts 
survival and neuroprotective effects in addition to its established proliferative 
effects (Inomata, et al., 2003; Matsui, et al., 2001; Singh, et al., 1999 & 2000; 
Nakamura, et al., 2000). Marubuchi and Zhou and their co-workers have detected 
the release of HDGF in the cultured neurons supernatants and proved its 
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importance for neuronal cell survival as a neurotrophic factor (Marubuchi, et al., 
2006; Zhou, et al., 2004). Interestingly, HRP-3 was found to be released in the 
supernatants of cultured mouse primary cortical neuron although it lacks a signal 
peptide-like hydrophobic region within its amino acid sequence. It was previously 
concluded that HDGF and CNTF as well as acidic and basic FGFs which all lack a 
signal peptide-like hydrophobic region (Burgess and Maciag, 1989) are secreted 
via non classical secretory pathways (Zhou, et al., 2004; Marubuchi, et al., 2006). 
Although the secretion mechanism is still to be investigated, HRP-3 may be 
secreted also via non classical secretory pathway(s) that is similar to or different 
from HDGF’s pathway. Interestingly, HRP-3, either released by the neurons 
themselves or exogenously-applied as a supplement to the culture medium, 
specifically functioned as a survival-promoting and a neurotrophic factor for 
cortical neurons. However, the mechanisms behind the effects of soluble HRP-3 
on cortical neurons remain to be elucidated. Neurotrophic, survival-promoting, and 
neurite outgrowth promoting effects of some proteins like HDGF, CNTF and BDNF 
on rodents hippocampal or motor neurons were also achievable by the 
exogenously-applied, affinity-purified recombinant proteins (Zhou, et al., 2004; 
Marubuchi, et al., 2006; Arakawa, et al., 1990; Sendtner, et al., 1990 & 1992; 
Oppenheim, et al., 1991 & 1992; Yan, et al., 1992; Henderson, et al., 1993; 
Koliatsos, et al., 1993; Mitsumoto, et al., 1994). Recent lines of evidence indicate 
that some neurotrophic factors are involved in synaptic modification, 
neurotransmitter release, and long term potentiation (Black, 1999; Lu and Chow, 
1999; Chao, 2000; Poo, 2001; Yamada, et al., 2002). In addition, some 
neurotrophic factors like BDNF have been reported to modulate hippocampal 
plasticity and memory in cell and animal models (Jankowsky and Patterson, 1999; 
Thoenen, 2000; Egan, et al., 2003). Furthermore, literature on the subject of 
neurotrophic factors and their roles in neurodegenerative diseases, including 
Alzheimer's and Parkinson's diseases, is expanding prodigiously (Siegel and 
Chauhan, 2000). Hence HRP-3 is presented here as a novel neurotrophic factor, it 
is not impossible to find in the near future a role for HRP-3 in healing, delaying or 
preventing at least one of the neurodegenerative diseases. 
On the other hand, HRP-3 used as an extracellular matrix for cell growth provided 
a proper substrate for neuronal cell adhesion as well as differentiation. In its 
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substrate bound form, HRP-3 was able specifically and significantly to promote 
neurite outgrowth and to induce the production of multiple neurites per cell. Using 
other proteins including HDGF as substrates allowed only cell adhesion but not 
any further effects on length or number of neurites. The decreased neurite length 
of neurons seeded on blocked HRP-3 coats provided an additional confirmation for 
the specificity of substrate-bound HRP-3 effects. Since the adhesiveness of 
neurons to surface structure is a necessary but not a sufficient condition for neurite 
outgrowth, these effects of HRP-3 on neurite outgrowth and cell sprouting can not 
be regarded only to improved adherence of neurons to the protein coated culture 
matrix.  
Neurite outgrowth promoting effect of substrate bound proteins was previously 
reported for some proteins like HB-GAM, amphoterin, fibronectin and 
Chondroitin/Dermatan sulphate when they were used as substrates for neuronal 
cell growth (Raulo, et al., 1992; Hori, et al., 1995; Li, et al., 2007). For these 
proteins also, it was not the improved adhesiveness of cells to the substrate that 
caused neurite outgrowth. It was shown before that highly adhesive surfaces may 
fail to promote neurite outgrowth. This was proved by Rauvala who showed that 
both fibronectin and concanavalin A had nearly the same adhesiveness properties 
but only cells on fibronectin were able to sprout and differentiate (Rauvala, 1984).  
Another protein that enhances neurite outgrowth is amphoterin which belongs to 
the high mobility group proteins (Parkkinen, et al., 1993). This protein exerts 
extracellular functions in the developing nervous and hematopoietic systems 
(Rauvala and Pihlaskari, 1987; Rauvala, et al., 1988; Merenmies, et al., 1991; 
Parkkinen, et al., 1993; Daston and Ratner, 1991; Daston and Ratner, 1994). Hori 
and co-workers showed that RAGE (receptor of advanced glycation end product) 
binds amphoterin and mediates neurite extension on amphoterin-coated 
substrates (Hori, et al., 1995). In fact, HRP-3 sequence lacks the HMG box that is 
conserved among HMG family proteins and is essential for the interaction with 
RAGE. This makes HRP-3 more likely to interact with a different receptor(s) to 
promote neurites outgrowth when used as an extracellular substrate. 
These in vitro findings suggest that for cortical neurons, HRP-3 plays many 
important roles: first, HRP-3 either secreted by neurons into their supernatant or 
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exogenously-applied to supplement their supernatant is of great importance for 
cell survival and integrity of neurites network and acts as a novel neurotrophic 
factor. Second, HRP-3 in its substrate-bound form promotes neurite outgrowth as 
well as sprouting of cortical neurons. These mentioned effects result in helping the 
neuronal cell to make connections to more cells both by keeping the integrity of 
the existing neurites network as well as by increasing the number and length of 
their cell-to-cell communication organs (neurites). All these functions reflect how 
important HRP-3 is during the life time of a neuron. Its role starts early in the 
young cells by promoting its differentiation and neuritogenesis. Later, when the 
neuronal cell matures and shows an established neurite network, HRP-3 remains 
as a very important factor in keeping the integrity of this established network of 
connections and hence, cell survival.  
5.4 HRP-3 expression in pathological conditions 
As HRP-3 was shown to be expressed in PNS (sciatic nerve) under normal 
conditions, it was interesting to find a correlation between the nerve damage and a 
modification in the level and distribution of HRP-3 signal. When a peripheral nerve 
is exposed to damage, the axonal end that is closer to the brain does not die but it 
undergoes a wallerian degeneration. After some time, the axon begins to heal and 
grow down the intact empty insulation cover (Mark and Greenberg, 1994). 
Because of the intrinsic reactive capacity of peripheral axons and the permissive 
environment provided by Schwann cells and the extracellular matrix, adult 
mammalian peripheral nerves are capable of regenerating and regaining gradual 
functional restoration (Fawcett and Keynes, 1990). Some growth factors like FGFs 
were reported to be up regulated in most DRG neurons as well as Schwann cells, 
satellite cells and macrophages following axotomy (Grothe, et al., 2001). Neuronal 
cells in the ganglion attached to a damaged nerve also react to nerve injury by a 
chromatolytic reaction. They show swelling of cell bodies, an eccentric nucleus 
position and dissolution of Nissl substance in addition to massive protein synthesis 
necessary for the regeneration steps (Lieberman, 1971). These morphological 
changes were observed in the damaged-nerve model (crushed sciatic nerve) and 
were accompanied by a dramatic change in the expression pattern of HRP-3. 
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Under damage conditions, the pre-existing nuclear HRP-3 signal was almost lost 
and only a structured cytoplasmic signal could be detected in ganglionic neurons.  
These observed changes in HRP-3 expression while the nerve goes through the 
healing phase led to the conclusion that an extranuclear expression of HRP-3 in 
stressed neurons may be a part of the nerve repair mechanism. In other words 
redistribution of HRP-3 in the cytoplasm may be related to the tendency of the 
cells to regain their ability to differentiate and compensate for the damaged fibres. 
As a result, they loose one of their maturity characters, namely the nuclear HRP-3 
signal. 
In another pathological condition, but in the CNS, HRP-3 expression was studied. 
In this case, medulloblastoma as a CNS tumour was examined for HRP-3 
expression. Medulloblastoma is one of the highly malignant primary brain tumours. 
This tumour originates in the cerebellum or brain stem possibly from cells of the 
external granular layer (Allen and Epstein, 1982). Under physiological conditions, 
this granular cell layer showed a very weak expression signal for HRP-3. Where 
the tumour developed within the cerebellar granular cell layer no increase in HRP-
3 expression level was detected. In vitro experiments using a cell line derived from 
this tumour type supported the in vivo data, as it showed that HRP-3 over 
expression within these cells was not sufficient to increase cell proliferation rate 
compared to the control.  
5.5 Perspectives  
In the next stages it will be of great importance to detect the receptor(s) 
responsible for the different roles identified for HRP-3 until now. Detecting such 
receptor(s) will possibly help in detecting more undiscovered roles for this protein. 
An additional line to investigate further roles for HRP-3 would be achieved if its 
gene could be successfully knocked out. By knocking out HRP-3 it would be 
possible to know how important HRP-3 is for the development of the nervous 
system and the whole animal. Also investigating the ability of HRP-3 supplements 
to rescue or protect susceptible neurons within animal models of 
neurodegenerative diseases would be an important and interesting step to confirm 
its neurotrophic effects in vivo. 
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6. Summary 
In this work, HRP-3 is presented as a hepatoma-derived growth factor family 
member that exhibits a unique expression pattern. In the first part of this work, 
HRP-3 expression is shown to be restricted to the nervous system from the very 
early stages in the embryonic life until the adulthood. Interestingly, HRP-3 is 
restricted to neurons and shows a developmental stage-dependent expression 
pattern in cortical and sensory neurons both in vivo and in primary culture models 
prepared from both cell types in vitro. HRP-3 is expressed in the extranuclear 
compartment in embryonic nervous tissue and almost restricted to the nuclear 
compartment in the adult mouse nervous tissue.  
The second part of this work focused on the possible intracellular and extracellular 
roles of HRP-3. It was possible to prove that the intracellular level of HRP-3 plays 
an important role in promoting neurite outgrowth and neuronal cell sprouting. 
Reducing the intracellular level of HRP-3 in one of the primary cell culture models 
using synthetic siRNAs against HRP-3 resulted in negative effects on neuronal cell 
differentiation. This effect was reversed by over-expressing HRP-3 within an 
inducible neuronal cell model. The nuclear localising signal located in the carboxy 
terminus (NLS2) of HRP-3 is the one responsible for its nuclear localisation while 
the nuclear localising signal located in its amino terminus (NLS1) is the one 
responsible for its neurite outgrowth promoting effect. These effects of HRP-3 are 
mediated through its interaction with microtubules as shown in studies based 
partially on this work.  
The results also show that extracellular HRP-3 has a positive effect on the 
differentiation of primary cortical neurons. It is also released by cortical neurons 
themselves to promote their own survival and differentiation and can protect 
primary cortical neurons cultured in stressful, supplement-free conditions.  
Together, the results of this work point to interesting roles of HRP-3 during the 
development of the nervous system. This work can be the basis for further 
interesting studies that may include an explanation of the molecular mechanisms 
through which it exerts its roles like detecting the receptor through which HRP-3 
signals and the signalling transduction pathways that result in these effects.    
Zusammenfassung 
113
7. Zusammenfassung 
Die vorgestellte Arbeit befasst sich mit HRP-3 einem Mitglied der Hepatoma-
derived growth factor Proteinfamilie (HDGF, LEDGF und HRP1-4). Im ersten Teil 
wird die differentielle Regulation der HRP-3-Expression in der Maus als 
Modellorganismus näher beschrieben. Dabei zeigt sich, dass die HRP-3-
Expression weitestgehend auf Neurone beschränkt ist. Dabei sind 
interessanterweise bestimmte Neuronenpopulationen – Körnerzellen des 
Kleinhirns und Hypothalamus – von der Expression ausgenommen. Darüber 
hinaus wird in der Arbeit eine interessante Veränderung in der intrazellulären 
Lokalisation von HRP-3 von einer extranukleären Lokalisation im embryonalen 
Nervensystem zu einer nahezu vollständig nukleären in der adulten Maus 
beschrieben. In zwei Zellkulturmodellen von primären Neuronen kann diese 
Veränderung der HRP-3-Lokalisation in Vitro nachvollzogen werden. 
Der zweite Teil der Arbeit ist auf mögliche Funktionen von HRP-3 fokussiert. Da 
die Mitglieder der HDGF-Proteinfamilie auch sezerniert werden, wird dabei 
zunächst zwischen Funktionen von intrazellulärem und extrazellulärem HRP-3 
unterschieden. Durch die Reduktion der HRP-3-Menge mit Hilfe von kleinen 
synthetischen RNAs konnte in einem der primären Neuronenmodelle eine 
Beteiligung von HRP-3 an der Differenzierung der Nervenzellen in Kultur 
nachgewiesen werden. Eine Überexpression in einem induzierbaren neuronalen 
Differenzierungsmodell bestätigte diese Beobachtung. In Studien, die teilweise 
über diese Arbeit hinausgehen, konnte gezeigt werden, dass die Interaktion von 
HRP-3 mit Komponenten des Zytoskeletts wichtig für diese Funktion von 
intrazellulärem HRP-3 ist. 
Weiterhin zeigen die Ergebnisse dieser Arbeit, dass extrazelluläres HRP-3 
ebenfalls einen positiven Einfluss auf die Differenzierung von Neuronen hat. 
Darüber hinaus hat das Protein eine starke protektive Wirkung auf diese Zellen 
unter Kulturbedingungen die suboptimal sind und daher eine Art neuronale 
Stressbedingung darstellen. 
Insgesamt deuten die Ergebnisse dieser Arbeit auf eine interessante Rolle von 
HRP-3 während der Entwicklung des Nervensystems hin und bilden die Grundlage 
für weitere Studien, die die Aufklärung der genauen Mechanismen dieser 
Wirkungen, wie zum Beispiel mögliche HRP-3-Rezeptoren und Signal-
transduktionswege, zum Ziel haben werden. 
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9. Appendix  
9.1 Supplementary data 
9.1.1 HRP-3 expression in mouse E13.5 neural tube 
Figure S 1: HRP-3 expression in E 13.5 neural tube visualized by a 
fluorescently labelled secondary antibody. Coronal floating sections showing 
the neural tube were prepared from PFA-fixed E13.5 embryo immersed in ice cold 
PBS using Leica vibratome. Section was stained against HRP-3 using a 
fluorescently labelled secondary antibody. The whole staining steps were 
performed in perforated-bottom small cups placed in the wells of a tissue culture 
24-well plate. The stained section was examined under confocal laser scan 
microscope and the strongest signal was detected in the oval bundles (OB), in the 
area of motor neuron cell bodies (MNC), the floor plate (FP) and the ependymal 
cell layer (EL) surrounding the central canal (CC). A weaker signal was detected in 
the spinal ganglia (SG), anterior and posterior nerve roots (ANR and PNR 
respectively) and the remaining parts of the neural tube. Roof plate (RP), in 
contrast to the floor plate did not show a significant HRP-3 expression signal. This 
pattern is similar to that obtained by the avidin-biotin complex method displayed in 
the results but it does not include the sympathetic ganglia and spinal nerves 
showing only the neural tube. Red dotted line represents the central canal outline. 
Bar is 50 µm.  
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9.1.2 Vector-based HRP-3siRNA reduced endogenous level of HRP-3 in 
primary cortical neurons 
Figure S2: Vector-based HRP-3siRNAs reduced HRP-3 level in primary 
cortical neurons. One day old primary cortical neurons were transfected with 
vector based HRP-3siRNA or control vector (pSilencer) together with GFPC3 (in 
10:1 ratio) using MaTRa magnetic beads. Two days after transfection cells were 
fixed and immunostained against HRP-3 (red channel), GFP (green channel) and 
β-III-tubulin (blue channel). A remarkable reduction of HRP-3 level in HRP-3siRNA 
targeted neurons was observed (arrows in C-H) compared to the adjacent 
untargeted or the control siRNA targeted neurons (arrows in I-K). Bars are 20 µm. 
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9.1.3 The effect of reducing the endogenous HRP-3 level on 
neuritogenesis 
Figure S 3: Reducing endogenous HRP-3 level resulted in shorter neurites 
and less cell sprouting. Primary cortical neurons were transfected with different 
HRP-3siRNAs directly before seeding using Lipofectamin 2000 as mentioned 
under methods. A scramble (ctrl siRNA) was used as a negative control. In the first 
experiment (A1 & B1) the control was Cy3 labelled siRNA and in the second and 
third experiments (A2, A3 & B2) it was unlabelled. Two days after transfection cells 
were fixed and immunostained against HRP-3 and β-III-tubulin to verify the identity 
of the transfected cells. More than 200 randomly chosen neurons were analysed 
from each condition in a blind way. Data analysis showed a reproducible and 
highly significant reduction in both the mean neurite length as well as the number 
of neurites arising from the cell body of HRP-3siRNA transfected neurons 
compared to control transfected neurons. The extent of reduction in neurite length 
was more obvious when only targeted neurons (detected by the Cy3 signal) were 
analysed as seen in A1 in which only neurons with a reduced endogenous HRP-3 
level were taken in consideration. In both cases, with labelled or unlabelled 
targeted cells, the experiments resulted in similar results every time. Bars 
represent the standard error and asterisks indicate a significant mean neurite 
length over HRP-3siRNA transfected neurons.  
0
5
10
15
20
25
30
ctrl siRNA1 siRNA2 siRNA3
m
e
a
n
 
le
n
gt
h 
in
 
µm
** 
A1 
Appendix 
139
0
10
20
30
40
50
60
ctrl siRNA1 siRNA2 siRNA3
m
e
a
n
 
le
n
gt
h 
in
 
µm
** 
A3 
Accumulation of number of branches arising from HRP-3siRNA 
transfected neurons
0
20
40
60
80
100
120
1 2 3 4 5 6 7 8 9 10 11
number of branches
pe
rc
e
n
ta
ge
ctrl
siRNA1
siRNA2
siRNA3
B1
0
10
20
30
40
50
60
ctrl siRNA1 siRNA2 siRNA3
m
ea
n
 
le
n
gt
h 
in
 
µm
** 
A2 
Appendix 
140
Accumulation of number of branches arising from HRP-3siRNA 
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9.1.4 Role of nuclear localization signals 1 & 2 in the neuritogenetic 
effect of HRP-3  
Figure S 4: NLS1 is responsible for the neurite outgrowth promoting effect of 
HRP-3 tested in B35 cells.
 B35 neuroblastoma cells were transfected with 
different NLS mutant constructs, wild type HRP-3 or the empty vector together with 
GFPC3 in a DNA ratio of 10 to 1 to detect the positively transfected cells under 
fluorescence microscope. Twenty four hours after transfection, differentiation was 
induced with 1 mM dBcAMP and cells were fixed and stained three days later. The 
length of the longest neurite arising from randomly chosen positively transfected 
cells in two independent experiments was estimated in a blinded assay. 
Performing the experiments under the same conditions resulted in the same 
tendency. In the first graph bars represent the standard error and asterisks 
indicate a significant mean over the control. 
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9.1.5 Neuron rescue by soluble HRP-3 
figure S 5: Soluble HRP-3 rescued mouse primary cortical neurons 
cultured under supplement-free conditions. Primary mouse cortical 
neurons were seeded into PDL-coated 48-well tissue culture plate in complete 
NBM. One day after seeding, neurons were thoroughly washed and incubated in 
supplement-free DMEM or DMEM supplemented with 100 ng/ml HRP-3, 100 ng/ml 
β-gal or 5 % FCS. Three days later, alamar blue was added to the culture medium 
according to manufacturer’s instructions and fluorescence was measured at 535 
nm excitation wave length and 595 emission wave length. The experiments 
showed similar results every time with minor differences related to culture 
conditions.   
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9.1.6 Determination of protein amount bound to glass surface 
Figure S 6: His-tagged HDGF bound PDL-coated glass coverslips more 
efficiently than his-tagged HRP-3 did but HRP-3 coat promoted neurite 
outgrowth stronger than HDGF coat. Different proteins (his-tagged HRP-3, his-
tagged HDGF, his-tagged β-gal or BSA) were used to coat PDL coated glass 
coverslips for 1 hr at 37°C. A colorimetric enzymat ic assay was used to estimate 
the amounts of bound protein in each case. The absorbance values showed that 
the amount of bound protein in case of HDGF was higher than the other tested 
proteins including HRP-3. However it did not exert any significant effects over the 
control concerning neurite outgrowth promoting. HRP-3 coat showed a medium 
absorbance value but its effects regarding neurite outgrowth promoting were 
extremely significant.   
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9.1.7 Effect of substrate bound HRP-3 on neuritogenesis 
Figure S 7: HRP-3 as an extracellular matrix promoted neurite outgrowth and 
branching of primary cortical neurons.
 Mouse primary cortical neurons were 
seeded on PDL-coated glass coverslips coated with histagged HRP-3, histagged 
HDGF, histagged β-gal as mentioned under methods. After 48 hours neurons 
were fixed and immunostained against a neuronal marker (β-III-tubulin). Random 
pictures from two different independent experiments were taken for each condition 
under a fluorescence microscope. The mean of neurite length (A1 & A2) and 
number of neurites arising from β-III-tubulin positive neurons (B) were analyzed 
independently. HRP-3 as a coat significantly increased the mean neurite length as 
well as the number of neurites arising from neurons in a reproducible manner 
when compared to the other substrates. 
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9.2 Vector maps 
9.2.1 pCDNA3 
9.2.3 pEGFP-C3 
pCDNA3
5.4 kb
Eco0109 
Stu I 
Dra III 
Eco0109 I
Mlu I 
MCS
BsrG I 
Age I
Eco47 III 
Nhe I 
SnaB I 
Ase I 
ApaL I 
Kan
Neo
HSV TK 
Poly A
pUC
ori
P
 CMV IE
EGFP
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Poly A
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P
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9.2.3 pBluescript  
9.2.4 pSilencer 3.0 H1 
Sca I, Tat I
Gsu l
Eam1105 
Eco31 I
Hind1 I
Bcg I
Ade I
Pdi I
Faq I
Sap I
AfIIII, Psc I, Xce
Cai I
Alo I
Pdm I
